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Aim:To test the interactive effects of the constructs of Modified Social Learning 
Theory (MSLT) in relation to predicting health behaviour in Type 2 
Diabetes.Methods: The study is mixed methods and employs an exploratory 
sequential design. Qualitative Phase: (N=12) Semi-structured interviews with adults 
with insulin-treated type 2 diabetes, explored how beliefs and values influence self-
management behaviour. Interim Phase: Thematic analysis allowed development of 
an adapted Health Value Measure.Quantitative phase: (N=107) Valid 
questionnaires measured Health Value, Health Locus of Control (HLC) and Self-
efficacy (SE). Health Value was measured pre and post diagnosis in order to 
compare any changes with time. Anxiety and depression was controlled for using the 
Hospital Anxiety and Depression(HAD) scale. Five subscales measured diabetes 
outcome behaviour: general diet, specific diet, exercise, blood sugar and foot care. 
Hierarchical Multiple Regression(HMR) analyses consisted of four blocks, including 
three two-way interaction terms and one three-way interaction term to test the 
interactive effects of the three-predictor variables on outcome behaviours. ANOVA’s 
were conducted in an effort to add support to HMR results. 
Results: The interviews suggest that people may hold terminal (beliefs about desired 
end states)/instrumental health values (beliefs about desired modes of action) pre-
diagnosis but these are mainly instrumental post-diagnosis in order to meet their new 
needs and maintain quality of life. The qualitative data also drew attention to the way 
in which LOC and SE beliefs impact on behaviour. Additionally, differing 
dimensions of various emergent themes highlight the demands Type 2 diabetes 
places on a person and how this influences beliefs and values.Interim phase results 
resulted in the new items being removed from the adapted health value measure prior 
to the quantitative data analysis, as item 5 was deemed problematic.Sensitivity 
analysis was carried out to increase the robustness of the quantitative findings due to 
removing 29 cases with missing data from Dataset 1. Dataset 1 includes 78 complete 
cases and Dataset 2 contains 107 cases, 29 of which had missing values and were 
replaced using regression imputation. HMRanalyses produced significant results that 
support MSLT when the three-way interaction variable was added to block 4. 
ANOVA results produced minimum support for MSLT.  
Conclusion: Support for MSLT has been found and can be used to inform 
interventions to change self-management behaviours of patients with poor 
diabetescontrol. Change in health value orientation post-diagnosis purports further 
investigation, as it is supported by qualitative results but not quantitative.
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1 Background To The Research 
1.1 Introduction 
The focus of this thesis is predicting health behaviour of Type 2 diabetes patients. In 
it a health behaviour theory is tested with the aim of establishing its significance of 
predictability of Type 2 diabetes patients’ outcome behaviours. The underlying 
meanings of the theoretical constructs of the theory are explored prior to the theory’s 
statistical testing to ensure that the theory’s constructs are measured appropriately. 
By doing so, this thesis relates to two areas of previous research that have focused on 
predicting health behaviour and the experiences of living with Type 2 diabetes.  
There are severalreasons why this research is particularly salient. Firstly, nationally 
and internationally diabetes has been recognised as one of the most significant 
threats to people’s health and has been considered an epidemic by some and as a 
serious clinical and financial threat by others (Bagust et al., 2002, Khunti, 2011, Bain 
et al., 2011). The recent Association of Public Health Observatories (APHO) (2011) 
prevalence model has estimated that there are 3.1 million people with diabetes in 
England. By 2020 an estimated 3.8 million adults, or 8.5%, will have diabetes and by 
2030 this is estimated to rise to 4.6 million or 9.5% of the adult population (APHO, 
2011). According to the most recent Scottish Diabetes Survey (SDS) there were 
247,278 people registered with diabetes in Scotland in 2011. 217,514 (88%) of all 
people that were registered have Type 2 diabetes compared to 28,272 (11.4%) of 
people who were registered with Type 1 diabetes (SDS, 2011). Bain et al. (2011) 
statethat the diabetes epidemic relates particularly to Type 2 diabetes and is set to 
increase rapidly over the coming decades. This increase is partly due to increased 
levels of obesity and the adoption of more sedentary lifestyles (Bain et al., 2011).  
The second reason this research is particular salient is that the guiding principles to 
treating Type 2 diabetes consider behaviour change(SIGN, 2010, NICE, 2011). 
SIGN (2010:9) guidelines state that 
‘helping patients to modify certain behaviours should take account of other 
factors such as the patient’s willingness to change, their perception of their 
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diabetes, and factors which may be indirectly related to their diabetes, such as 
depression and adverse effects on quality of life’.  
Whereas NICE (2011:29) guidelines offer five guiding principles of supporting 
behaviour change of patients with Type 2 diabetes: 
1. Helping them understand the short, medium and longer-term 
consequences of health related behaviour. 
2. Helping them feel positive about the benefits and value of health 
enhancing behaviours and changing their behaviours. 
3. Recognising how people’s social contexts might affect their 
behaviour. 
4. Helping people plan changes in terms of easy sustainable steps over 
time. 
5. Identifying and planning for situations that might undermine the 
changes people are trying to make, and planning for coping strategies 
to maintain changes in behaviour. 
Adopting ‘good’ health behaviour is a critical component in promoting self-
management and lifestyle change to patients with Type 2 diabetes. Health behaviour 
can be defined as  
‘an action taken to maintain good health and prevent illness’(Ogden, 2003:3). 
Health behaviours that are particularly associated with Type 2 diabetes include the 
appropriate management of diet, exercise and pharmaceutical interventions. 
Adopting health behaviours such as this can help prevent or delay the myriad of 
macro and micro vascular complications associated with Type 2 diabetes (Wallston 
et al., 2007). Furthermore, adopting health behaviour has been associated with a 
significantly improved concept of health and improvements of overall quality of life 
(Adulv et al., 2010). Despite these potential benefits people with diabetes are at times 
incapable of adopting and sustaining the necessary ‘good’ health behaviours for 
optimal diabetes disease management. As recommended by SIGN (2010) and NICE 
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(2011) guidelines there is a need to understand patient’s willingness to adopt health 
behaviours in order to help patients adhere to effective behaviour change regimes. 
This research expects to contribute to two ways of establishing this understanding. 
Firstly, by exploring the beliefs and values that underpin the practicing of health 
behaviours and secondly by identifying and testing a theory that could predict Type 2 
diabetes  patients’  behaviours.  The  results  of  this  research  could  be  beneficial  to  
health professionals supporting behaviour change in practice.  
A third reason why this research is particularly salient is that the results of this thesis 
have the potential to contribute to informing nursing science and practice.  This 
research is an example of nursing science adopting a concept from psychology to 
explore the phenomena of predicting diabetes patients health related behaviours. The 
results may offer a method that could be used to identify patients who may be at risk 
of poor adherence to diabetes regimens.  
Few researchers have investigated the interactive effects of the constructs of health 
value and perceived control (self-efficacy and internal health locus of control) and 
none according to the researcher’s knowledge have examined them in line with 
modified social learning theory as theorised by Wallston (1992).By testing the 
interaction  of  modified  social  learning  theory’s  (MSLT)  constructs  of  health  value,  
internal  health  locus  of  control  and  self-efficacy  this  research  expects  to  present  a  
new approach to investigating the phenomenon of interest predicting health 
behaviour. 
The aim of this chapter is to set the scene for this thesis by outlining the biomedical 
background to Type 2 diabetes, the provision of diabetes care in Scotland and to 
introduce MSLT. Following on from this the aims and objectives of the research and 
an outline of the topics covered within each chapter will be provided.  
This chapter is structured as follows: 
· Section 1.2 
 
Diabetes mellitus 
· Section 1.3 
 
Diabetes care in Scotland 
· Section 1.4 
 
An introduction to MSLT 
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· Section 1.5 
 
Aims and objectives 
· Section 1.6 Thesis outline 
 
1.2 Diabetes mellitus 
Diabetes mellitus is a condition in which there is a chronically raised blood glucose 
concentration (Williams and Pickup, 2004). This is attributed to an absolute or 
relative lack of the hormone insulin where insulin is not produced by the pancreas or 
there is insufficient insulin or insulin action for the body’s needs (Williams and 
Pickup, 2004). In contrast a healthy person’s pancreas would produce enough insulin 
to maintain blood glucose levels.  
Diseases with the clinical features of diabetes have been recognised since ancient 
times. The word diabetes was first used by Aretaeus of Cappadocia in the 2nd century 
AD, it  comes  from  the  Greek  meaning  siphon  because  the  disease  is  often  
characterized by excessive thirst and urination(Williams and Pickup, 2004).Hindu 
physicians from the 5th and  6th century  commented  on  the  importance  of  
psychosocial factorsrelevance of both behaviour and affluence as a contributor to 
diabetes: 
‘It  is  a  disease  of  the  rich  and  one  that  is  brought  about  by  the  gluttonous  
over-indulgence in oil-flour and sugar’ (Williams and Pickup, 2004:6). 
In  the  16th century a western physician known as Thomas Willis added the word 
mellitus that means honeyed (Royal College of Physicians Edinburgh, 2011). It was 
not until a century later, in 1777, that Mathew Dobson proved conclusively that the 
urine of diabetics contained sugar (Royal College of Physicians Edinburgh, 2011). 
Then in 1889 a German physician Paul Langerhans discovered the islets cells of the 
pancreas but he was unable to explain their function. Langerhans discovery led 
future scientists to discover the function of insulin and its benefits in the treatment of 
diabetes(Williams and Pickup, 2004).  
The treatment of diabetes depends on diabetes classification and the individual 
requirements  of  the  patient.  The  World  Health  Organisation  (WHO)  classifies  
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diabetes into Type 1 and Type 2 and four other types covering genetic forms, drug or 
chemical induced, gestational and unknown (Alberti and Zimmet, 1998). All of these 
categories have guidelines available to support and inform the management of 
diabetes (Royal College of General Practitioners and NHS Diabetes, 2011). In 
England the National Institute for Health and Care Excellence (NICE) and in 
Scotland the Scottish Intercollegiate Guidelines Network (SIGN) make separate 
recommendations  for  the  effective  management  of  diabetes  within  the  UK.  The  
treatment  for  Type  1  and  Type  2  diabetes  differs  due  to  the  aetiology  of  diabetes  
type. 
Type 1 diabetes is due primarily to autoimmune mediated destruction of pancreatic 
beta cells islets, resulting in absolute insulin deficiency(Tortora and Grabowski, 
2003).People with Type 1 diabetes must take exogenous insulin to prevent the 
development of ketoacidosis and death. Diabetic ketoacidosis results from absolute 
insulin deficiency and in response the body switches to burning fatty acids and 
producing acidic ketone bodies that cause most of the signs and symptoms(Tortora 
and Grabowski, 2003). Insulin resistance and/or abnormal insulin secretion either of 
which may predominate depending on the individual characterize type 2 diabetes. 
People with Type 2 diabetes are not dependent on exogenous insulin, but may 
require it for control of blood glucose levels if this is not achieved with diet alone or 
with oral anti-hyperglycaemic agents.  
The choices of treatment for Type 1 and Type 2 diabetes are characterized by a 
patient’s level of blood glucose control. Blood glucose control is assessed by 
measuring the percentage of glycaeted haemoglobin (HbA1c) in the blood. This 
gives an indication of blood glucose control over the preceding two to three months 
(Williams and Pickup, 2004). Diabetes UK (2013a)recommend HbA1c levels should 
be between 48-58 mmol/mol.  
The benefits of lowering blood glucose of patients with Type 2 diabetes in order to 
prevent macro and micro vascular complications are apparent (ADA, 2002). 
However, there has been some controversy over how ‘tight’ glycaemic control 
should be, as the use of insulin and some oral glucose lowering agents have been 
associated with iatrogenic hypoglycaemia (UK Prospective Diabetes Study Group, 
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1998). In hypoglycaemia, blood glucose levels fall too low to provide energy to the 
brain which can, but not always, lead to symptoms such as dizziness, nausea and 
sweating, and eventually can cause a loss of consciousness and death (Williams and 
Pickup, 2004).  
Understanding the biomedical background of Type 2 diabetes, the treatments 
available and the side effects of the treatments were imperative to this research, 
especially during data collection and data analysis. This understanding facilitated a 
thorough interpretation of both the qualitative and quantitative results of this study.  
The following section details the processes of delivery of diabetes care in Scotland. It 
is important to discuss this topic at the beginning of this thesis in order to situate the 
context of this research.  
1.3 Diabetes care in Scotland 
Up until the late 1990’s diabetes care in Scotland was concentrated mainly in 
secondary  care  services.  This  was  perhaps  due  in  part  to  the  complexity  of  the  
treatment regimes of diabetes and the associated complications and comorbidities of 
the disease. The publication of the white paperCaring for People(Department of 
Health, 1989), introduced the concept of collaboration between primary health care 
services and secondary health care. In Scotland, in 1998, the Scottish Acute Services 
Review  recognised  that  it  was  not  tenable  for  hospitals  to  provide  all  the  facilities  
necessary for its catchment area and proposed the development of managed clinical 
networks (Baker and Lorimer, 2000). Managed clinical networks are linked groups 
of health professionals from primary, secondary and tertiary care working in a 
coordinated manner to ensure equitable delivery of high quality care (Baker and 
Lorimer, 2000). The participants in this study are all cared for within the remit of the 
Lothian Diabetes Managed Clinical Network (MCN).  
Most recent white papers such as the Partnership for Care (The Scottish Government, 
2003) and the Delivering for Health (The Scottish Government, 2005) advocated a 
change in health services for diabetes to mainly primary care services to keep pace 
with population trends, patient needs and medical advances.The Lothian MCN for 
diabetes helped to organise the move of the majority of diabetes care into Lothian’s 
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primary care services. The diabetes patients that are now treated in hospital include 
only those requiring specialist diabetes treatments, whilst in primary care the cohort 
of diabetes patients treated include those with type 2 diabetes not requiring insulin 
and interim follow up of patients with risk factors once assessed by a diabetes clinic.  
There are many strategies of improvement specific to diabetes in place in Scotland. 
One in particular includes The Quality Strategy for Healthcare (The Scottish 
Government, 2012),which sets out the measurable and achievable actions that relate 
to the key drivers of healthcare quality. Another strategy includes the criteria in the 
diabetes domain of the Quality and Outcomes Framework (QOF) in the new General 
Medical Services Contract (nGMS)(Department of Health/NHS Confederation, 
2003). The QOF initiative was intended to better match payment and existing 
workload, improve quality of patient care and reduce variation between practices 
(Grant et al., 2009),however, this protocol driven approach to health care has been 
met with mixed views. Grant et al. (2009) have argued that care has been more 
biased towards pharmaceutical interventions and measurable outcomes, whilst others 
recognise these outcomes as resulting improvements in diabetes care (Kenny, 2013). 
The most recent planned changes to the QOF for 2013/2014 have also been met with 
a mixed response due its imposing nature on healthcare professionals (Hadley-
Brown, 2013), however, the indicator that requires structured education to be 
provided to all people newly diagnosed with diabetes should be welcomed by most.  
The above section has highlighted the dynamic influences of government policies on 
diabetes care in Scotland. Despite the number of quality improvement initiatives in 
place inpatient admissions to hospital of patients with Type 1 and Type 2 diabetes 
are  costing  Scotland.  The  estimated  total  annual  cost  for  patients  with  Type  1  and  
Type 2 diabetes was £26 million and £275 million respectively of approximately 
12% of the Scottish inpatient budget (£2.4 billion) (Govan et al., 2011). These 
findings reinforce the importance of addressing modifiable risk factors for 
cardiovascular and renal disease through behaviour change in both Type 1 and Type 
2 diabetes patients.  
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The following section introduces modified social learning theory(MSLT) a 
behavioural theory that is tested in this research to determine its ability to predict 
health behaviour of patients with Type 2 diabetes.  
1.4 An introduction to MSLT 
MSLTwas developed by Wallston (1992) and is a rapprochement of Rotter’s (1954, 
1966) Social Learning Theory (SLT) and Bandura’s Social Cognitive Theory (SCT) 
(Bandura, 1986).  
The main tenet of social learning theory (SLT) is that the likelihood of a behaviour 
occurring in a given situation is a joint function of the individual’s expectancy that 
the behaviour will lead to a particular reinforcement and the extent to which the 
reinforcement is valued (Conner and Norman, 2009).Rotter (1966) developed the 
locus  of  control  (LOC)  construct  as  a  generalised  expectancy  and  made  the  
distinction between internal and external locus of control belief orientations. Locus 
of control refers to the extent to which people believe events are controlled by 
them.People with internal locus of control beliefs believethat events are a 
consequence of their own actions whereas people with external locus of control 
beliefs believe events are unrelated to their own actions. 
Social cognitive theory (SCT) assumes that human motivation and action are based 
on three expectancies; situation outcome, action-outcome and self-efficacy (Conner 
and Norman, 2009). The construct of self-efficacy (SE) from SCT is the expectancy 
construct of interest to MSLT. Bandura (1995:5)defines self-efficacy as  
‘the belief in one’s capabilities to organize and execute the courses of action 
required to manage prospective situations’. 
An important point when introducing the origins of MSLT is to draw attention to the 
fact that Rotter chose LOC as the first major generalised expectancy construct for 
SLT.Wallston (1992:184) states that  
‘there is nothing inherent in Rotter’s SLT proposition that necessitated locus 
of control as opposed to perception of control (SE) to be the major 
generalised expectancy in SLT’. 
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Wallston et al. (1978) built on the locus of control construct by developing the Multi-
dimensional Health Locus of Control (MHLC) Scales which measures expectancy 
beliefs with respect to health along three dimensions including internal health locus 
of control beliefs, powerful others and chance. The main prediction from the MHLC 
scales is that people who score higher on the internal health locus of control (IHLC) 
subscale should be more likely to engage in health promoting behaviours. The health 
LOC (HLC) construct has been applied to a wide range of health behaviours such as 
smoking, alcohol intake, exercise, diabetes related behaviours, nutritional related 
behaviours, general health promoting behaviours and to peer pressure behaviour in 
adolescents(a review of studies that include the HLC construct is provided in Chapter 
2). Studies linking HLC beliefs to the performance of preventative health behaviour 
have produced a mixed set of results (Bennett et al., 1997, Bennett et al., 1998, 
Norman et al., 1997, O'Hea et al., 2005). Overall a number of reviews on the HLC 
construct have concluded that the relationship between health locus of control and 
health related behaviour is only modest(Wallston, 1992, Norman and Bennett, 1995). 
Wallston (1992) has argued that a reason for this is that HLC beliefs should only 
predict behaviour when people value their own health. Studies which include the 
HLC and health value constructs have produced some positive results (Lau et al., 
1986) whilst others have failed to find such an interaction (Norman et al., 1997, 
Steptoe and Wardle, 2001). The failure to support the interaction between HV and 
HLC thus far could be because the perceived health competence construct of self-
efficacy (SE) has not been taken into account. Wallston (1992) maintains that even 
when a person values their health and feels responsible for his/her health (IHLC 
belief)  this  does  not  mean that  the  person  feels  capable  of  taking  the  right  steps  to  
control his/her health status. This is where perceived self-competency (SE) can take 
an effect. 
Modified Social Learning Theory for health states that the potential for an individual 
engaging in a set of health related behaviours is a function of the interaction of health 
value (HV) and perceived control (IHLC and SE) over health. MSLT not only 
incorporates one of the most powerful predictors of health behaviour, self-efficacy, 
but also outlines a role for HLC as a moderator to predicting health behaviour 
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(Conner and Norman, 2009). MSLT has seen little or no application in the health 
behaviour field and requires further testing.  
By  testing  MSLT  in  a  health  domain  the  researcher  will  examine  the  interactionof  
HV, HLOC and SE on predicting health behaviours in a Type 2 diabetes population. 
If what the theory postulates is correct, the researcher will establish that these 
interactions are more predictive of health associated behaviours than HV, HLOC or 
SE alone. It is hoped that these potential findings could then be used to inform 
nursing interventions and diabetes management and prevention programmes in the 
future. 
A diagrammatic illustration of MSLT and its possible interactive effects on health 
behaviour is illustrated in figure 1.1 below. 





1.5 Aims and objectives 
The primary aim of this study is to test the interactive effects of the constructs of 
Modified Social Learning Theory (MSLT) in relation to predicting health behaviour 
in a Type 2 diabetes population. In order to meet the primary aim of the study a 
primary research objective was formed, that is, through a mixed methods approach of 
qualitative and quantitative means the researcher will test MSLT in a Type 2 diabetes 
population. By qualitative means of semi-structured interview and by quantitative 
means of measurement the researcher will aim to determine the interactive effect of 
health value and perceived control on predicting health behaviour in a Type 2 
diabetes population. The research questions and subsequent hypotheses formulated to 
explore and test MSLT are presented in Chapter 3 section 3.3 pages 46-48. 
1.6 Thesis outline 
This thesis is divided into eight chapters. The purpose of Chapter 2 is to critically 
review the existing literature related to the principal aim of this research. Secondly 
the literature review aims to highlight the rationale for the proposed research 
questions of this study. A search strategy for identifying relative literature is defined 
and following on from this an organised review of the literature is presented. 
Chapter 3 begins with an introduction to the rationale for the methodology of this 
research followed by a description of the purpose of this study. Next the 
epistemological  and  theoretical  position  of  the  research  is  presented  followed  by  a  
critical discussion that validates the choice of research design. Ethical considerations 
that were made during the research process are then discussed followed by a 
description of the research process. The inclusion and exclusion criteria for the 
sample for both the qualitative and quantitative phases of this research are then 
outlined. Following on from this the differences in sampling strategies for each phase 
are examined.  
Chapter 4 presents the methods of data collection and data analysis of the qualitative 
phase.Chapter 5 provides a full account of the qualitative findings. The findings from 
the  a  priori  themes  of  the  constructs  of  MSLT  are  presented  first  followed  by  the  
emergent themes from the data. Connections between themes are discussed 
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consistently throughout each section howevereach section interprets the meaning of 
each a priori and emergent theme separately. The differing dimensions of each theme 
and the variations in meaning of each theme to participants are also discussed in 
relative sections. Existing literature that was regarded as important to the 
interpretation of a theme is presented concurrently to facilitate a deeper 
understanding of the underlying meaning of that theme.  
The interim phase section of Chapter 5 introduces the qualitative findings that 
contributed to the development of two new research questions and hypothesis that 
were tested in the quantitative phase of this research. The methods employed to 
develop the qualitative findings prior to the quantitative phase are also discussed in 
the interim phase section. The statistical results of the item-total correlations that 
were used to test the reliability of two new items that were developed and added to a 
health  value  scale  prior  to  the  scales  inclusion  in  the  quantitative  phase  are  also  
presented here.  
Chapter 6 demonstrates the rationale for the quantitative data collection and 
statistical  analysis  methods  chosen.  Chapter  7  presents  the  statistical  results  of  the  
quantitative phase of the research. Scale scores present the results of emergent 
research questions 9 and 10. The results of the hierarchical multiple regression 
analysis that aimed to test the interactive effects of MSLT are demonstrated. This is 
followed by the results of three-way independent ANOVAs. 
Chapter 8 is the main discussion chapter of this thesis. In this chapter results from all 
phases of this research are integrated to provide an overall critical appraisal of their 
meaning and possible impact. Following this critical appraisal of the results the 
potential clinical application of MSLT is discussed. Succeeding this the significance 
of the study is presented followed by a discussion on the implications of this research 
in practice. Next future research recommendations are made and then Chapter 8 ends 
with a concluding summary of the research. 
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2 Literature Review 
2.1 Introduction 
The purpose of this literature review is twofold. Firstly, the review aims to provide 
an in depth review into each construct of MSLT, that is, health value, self-efficacy 
and health locus of control. By doing so the individual importance and relevant 
evidence supporting or opposingeach construct is critically analysed. Furthermore, 
the literature review focuses on existing literature that has examined the relationships 
between the constructs of MSLT and their interactions. This enables justification for 
the research questions that will be examined in this study. Secondly, the literature 
review considers the current provision of diabetes care, the barriers to this care and 
as a result how this influences diabetes outcome behaviours.  
This Chapter is structured as follows: 
· Section 2.2 
 
Search strategy 
· Section 2.3 
 
Health value 
· Section 2.4 
 
Self-efficacy 
· Section 2.5 
 
Health locus of control 
· Section 2.6 
 
Investigating interactions 
· Section 2.7 
 
Perceived control 
· Section 2.8 
 
Traditional theories of health behaviour & MSLT 
· Section 2.9 
 
· Section 2.10 
 
· Section 2.11 
Barriers to diabetes care & outcome behaviours 
 





2.2 Search strategy 
A search strategy was devised that involved defining the research topic, scope of the 
research topic and possible outcomes of each stage ofthe review.Hart 
(2003)recommends carrying out this process prior to reviewing the literature as it 
adds clarity and justification for the literature included in the review. Figure 2.1 
demonstrates this process. Having defined the research topic a provisional list of key 
authors and words was established to facilitate a more extensive search. The key 
words used to search for literature were divided into common terms/topic. To locate 
studies that are pertinent to MSLT the key words used included Modified Social 
Learning Theory and the three individual theoretical constructs of MSLT that are 
health value, self-efficacy and health locus of control. Additionally, the theoretical 
construct of perceived control (IHLC and SE) was included as a key word within this 
search.When searching for relevant articles on diabetes and health behaviour issues 
key words used included: self-management, predicting outcome behaviour, education 
and barriers to diabetes care.  
In addition to creating key words inclusion and exclusion criteria for literature 
included in the review was developed. All relevant literature in the English language 
from any country could be included in the review. Any literature in a different 
language was excluded due to the lack of resources to translate this literature. 
Relevant articles and texts were retrieved that had been disseminated between 1954 
and 2013. Inclusion of literature within this timeframe allowed for a review of 
seminal and most recent literature on the research topic. Literature that was not 
relevant to the research topic or key terms/topics was excluded from the review.  
Appendix A Table 10.1 summarises selected key studies referred to in this literature 
review. Key studies included in Appendix A were chosen based on their contribution 
to the methodology of this research. The studies presented are contextualised 
according to the study sample, setting, design, measures, results and strengths and 
limitations. Key studies are identified in the table using an * sign. There are two 
studies presented in the table that are not key to this research (Samuel Hodge et al., 
2002, Arnold et al. 2005), however, they are integrated here for review. 
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Figure 2.1 Literature review stages 
 
 
2.3 Health value 
The word value is defined in the Oxford English Dictionary (2011:1598) in various 
ways. Two definitions were chosen to demonstrate the context with whichhealth as a 
value will be subjectively and objectively examined in this research. The first 
definition defines a value as the  
‘regard that something is held to deserve importance or worth’ and secondly 
values can be defined as ‘principles or standards of behaviour’. 
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Thus,this research investigates the level of importance of health to participants in this 
study and the relation of health value as a guiding principle or standard towards 
behaviour.  
Each person can hold numerous values with varying degrees of importance (Bardi 
and Schwartz, 2003). Values can be considered a motivational construct as they 
represent broad goals that apply across contexts and time (Rokeach, 1973, Schwartz, 
1996, Bardi and Schwartz, 2003). Values can be difficult to assess as people may act 
in accordance to their values even when they are not consciously thinking about 
them (Rohan, 2000, Bardi and Schwartz, 2003). However, Bardi and Schwartz 
(2003) advocate that values may operate outside of awareness but they are 
retrievable from memory. Furthermore, a consistent finding amongst value 
researchers suggests that values are relatively stable motivational characteristics of a 
person and that they change very little during adulthood (Rokeach, 1973, Schwartz, 
1992, Schwartz, 1994, Rohan and Zanna, 2001). The current research examines 
relations of a particular value,  that  is  health value,  to a wide range of diabetes self-
management behaviours. The underlying concepts of the construct of health value 
are critically reviewed in this section. 
Rotter’s (1954) social cognitive theory indicates that individuals engage in goal 
directed behaviour only if two conditions are met, firstly, the individual must value 
the particular goals available and secondly the individual must believe that their 
actions will be effective in obtaining these goals. Consequently, the theoretical 
stance of MSLT asserts that the relative value of health and the level of perceived 
control (LOC and SE) when combined may be better predictors of health behaviour 
(Wallston, 1992). Therefore, the argument over whether individuals do or do not 
value their health reflects the common assumption that individuals will engage in a 
behaviour that they believe will enhance the likelihood of achieving their valued 
goals (Rotter, 1954, Wallston, 1992).  Smith and Wallston (1992) emphasize that the 
degree to which health is valued independently from other desired outcomes varies 
among  individuals.   However,  there  is  a  widespread  belief  that  health  is  so  highly  
valued that there is no reason to assess its value as an individual difference measure 
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(Wallston et al., 2007).  Despite this criticism of measuring the construct of health 
value (HV)Smith and Wallston (1992:134) state that  
‘ultimately,  the  extent  to  which  we value  our  health  is  a  prime determinant  of  
whether or not we will survive and the quality of our survival.’ 
HV has not been included in many studies on health behaviour because of the 
difficulty in measuring the construct. Ranking procedures and Likert scales are the 
two  most  common  measures  used  for  assessing  HV,however,  both  have  their  
limitations (Rokeach, 1968, Wallston et al., 1976, Lau et al., 1986).Rokeach (1968) 
examined value differences using anovel value ranking procedure. The study 
included297 Michigan State University students who differ in their attitudes towards 
civil rights demonstrations. Rokeach found that the students exhibited statistically 
significant value differences. Students who considered themselves as liberals valued 
a world at peace, equality and wisdomsignificantly more than conservatives. 
Conservatives were found to value social recognition significantly more than 
liberals.  This early research by Rokeach (1968) led to the further development of the 
value ranking procedure.Rokeach’sranking procedure recognised the concept of a 
value system and was sub-divided into two systems, an instrumental value system 
and a terminal value system. Instrumental values can be defined as a person’s mode 
of conduct whereas terminal values point to a person’s desired end state of existence. 
Rokeach’s value survey did not include health as a value in its ranking procedure 
thus, Wallston et al. (1976) adopted Rokeach’s technique and developed a similar 
measure that included health value.Wallston et al. (1976) initial test of this adopted 
measure involved examining health related information seeking as a function of 
health related locus of control and health value in two concurrent comparative 
studies. N=185 university students from Nashville Tennessee participated in the 
studies. Results demonstrated support for the assertion that information seeking is a 
joint function of health locus of control and health value. However, Wallston and 
colleagues’ (1976) value survey simply consisted of terminal values whereby 
participants were asked to rank ten terminal values such as happiness, freedom and 
health in order of importance to them. Using Wallston et al. (1976) value survey to 
measure HV in this study could have introduced a limitation in the measurement of 
the  HVconstruct,  as  it  does  not  allow  for  the  measurement  of  
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theinstrumental/terminal dichotomy. Likewise, identifying differences in individual 
value systems could have been limited. The potential to identify these differences 
amongst participants was considered important to this research in order to ensure that 
the HV construct was tested adequately in line with MSLT.Furthermore, according 
to the researcher’s knowledge no one has assessed health as an instrumental value.  
Consequently, Lau et al. (1986) health value scale was reviewed for suitability to this 
research.Lau et al. (1986) established reliability and validity of their health value 
scale by carrying out an initial scaling study followed by a study whereby the 
concept of health value and health locus of control were examined together to 
ascertain how both can be empirically and theoretically useful. The initial scaling 
study included 326 students from Carnegie Mellon University in America. 
Participants in the study provided test-retest data of the scale. Co-efficient alpha 
reliability for the scale was .67 and it had a test retest reliability of .78. Although this 
scale was found to be valid and reliable, a limitation identified by Lau et al. (1986) is 
that the health value measure does not measure what aspect of health people are 
referring to when they respond to health value questions. N=1029 students from 
Carnegie Mellon University participated in the second study that involved 
completing a questionnaire that focused on a variety of preventative health 
behaviours. Lau et al. (1986) found that out of the preventative health behaviours 
examined,‘breast self-examination’ provided the best test of the hypothesis that 
relevant health locus of control beliefs should predict the performance of 
preventative health behaviour only among those who place a high value on health.As 
a result of this finding Lau et al. (1986) recommend that when measuring health 
value other beliefs and values should also be measured to help explain the success or 
failure of any change in health behaviour.  
Lau’s  (1986)  health  value  scale  adopts  a  Likert  format  and  has  four  items  that  
measure current health value. Following a review of this scale it was concluded that 
it was suitable for this study as itcould facilitate testing of current health value and 
the items could be distinguished by the instrumental/terminal dichotomy if required. 
However, in order to justify whether this method of distinction of items was 
necessary the instrumental/terminal dichotomy of health value was explored in the 
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qualitative phase of this research prior to the scale’s inclusion in the quantitative 
phase. Chapter 5 elaborates upon the methods used to accomplish this.  
The following section discusses the construct of self-efficacy. Firstly, a review of the 
construct’s theoretical origins is provided followed by a critical appraisal of studies 
that include the construct. Next a brief review of available self-efficacy measures is 
given. This is then succeeded by the rationale for choosing a self-efficacy measure 
for this study. 
2.4 Self-efficacy 
Self-efficacy, or perceived competence as it is sometimes referred to, can be 
described as the confidence a person has in his or her own ability to perform goal 
directed behaviours (Wallston, 1992). Self-efficacy is a leading concept in Bandura’s 
(1986) social cognitive theory (SCT), which argues that cognitive, self-regulatory 
and self-reflective processes are central to human adaptation and change.Self-
efficacy has an influence on preparing for action because self-related cognitions are a 
major ingredient in the motivation process (Conner and Norman, 2009). Self-efficacy 
levels can enhance or inhibit motivation. People with low self-efficacy harbour 
pessimistic thoughts about their likely accomplishments and personal development. 
A person’s perceived self-efficacy represents the confidence that one can employ the 
skills necessary to resist temptation, cope with stress and mobilise one’s resources 
required to meet any situational demands (Conner and Norman, 2009). Furthermore, 
self-efficacy beliefs affect the amount of effort to change risk behaviour and the 
persistence to continue striving in the face of barriers and setbacks that may 
undermine motivation (Conner and Norman, 2009). People’s beliefs about self-
efficacy can be developed by four main sources of influence (Bandura, 1997). Firstly 
self-efficacy beliefs can be developed through personal accomplishment or mastery. 
Success can build a robust belief in one’s personal efficacy (Bandura, 1997). The 
second way of creating and strengthening self-efficacy beliefs is through the 
vicarious experiences provided by social models. This involves observing a person 
similar  to  oneself  succeed,  thus  raising  the  observer’s  beliefs  that  they  too  possess  
the capabilities to master comparable activities required to succeed (Bandura, 1997). 
Thirdly, social persuasion is a way of strengthening people’s beliefs that they have 
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what it takes to succeed. According to Bandura (1997) people who are persuaded 
verbally that they possess the capabilities to master given activities are likely to 
mobilise greater effort and to sustain it than if they harbour self-doubts and dwell on 
personal deficiencies when problems arise. Lastly, the fourth way of modifying self-
efficacy beliefs is to reduce people’s stress reactions and alter their negative 
emotional proclivities and misinterpretations of their physical states (Bandura, 1997).  
When considering health behaviour change a person’s perceived self-efficacy may 
include outcome expectancies, as individuals believe that they can produce the 
responses necessary for desired outcomes (Conner and Norman, 2009). Outcome 
expectancies pertain to the perception of possible consequences of one’s action and 
can be organised along three dimensions: area of consequences, positive or negative 
consequences or short and long term effects of behaviour change. Areas of 
consequence can refer to physical outcome expectations such as expectations of 
disease symptoms and the anticipation of what will be experienced after behaviour 
change takes place.These include both the short and long term effects of behaviour 
change (Conner and Norman, 2009). For example, a person with Type 2 diabetes 
who is started on an oral anti-hyperglycaemic agent might expect better glycaemic 
control (positive consequence) but an increased susceptibility to weight gain 
(negative consequence). Both outcome expectancies and self-efficacy beliefs play 
influential roles in adopting new health behaviours, eliminating detrimental habits 
and maintaining what has been achieved (Conner and Norman, 2009). For most 
health conditions, the greater patients’ self-efficacy beliefs, the greater their health 
outcomes (Bandura, 1997, Wallston et al., 2007). 
The construct of self-efficacy has been applied countless times in health research and 
has considered diet, exercise, smoking, addiction and disease management 
behaviours. The majority of studies reviewed for this literature review regarding self-
efficacy either explored levels of self-efficacy and its subsequent effects on outcome 
behaviours or many studies included the construct in an intervention or education 
programme and investigated its effects through a longitudinal study. Irrespective of 
the way in which the construct has been examined in the literature it has been 
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consistently supported as a positive behavioural construct in relation to health 
outcomes.  
Mc Auley and Blissmer (2000)carried out a brief review on studies that investigated 
self-efficacy (SE) determinants and consequences of physical activity. A common 
finding identified from the review was that self-efficacy is a significant predictor of 
exercise adoption. Other researchers have reported similar influences of exercise 
interventions in diseased populations including osteoarthritis, cardiovascular disease, 
diabetes and chronic obstructive pulmonary disease (COPD)(Kaplan et al., 1994, 
Lox and Freehill, 1999, Krichbaum et al., 2003). Kaplan et al. (1994) investigated 
the  validity  of  self-efficacy  expectations  as  predictors  of  mortality  amongst  119  
patients with COPD in San Diego, California. Measures included pulmonary and 
exercise function tests and a self-efficacy questionnaire. Kaplan and colleagues 
(1994) found that a self-report rating of self-efficacy expectation of COPD is a 
significant predictor of survival.It could be argued that this self-efficacy finding is 
unimportant  as  it  only  represents  disease  severity  that  can  also  be  expressed  using  
physiologic measures. However, Kaplan and colleagues (1994) point out how it is 
impressive that a self-efficacy rating can compete favourably with standardized 
laboratory tests as predictors of mortality. Similarly, Lox and Freehill (1999) 
investigated changes in psychological, physiological, and behavioural performance 
variables as a function of pulmonary exercise rehabilitation. Forty patients diagnosed 
with COPD were recruited for participation in a 12-week outpatient pulmonary 
rehabilitation program in a community hospital in Illinois. Measures used included a 
quality of life questionnaire, a 6-minute walking distance test, a 6-minute walking 
distance self-efficacy test and measures of dyspnoea, fatigue and emotional function. 
Lox and Freehill (1999)found that the pulmonary rehabilitation intervention 
outpatient program resulted in significant increases in self-efficacy in COPD 
patients. A limitation of Lox and Freehill’s (1999) study is the lack of a control 
group as this omits the extent to which psychological and emotional changes are 
related to the stimulus properties of exercise as opposed to other unknown variables. 
Krichbaum et al. (2003) conducted a systematic review of existing literature from 
1985-2001 to explore the connection between self-efficacy (SE) and effective 
diabetes self-management behaviour. Krichbaum et al. (2003) review supports the 
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inclusion of SE interventions in diabetes education programs as higher levels of SE 
associated with diabetes self-management has been found to improve diabetes 
outcomes (this point is further reviewed in section 2.6 and 2.7 of this chapter).  
Closely linked to the findings on the benefits of SE to exercise and disease 
management outcomes are studies that have examined self-efficacy interventions 
with addictive behaviours such as smoking, alcohol and drug use.DiClemente (1981) 
examined self-efficacy and its impact on smoking cessation maintenance. The study 
operationalized the construct of self-efficacy and applied it to the problem of long 
term maintenance of smoking cessation. A measure of self-efficacy for avoiding 
smoking was used to analyse the relationship between self-efficacy and participants’ 
ability  to  maintain  post-treatment  abstinence  at  a  five-month  follow  up.  The  
questionnaire was administered to N=63 participants at an outpatient service in 
Texas 4 weeks after quitting smoking. Maintenance was then assessed at a five-
month follow up. Smokers who maintained their abstinence from smoking over a 
five-month period showed higher levels of self-efficacy than those who did not. Ilgen 
et al. (2005) reported similar findings but with patients who have substance 
addictions. Ilgen et al. (2005) examined the relationship between abstinence self-
efficacy and treatment outcomes in N=2967 substance use disorder patients from 15 
residential substance use disorder treatment programs in California. Participants were 
assessed at treatment entry, discharge and one year follow up. Measures included 
frequency of drug use, level of alcohol use, substance related problems, psychiatric 
symptoms, a situational confidence and SE questionnaire and abstinence at one year 
follow up. Results indicated that participants who had full (100%) confidence in 
abstinence at discharge had the strongest predictor of abstinence at one year above 
and beyond all other predictors. Ilgen et al. (2005) point out that it is clear that not 
every patient with high abstinence self-efficacy is abstinent at one-year follow up. 
However, Ilgen et al. (2005)recommend that treatment providers should focus on 
obtaining a high level of self-efficacy in relation to abstinence when it comes to 
treating addiction problems. Focusing attention on this can allow for identification of 
sub-groups of patients who may be either more or less likely to have positive 
outcomes following treatment (Ilgen et al., 2005). 
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It is apparent from the literature reviewed that self-efficacy can be considered a 
predictor of health behaviour, however, it is also clear that self-efficacy is but one of 
the many determinants of health behaviour (Wallston, 1992). Self-efficacy will be 
reviewed in this research as a prime contributor to predicting health behaviour and as 
a moderator to predicting health behaviour alongside health value and health locus of 
control. 
Many scales were reviewed to ascertain which measure would best assess patients’ 
levels of self-efficacy (SE) in this study(Smith et al., 1995, van der Bijl et al., 1999, 
Anderson et al., 2000, Wallston et al., 2007). Van der Bijl et al. (1999) Diabetes 
Management Self-efficacy scale was reviewed for suitability to this study. This self-
efficacy scale was developed based on the self-care activities these patients have to 
carry out in order to manage their  diabetes.  A panel of experts in diabetes and four 
self-efficacy experts evaluated the original scalethat contained 42 items for validity 
and clarity. This evaluation of content validity resulted in a final scale that consisted 
of 20 items (van der Bijl et al., 1999). N=94 patients with Type 2 diabetes in the 
Netherlands were invited to complete the 20-item scale twice. The internal 
consistency of the scale resulted in an alpha of 0.81 and the test-retest reliability of 
the scale with a five week time interval was r=0.79 (P<0.001). Although van der Bijl 
et al. (1999) scale was found to be reasonably reliable with regard to validity it has 
been shown that the self-efficacy scale does not measure the dimension of strength in 
relationto four clusters of self-care activities which patients with Type 2 diabetes 
have to perform to prevent short and long term diabetes related complications. 
Continuing research with this scale would have to conform or modify these findings 
(van der Bijl et al., 1999). Additionally, a scale with twenty items may be considered 
by some as lengthy to complete.Another diabetes self-efficacy scale reviewed 
included the Diabetes Empowerment Scale (DES), which is a measure of diabetes 
related psychosocial self-efficacy developed by Anderson et al. (2000). Anderson et 
al. (2000) calculatedthe psychometric properties of this scale using a sample of 375 
patients with Type 1 and Type 2 diabetes from Michigan. To establish validity, DES 
subscales were compared with two previously validated subscales of the Diabetes 
Care Profile (DCP). Factor and item analyses were conducted to develop subscales 
that were coherent, meaningful, and had an acceptable co-efficient alpha. The 
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psychometric analyses resulted in a 28-item DES that has a co-efficient alpha of 0.96 
and three subscales that measure managing the psychosocial aspects of diabetes, 
assessing dissatisfaction and readiness to change and setting and achieving diabetes 
goals (Anderson et al., 2000). Additionally, consistent correlations in the expected 
direction between DES subscales and DCP subscales provided evidence of 
concurrent validity. Anderson et al. (2000) found preliminary evidence that the DES 
is a valid and reliable measure of diabetes related psychosocial self-efficacy and 
should be a useful outcome measure for educational and psychosocial interventions 
related to diabetes. The DES was considered for inclusion in this research, however, 
it  was  decided  that  a  scale  that  specifically  measures  the  construct  of  self-efficacy  
would  be  more  beneficial  to  the  testing  of  MSLT.  The  perceived  diabetes  self-
management scale (PDSMS) developed by Wallston et al. (2007) is a diabetes 
specific self-efficacy scale. This scales is an adapted version of an original scale 
known as the Perceived Health Competence Scale (PHCS) developed by Smith et al. 
(1995) and the Perceived Medical-Condition Self-Management Scale (PMCSMS)  a 
modified version of the PHC scale.The PMCSMS has been shown to be a valid and 
reliable tool in numerous studies including Samuel-Hodge et al. (2002) study of 
perceived diabetes and dietary competence in African American women with Type 2 
diabetes and (Arnold et al., 2005) study of the relationship between self-efficacy and 
self-reported physical functioning in chronic obstructive pulmonary disease (See 
appendix A for details of both of these studies).Wallston et al. (2007) tested the 
reliability and validity of the PDSMS in a study with N=398 patients with either 
Type 1 or Type 2 diabetes from four different healthcare settings in Nashville 
Tennessee.Diabetes self-efficacy was assessed by the 8-item PDSMS that was made 
diabetes  specific  by  replacing  the  word  condition  with  diabetes  in  each  item of  the  
PMCSMS. Additionally, diabetes self-care behaviours were assessed in this study 
using the Summary of Diabetes Self-care Activities measure (Toobert et al., 
2000).Cronbach alpha of the PDSMS was .83. This indicates internal consistency. 
The scale was found to have construct validity as most of the demographic variables 
examined in the study had either no association with PDSMS scores or only weak 
associations. The PDSMS was deemed fit for the purpose of this study as it was 
found to be valid and reliable. Furthermore, in comparison to the other scales 
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reviewed it was short, concise, measured diabetes specific self-efficacy and did not 
require further modification or testing. 
The following section critically appraises the health locus of control construct. The 
section begins with a brief review of the construct and its development. Following on 
from this, existing literature that supports or opposes the construct’s use within the 
health behaviour field is critically discussed. Next,section 2.5 examines the 
relationship of the HLC construct with SE and HV and ends with ananalytical review 
of the importance of investigating the interactions of behavioural constructs such as 
HLC, SE and HV. 
2.5 Health locus of control 
The health locus of control (HLC) construct has played a key role in the prediction of 
the physical and psychological adjustment to chronic disease (Wallston, 1992, 
Cvengros et al., 2005). Many researchers have used the multi-dimensional health 
locus of control (MHLC) scales developed by Wallston et al. (1978) to examine 
health specific locus of control expectancies. The MHLC scales have lead to a multi-
dimensional conceptualisation of the locus of control construct and provided a way 
of applying the internal/external dimension of the HLC construct to the health 
domain. The health domain in this respect is constrained to the subjective 
interpretation of various phenomena such as health behaviours, health outcomes and 
health care (Wallston et al., 1978). As previously mentioned in Chapter 1 the term 
locus refers to the location where control resides, either internal to the individual 
(based on one’s traits or behaviours) or external to the individual (due to other forces 
or chance) (Cvengros et al., 2005). 
Levenson (1972) was the first to challenge the uni-dimensional nature of the locus of 
control construct by demonstrating that internal and external locus of control were 
separate dimensions. Additionally Levenson’s (1972) research concerning scale 
development demonstrated that external beliefs consist of separate means of control 
such as self, powerful others and luck. Following this,Wallston et al. (1978) 
demonstrated the validity of these three means of control in the context of health 
beliefs, by developing the MHLC scales.  The original measurement of MHLC used 
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two  forms  A  and  B  that  refer  to  wide  areas  of  functioning,  health  and  medical  
conditions. Forms A and B were designed to measure healthy individuals rather than 
patients with current or chronic conditions.Wallston et al. (1994) thendeveloped 
Form C of the MHLC scale to provide a scale that can be condition specific for 
individuals with an acute or chronic illness (See appendix A). Form C contains a 
generic word ‘condition’ that can be replaced with a specific disease such as 
diabetes.  Form  C  is  the  MHLC  scale  of  choice  for  this  study.  The  word  condition  
was replaced with diabetes in the relevant items of the MHLC scale for use in this 
study. Additionally, the introductory instructions at the beginning of the MHLC scale 
used in this study were edited to refer to Type 2 diabetesself-management (See 
Appendix E). The MHLC scales contain three subscales one internal locus of control 
dimension and two external locus of control dimensions all of which are considered 
to be orthogonal. According to Wallston and Strudler-Wallston (1982) the 
internal/external dimensions are important to distinguish, as one can simultaneously 
hold  both  internal  and  external  locus  of  control  (LOC)  beliefs  about  control  of  an  
event or behaviour. It is important to note thatthe internal and external dimension is 
assessed  in  two  ways  in  this  research.  Firstly,  through  a  subjective  exploration  of  
participants beliefs surrounding diabetes self-management and secondly by using 
Form C of the MHLC scale. This method of exploring and testing the HLC construct 
expects to provide support to existing literature that recognises the multi-dimensional 
nature of this construct.  
The HLC construct has been widely reviewed with mixed results. Someearly studies 
found internally controlled medical patients to have better health behaviours such as 
seeking more information about their illness (Wallston et al., 1976), greater success 
in weight loss programs (Kincey, 1981) and greater success in smoking cessation 
programs (Schwebel and Kaemmerer, 1977). Kincey (1981) examined how the locus 
of control (LOC) construct relates to various aspects of non-compliance with health 
related advice. A sample of 131 twenty to sixty year old obese women participated in 
the study following a behavioural weight loss programme. Personal control variables 
were measured using the Short Eysenck Personality Inventory, a self-acceptance 
scale and a personal control subscale from Rotter’s internal/external LOC subscale. 
Participants with higher levels of internal locus of control achieved greater mean 
 27
weight loss. Kincey (1981) reported that internal control orientation was associated 
with higher extraversion and self-acceptance, however, neither of these variables 
correlated with weight loss. Schwebel and Kaemmerer’s (1977) study compared 
college students smoking behaviour focusing on smoking, alienation and LOC. 
Smokers, ex-smokers and non-smokers completed Rotter’s internal/external LOC 
scale.Schwebel and Kaemmerer (1977) found a predicted significant difference 
between smokers and non-smokers relationship of LOC beliefs and alienation rather 
than will power. Alienation in this study refers to ‘psychological body alienation’ in 
that  smokers  considered  themselves  alienated  from  their  bodies  and  thus  have  not  
internalized their intellectual knowledge that smoking can endanger their bodies. 
Schwebel and Kaemmerer (1977) findings highlight the usefulness of assessing 
internal LOC amongst smokers to identify people with low internal LOC that require 
intervention. 
Furthermore, regular physical exercise has been associated positively withinternal 
health locus of control (IHLC)but negatively with chance and powerful others LOC 
(Duffy, 1997, Norman et al., 1997).Duffy (1997) examined the extent to which 
selected demographic modifying factors, health locus of control, self-efficacy and 
health status explained engaging in six health promotion practices. N=397 employed 
Mexican American women aged nineteen to seventy years who lived in Texas were 
included in the study. Methods of measurement included self-administered scales 
such as the MHLC scale Form A, the health perception questionnaire, a self-efficacy 
scale and a health promoting lifestyle profile that measured self-actualisation, 
nutrition, health responsibility, exercise, nutrition, interpersonal support and stress 
management.Duffy (1997) carried out a canonical correlational analysis. This 
statistical technique allowed Duffy (1997) to simultaneously examine relationships 
of two sets of relationships amongst variables by generating pairs of linear 
combination variables. Duffy (1997) found that women in midlife with high internal 
LOC and good current health status were more likely to practice exercise, 
interpersonal support and self-actualisation health promotion behaviours. The 
homogeneity of the sample of Mexican American women may be perceived as a 
limitation as it limits generalizability to the wider population. Norman et al. (1997) 
examined the relationship of health locus of control and exercise behaviour in a 
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sample of over 13,000 adults in Wales. Participants completed a shortened version of 
the MHLC scales and Lau et al. (1986) health value scale. Results indicated weak but 
significant correlations between the health locus of control dimensions and exercise 
behaviour. Norman et al. (1997) found no evidence to support the moderating role of 
health value in predicting exercise behaviour. Norman et al. (1997) assert that other 
expectancy beliefs need to be considered when predicting exercise behaviour. Null 
findings on the HLC construct were reported byCallaghan (1998) who examined 
social support and LOC beliefs of 114 UK nurses health related behaviours. The 
nurses studied were attending third level education courses in London and Essex. 
Measures used in the study includedthe Health and Behaviour Survey, the Six Item 
Social Support Questionnaire and the MHLC scale. Results demonstrated that social 
support was not related to any health related behaviour except eating fruit. 
Participants with high internal LOC reported better dietary habits than those with 
lower internal LOC beliefs. However, LOC beliefs were not significantly related to 
any other health behaviour thus Callaghan (1998) concluded that LOC is a poor 
predictor of health behaviour.  
More recent studies have demonstrated support for the IHLC construct in regards to 
positive health outcomes and behaviour(Burker et al., 2005, Naus et al., 2005). 
Burker et al. (2005) investigated whether health locus of control beliefs measured 
pre-transplant predicted survival after lung transplant. N=100 participants completed 
the MHLC scale before and after transplant. Burker and colleagues (2005) found that 
patients with medium and high levels of IHLC lived longer after lung transplant than 
those with low levels of locus of control. Similarly,Naus et al. (2005)reported 
positive findings from their study of 109 early stage breast cancer survivorswho had 
high IHLC beliefs. Naus et al. (2005) measured LOC beliefs using Form C of the 
MHLC scale. Depression and anxiety were controlled for using the Beck Depression 
and Anxiety Inventory scales. Patients with high internal LOCwere less likely to 
suffer from anxiety and depression and as a result demonstrated enhanced treatment 
outcomes(Naus et al., 2005). Despite the limitations of the small sample size of this 
study and the cross-sectional nature of the design the pattern of results demonstrate 
support for examining interactions of LOC beliefs with other constructs in patients 
with serious chronic and terminal health threats. 
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2.6 Investigating interactions 
As previously discussed, although the construct of HLC has received some support 
other research studies and reviews have not found locus of control to be consistently 
related to successful health outcomes or behaviour change (Wallston, 1991, Steptoe 
and Wardle, 2001). Wallston has argued that the reason for these inconsistencies may 
be that studies examining the construct of control have often examined locus of 
control to the exclusion of other constructs that may contribute to control (Wallston, 
1992, Wallston, 2005a). Wallston et al. (2005a) suggest that studies that simply use a 
locus of control scale to investigate perceived control may not tap into the 
construct’s multi-dimensionality, particularly if interactions among perceived control 
(LOC and SE) are ignored. Some studies have tested the interaction between the 
constructs of health valueand locus of control(Lau et al., 1986, Bennett et al., 1997, 
Norman et al., 1997, Bennett et al., 1998, Laffrey and Isenberg, 2003, Masters and 
Wallston, 2005)and self-efficacy and locus of control(Gramstad et al., 2001, Bonetti 
et al., 2001).Comparable to research on the HLC construct alone these studies have 
yielded mixed results.  
Lau et al. (1986) hypothesised that health locus of control beliefs of university 
students should correlate with relevant health behaviours only among those who 
value their health highly. This hypothesis is supportive of MSLT. Results indicated 
that a combination of believing in self-control over health and placing a high value 
on health in general predicted the performance of preventative health behaviours 
(Lau et al., 1986) (See Section 2.3 and Appendix A for in depth details of study). A 
study by Laffrey and Isenberg (2003) report conflicting findings to Lau et al. (1986), 
as little support for the health value and locus of control constructs were found when 
measured together to assess perceived importance of exercise and participation in 
physical activity during leisure-time. N=70 women from adult education classes in 
three unrelated Midwest cities in America participated in the study. Measures used to 
examine perceived importance of exercise and participation in physical activity 
included a physical activity during leisure questionnaire, Form A of the MHLC 
scales, a perceived importance of physical exercise scale and an adapted version of 
Rokeach’s terminal value ranking scale was used to measure health value. Results 
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demonstrated that these variables proved to have little effect when leisure was 
considered as the outcome variable. Laffrey and Isenberg (2003) point out that their 
findings simply suggest that LOC and health value in this instance may not have 
tapped into the perceptions of their participants.In contrast to Laffrey and Isenberg’s 
(2003) study a more recent study by Masters and Wallston (2005)states that the 
relationship between highIHLC and health value is positive. Masters and Wallston 
(2005) explored advantages of canonical correlation in relation to measures of 
coping affect and values. N=659 college students who were attending private or 
public universities in Alabama, Tennessee, Washington, D.C, Iowa and central 
California participated in the study.Measures used included an enhanced version of 
Form  A  of  the  MHLC  scales,  the  Brief  Cope  Inventory  Scale,  the  Positive  and  
Negative Affect Schedule and a value survey. Results verified some previous 
hypothesised relations that external health control relates to passive coping 
mechanisms. New findings from the study pertaining to the relations between 
networks of MHLC variables indicate that a positive affectregarding health relates to 
a collaborative control between self and an external control factor such as God.  
Additionally,Masters and Wallston (2005) found that perceiving oneself as the locus 
of health control was significantly correlated with a set of values characterised by 
happiness and health and negatively by pleasure. This study demonstrates how 
canonical correlation can provide a greater understanding of relations of HLOC and 
other multi-dimensional variables than can be obtained through simpler analytic 
strategies (Masters and Wallston, 2005). 
Waller and Bates (1992) examined HLC beliefs and SE beliefs in a healthy elderly 
sample  of  57  people  in  Ohio,  America.  Participants  completed  the  MHLC  scale,  a  
self-efficacy scale and a health-style self-test for senior citizens. The healthy elderly 
sample was found to be characterized by high IHLC and high SE beliefs and good 
health behaviours. Additionally, Bonnetti et al. (2001) investigated the dimensions of 
the perceived control construct in relation to activity level and mood. The sample 
included N=106 Scottish students and N=145 Scottish, Spanish and Irish patients. 
All participants completedthe MHLC scale, a generalised self-efficacy scale and the 
perceived health competence scale. The patient sample completed a version of the 
Sickness Impact Profile.Bonetti et al. (2001) foundcorrelations between SE and 
 31
IHLC in relation to activity but these were rather low. In some cases, Bonetti et al. 
(2001) reported that the relations between SE and MHLC scale scores were non-
significant. Furthermore, the patient sample had significantly lower expectancies 
concerning their personal control and significantly higher expectancies concerning 
the role of other people and chance factors in health specific situations. This finding 
is consistent with previous research on perceived health competence by Smith et al. 
(1995). Bonetti et al. (2001) findings indicate that perceived control is a multi-
dimensionalconstruct regardless of health and culture and adequate assessment of the 
construct requires multiple perceived control measures. Moreover, Gramstad et al. 
(2001) carried out a study that searched for the predictors of quality of life and 
psychosocial  adjustment  in  a  sample  of  101  patients  with  epilepsy  from  a  hospital  
setting in Norway. The main hypothesis for this study was that negative and positive 
affectivity, self-efficacy and HLOC are important for psychosocial adjustment in 
patients with epilepsy. All participants completed the Washington Psychosocial 
Seizure Inventory, the Positive and Negative Affect Schedule, the MHLC scales, the 
generalised self-efficacy scale and a scale measuring self-efficacy in epilepsy.  
Gramstad et al. (2001) findings indicate that correlations between self-efficacy and 
general health outcomes in patients with epilepsy were stronger than correlations 
between MHLC and general health outcomes. These findings offer support to 
theorists who argue that self-efficacy is a more powerful predictor than HLC 
(Wallston, 1992, Frank et al., 2007, O'Leary et al., 2008). 
The argument that SE is a more powerful predictor holds true for MSLT which 
advocates that the construct of LOC plays a far less significant role in predicting 
health directed behaviour than does either health value by itself or self-efficacy 
(Wallston, 1992). The HLC construct in MSLT is viewed as a moderator of health 
behaviour rather than a major predictor variable. This view led to the development of 
research question (RQ) 4(see Chapter 3 section 3.3 pages 46-48) for a detailed 
explanation  of  RQ’s),  which  questions  whether  HLC  acts  as  a  moderator  of  
predicating health behaviour in a Type 2 diabetes population. Furthermore, as 
identified above,the measurement of health value and perceived control (LOC and 
SE) when taken together requires further investigation that led to the development of 
RQ5 and RQ6. The theoretical formulation of MSLT states that the interaction of 
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internal locus of control, self-efficacy and health value predicts the potential for an 
individual to engage in a set of behaviours, this theoretical stance will facilitate the 
examination of RQ1, RQ4, RQ5 and RQ6(see Chapter 3 section 3.3 pages 46-48 for 
a detailed explanation of RQ’s). 
According to the researcher’s knowledge, the three-way interaction of these variables 
has not been investigated in the specific way proposed by this research. However, 
O’Hea et al. (2009) previously investigated the interaction of LOC, SE and outcome 
expectancy in relation to HbA1c in 109 patients with Type 2 diabetes. Participants 
were recruited from internal medicine and family practice clinics at a public teaching 
hospital in Louisiana. Measures used in the study included a demographic 
questionnaire, Form C of the MHLC scales, the Multidimensional Diabetes 
Questionnaire and HbA1c results were recorded as biological markers of regimen 
adherence. O’Hea et al. (2009) used Pearson product moment correlations to 
determine if any of the continuous demographic variables were significantly 
correlated with the dependent variable HbA1c. To test the interaction of the 
independent variables a hierarchical multiple regression (HMR) analysis was 
performed. The correlation results suggested a moderate correlation between internal 
LOC and self-efficacy. This finding suggests that each construct taps into a different 
aspect of perceived control. The HMR results demonstrated that patients who 
reported low self-efficacy and low outcome expectancy tended to benefit the most 
from high internal LOC. However, for patients with low self-efficacy and high 
outcome expectancy,  higher  scores  on  internal  LOC were  related  to  poorer  HbA1c 
levels. Thesefindings demonstrate support for the three-way interaction of IHLC, SE 
and outcome expectancy.Although, O’Hea et al. (2009) argued that they were testing 
MSLT, their study did not include a health value measure. Health value is a key 
construct of MSLT and is conceived of as a moderator of the relationship between 
IHLC beliefs and health behaviour.Outcome expectancy assesses the motivation of 
partaking in health behaviour rather than the value of the behaviour. This research 
expects to support this finding and add a unique contribution to the literature on the 
way in which MSLT is tested.  
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The following section explains how perceived control (LOC and SE) is 
operationalized  in  relation  to  this  research  followed  by  a  critical  review  of  the  
importance of the perceived control construct.   
2.7 Perceived control 
It is difficult to offer a single universal definition of perceived control despite general 
agreement in the literature that perceived control is beneficial and that a lack of 
perceived control is detrimental to an individual (Allison, 1991, Wallston, 1992, 
Bonetti et al., 2001). A reason for this difficulty is that different formulations of 
perceived control have been incorporated into many theoretical frameworks 
including social learning theory (SLT) (Rotter, 1966), social cognitive theory (SCT) 
(Bandura, 1986), the theory of planned behaviour (Ajzen, 1988) and modified social 
learning theory (Wallston, 1992). The theoretical framework of MSLT determined 
the operationalization of perceived control for this research.MSLT combines a 
behavioural expectancy construct known as perceived competence or self-efficacy 
and an outcome expectancy locus of control, this combination of constructs generates 
a generalised expectancy belief termed perceived control (Wallston, 1992). 
The concept that an individual’s beliefs in personal control are related to taking 
preventative health behaviour is appealing to health professionals. The reason for this 
is that individual perceptions concerning control over health related factors lead to 
actions taken to prevent disease or other conditions (Allison, 1991). This argument is 
compatible with many of the traditional philosophical underpinnings of health 
behaviour that have emphasized voluntary change and individual responsibility for 
health (Allison, 1991, Conner and Norman 2005). Despite its attractiveness to health 
professionals and researchers, the hypothesized perceived control and preventative 
health behaviour relationship has not been demonstrated to be very strong (Allison, 
1991, Wallston et al., 2007). Allison (1991) suggests that this disappointing result 
may be due to the use of generalized as opposed to specific measures of control and 
the likelihood that perceived control is one of a number of variables predicting health 
behaviour. Wallston (1999) points out that perceptions of control moderate or are 
moderated by, many other constructs, among them individual differences in 
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demographic characteristics, background experiences, situational factors and value 
orientations. Furthermore, Wallston (1999:56) states that  
‘without adopting an interactionist perspective, health professionals and 
researchers will fail to discover the full explanatory power of perceived 
control’.  
A brief review of the traditional theories of health behaviour and MSLT is provided 
in the following section. 
2.8 Traditional theories of health behaviour& MSLT 
Traditional theories of health behaviour may assist in the design of behaviour change 
interventions in various ways, by promoting an understanding of health behaviour, 
directing research and facilitating the transferability of an intervention from one 
health issue or healthcare setting to another (Munro et al., 2007). Social cognition 
models (SCMs) are concerned with how individuals make sense of social situations. 
The cognitive perspective includes theories such as the health belief model 
(HBM)(Rosenstock, 1966), social cognitive theory (SCT)(Bandura, 1986), the 
theories of reasoned action (TRA) and planned behaviour (TPB)(Fishbein and Ajzen, 
1975) and the protection motivation theory (PMT)(Rogers, 1975) and MSLT 
(Wallston, 1992). These theories focus on cognitive variables as part of behaviour 
change, and share the assumption that attitudes and beliefs, as well as expectations of 
future outcomes, are determinants of health behaviour (Munro et al., 2007). 
Numerous reviews have identified that the SCMs mentioned above have many 
weaknesses(Michie et al., 2005, Munro et al., 2007, Conner and Norman, 
2009).Munro et al. (2007) concluded from their review of SCMs that these theories 
do not adequately address the behavioural skills needed to carry out ‘good’ health 
behaviour. Furthermore, Michie et al. (2005) found that little attention is given to the 
origin of beliefs and how these beliefs may influence other behaviours. This point is 
relative toMSLT as similar to the other SCMs it does not address the origin of health 
behaviour beliefs. Nevertheless, MSLT takes into account one’s belief orientation 
when considering HLC and SE beliefs. MSLT’s theoretical framework aims to 
enable health professionals to determine a patient’s disposition to act in a certain 
manner in health related situations (Wallston, 1992).  
 35
Despite the limitations of these theories SCMs provide a basis for understanding the 
determinants of behaviour and behaviour change (Conner and Norman 2009). Munro 
et al. (2007) recommend that future research should focus not on the development of 
new theories but rather on the further examination of those already developed.This 
research expects to contribute to the advancement of an existing theory by testing the 
theoretical stance of MSLT. 
Thus far the literature review has highlighted the dynamic nature of the field of 
health behaviour. The following section highlights the barriers to diabetes self-care 
followed  by  an  analytical  review  of  the  literature  of  diabetes  studies  that  examine  
behavioural constructs and their impact on outcome behaviours.  
2.9 Barriers to diabetes care& outcome behaviours 
Diabetes is a complex disease which places high behavioural demands on the person 
living with the illness on a daily basis (Diabetes UK, 2008). Although access to 
healthcare is a key component of diabetes care, most of the burden of care remains 
with the individual with diabetes, as they live their lives for more than 99% of their 
time away from contact with their diabetes team (Diabetes UK, 2008). Recent 
research has identified that the majority of people living with diabetes fail to achieve 
optimal blood glucose control leading to poor health outcomes (Simmons et al., 
1998, Glasgow et al., 1997, Glasgow et al., 2001, Peyrot et al., 2005b). A possible 
reason for these negative findings is that barriers of care related to the experiences 
and perceptions of patients with diabetes remain poorly defined and unstructured 
(Simmons et al., 1998, Diabetes UK, 2006, Diabetes UK, 2008). A key aspect of 
diabetes care that relates to patient experiences and perceptions is psychological care. 
Diabetes UK (2008) ‘minding the gap’ survey investigated 464 diabetes services in 
the UK and found that 85% of people with diabetes in the UK have either no defined 
access to diabetes psychological support and care or at best only in the form of local 
generic services. Another barrier to diabetes care identified in the literature include 
poor rates of diabetes regime adherence due to numerous factors such as socio-
economic and psychosocial influences(Balkrishnan et al., 2003, O'Hea et al., 2005, 
Peyrot et al., 2005b). Furthermore, high rates of anxiety and depression amongst 
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patients with diabetes has been found to contribute to poor diabetes self-management 
(Gonzalez et al., 2007).  
The term self-management has been reported in literature associated with chronic 
illness as the activities people undertake to create order, discipline and control in 
their lives (Clark et al., 1991, Kralik et al., 2004). Many studies looking at barriers to 
diabetes self-management have focused on the impact of patient beliefs on processes 
of decision-making or adherence rates. The majority of these studies have found that 
beliefs can either positively or negatively influence outcome behaviours of patients 
with Type 2 diabetes. Despite these findings interventions focusing on patients 
beliefs to assess behaviour change are not widely adopted in practice. This could be 
as a result of the inconsistencies found within health psychology literature regarding 
the role of behavioural constructs, such as health locus of control, self-efficacy and 
health value.  
Contradictory evidence regarding HLC is found in the diabetes literature. Gregg et 
al. (1996)carried out a study to investigate the relationship of the LOC of control 
construct to physical activity amongst a sample of 580 Pima Indianswith and without 
diabetes in Arizona, America. LOC was measured using a version of Rotter’s 
internal/external LOC scale and participants’ total physical activity from the past 
year was examined using an interviewer-administered questionnaire. Among both 
men and  women without  diabetes  individuals  with  a  high  internal  LOC score  were  
significantly more active than those with a high external LOC score than those 
participants with diabetes. Gregg et al. (1996) conclude from their findings that by 
enhancing perceptions of internal LOC this may influence physical activity and thus 
have implications for diabetes prevention.Auerbach et al. (2002) carried out a study 
that examined 54 Type 1 and Type 2 diabetic patients’health-related control 
appraisals and physician–patient interpersonal impact in relation to patients’ 
metabolic control and satisfaction with treatment during regular medical 
consultations. At the end of the consultation, both patients and the physician 
completed a measure describing the interpersonal impacts produced in each by the 
other’s control and affiliation behaviors. Findings from Auerbach et al. (2002) study 
suggest  that  patients’  satisfaction  with  treatment  was  unrelated  to  diabetes  control  
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measures. Auerbach et al. (2002) argues that HLC does not predict some aspects of 
diabetes related outcomes such as metabolic control. Furthermore, Auerbach et al. 
(2002) stipulate from their findings that a patient’s self-reported desire for 
involvement in his or her healthcare and the transactional fit of patient-physician 
interpersonal behaviours are potentially important contributors to diabetes outcomes.  
Additionally, some researchers have not found a connection between internal locus 
of control and diabetes outcomes (Kneckt et al., 1999, Bunting and Coates, 
2000).Kneckt et al. (1999) evaluated the correlation between dental and diabetes 
LOC beliefs in predicting oral health behaviour such as tooth brushing, dental 
visiting, oral indexes, dental status, diabetes compliance, and HbA1c level by using 
situation specific LOC scales. N=149 insulin dependent diabetics who had their own 
teeth were included in this Scandinavian study. Dental and diabetes LOC beliefs 
correlated with each other. Kneckt et al. (1999) results demonstrate that dental locus 
of control is associated with frequency of dental visiting, plaque index, decayed 
surfaces,  and  with  root  caries,  but  diabetes  locus  of  control  was  found  to  be  only  
weakly associated diabetes adherence self-care regimens and not at all with HbA1c 
level. Bunting and Coates (2000) examined the stability and predictors of blood 
glucose levels of 184 people who attended a diabetes clinic in Northern Ireland. Data 
collected included six aspects of perceived control that was examined using the 
Diabetes Perceived Control Scales. In addition the type of injection regime, age, 
gender and years since diagnosis of each patient was recorded. Bunting and Coates 
(2000) found the explanatory power of LOC to be insignificant and regular 
attendance at the outpatient clinic was found to have little effect on reducing blood 
glucose levels in this patient sample.  
The dependent variable under investigation in this research is Type 2 diabetes 
patients’ outcome behaviours. Diabetes outcome behaviours are dependent on a 
range of activities such as self-monitoring of blood glucose, dietary considerations, 
exercise and foot care (Toobert et al., 2000). These activities require effective self-
management. To measure diabetes outcome behaviours self-reported assessment is 
deemed to be the most practical and cost-effective approach to self-care assessment 
(Toobert et al., 2000). Patients self-reports are open to bias but can be made more 
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reliable by asking specific, non-judgemental questions in questionnaires (Abraham 
and Hampson, 1996). The Summary of Diabetes Self-Care Activities Measure 
(SDSCA) developed by Toobert et al. (2000) was chosen to measure outcome 
behaviours of patients with Type 2 diabetes in this study. Toobert et al. (2000) 
reviewed the reliability, validity and normative data of 7 different studies involving a 
total of 1,988 people with diabetes and provided a revised version of the SDSCA for 
use in practice. The review involved examination of the means and standard 
deviations, inter-item and test-retest reliability, correlations between the SDSCA 
subscales and a range of criterion measures and sensitivity to change scores were 
presented for the seven different studies. The seven studies that Toobert et al. (2000) 
examined demonstrated that the SDSCA is a multi-dimensional measure of diabetes 
self-management with adequate internal and test-retest reliability with evidence of 
validity and sensitivity to change. Additionally, the small number of significant 
correlations between the SDSCA subscales and participant characteristics 
demonstrates that the SDSCA can be generalised to different diabetes subpopulations 
including insulin, status, sex, number of comorbid conditions and diabetes duration 
(Toobert et al., 2000). A limitation of this review is the number of inconsistent items 
and  constructs  in  each  of  the  7  studies  that  constitutes  a  weakness  in  analysis  
(Toobert et al., 2000).  However, despite this limitation validity and reliability of the 
scale was found to be stable. On the basis of this review Toobert et al., (2000) 
devised a revised version of the SDSCA scale (Toobert and Glasgow, 1994). The 
revised scale consists of a set of 11 core items with an expanded list of 14 additional 
questions that may be used by researchers or clinicians. The revised version also 
includes items on foot care and smoking. To simplify the scoring of the SDSCA the 
items are now measured as days per week. The strengths of the 11 core items of the 
revised SDSCA include their brevity and ease of scoring (Toobert et al., 2000). 
As previously mentioned in section 2.6 studies that have investigated the interactions 
or combinations of constructs such as HLC and SE and HLC and HV, have not 
provided the diabetes literature with a solution for best predicting outcome 
behaviours of diabetes patients. It is anticipated that by testing the interaction of the 
constructs of MSLT this research may contribute to filling this gap in the literature 
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and provide support to a behavioural theory that could potentially be used in practice 
to predict health behaviour.  
The following section reviews the concept of diabetes self-management education.  
2.10 Diabetes self-management education 
Diabetes self-management education is the process of teaching individuals to manage 
their diabetes (National Standards Task Force, 1995). The rationale for reviewing 
diabetes  self-management  education  was  to  facilitate  an  understanding  of  the  
possible knowledge and skills gained by participants that would be included in this 
study. In addition it was anticipated that knowledge gained would aid interpretation 
of the qualitative data.  
The NICE (2003) guidance on the use of patient education models for diabetes 
recommends that structured patient education is made available to all people with 
diabetes at the time of initial diagnosis and then as required on an on-going basis, 
based on a formal regular assessment of need. The national institute for health and 
care excellence (NICE) has taken responsibility for determining the quality and 
outcome framework (QOF) indicators (see section 1.3 for further detail on QOF) in 
an attempt to refocus the scheme on patient outcomes rather than process-based 
targets (Kenny, 2013). QOF indicator DM014 has been newly introduced in 2013and 
it requires that structured education is offered to all people with diabetes (NHS 
Commissioning Board et al., 2013). It is expected that this new indicator may reduce 
‘ad hoc’ practice services for diabetes education and where necessary result in 
healthcare practices pressing for increased provision of ‘what has to be a cornerstone 
of diabetes care’ (Hadley-Brown, 2013:68).  
According to Diabetes UK and Department of Health (2005:12) the key criteria that 
underpin the philosophy ofdiabetes education are that,  
‘it should be evidenced based, dynamic, flexible to the needs of the individual 
and users should be involved in its on-going development. The programme 
should have a specific aim and learning objectives, which are shared with 
patients’ carers and family. The programme should support self-management 
attitudes, beliefs, knowledge and skills for the learner, their family and their 
carers’. 
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Currently there are two national group education programmes for adults with 
diabetes that meet the key criteria for structured education (Diabetes UK and 
Department  of  Health,  2005).  They  are  DAFNE  for  patients  with  Type  1  diabetes  
and DESMOND for patients with Type 2 diabetes.  DAFNE – Dose Adjustment for 
Normal Eating, is a skills based education programme in which adults with Type 1 
diabetes learn how to adjust insulin to suit their free choice of food, rather than 
having to work around their insulin dosages (DAFNE Study Group, 2002). 
DESMOND – Diabetes Education and Self-management for On-going and Newly 
Diagnosed, is a structured group education programme for individuals with Type 2 
diabetes. This structured group education is based on a series of psychological 
theories of learning including Leventhal’s common sense theory(Leventhal et al., 
1980), the dual processes theory(Chaiken et al., 1996) and social learning theory 
(Bandura, 1986).  
Due to the nature of the sample of this study the remainder of this section focuses on 
existing literature of Type 2 diabetes education and its influences on diabetes 
outcomes. However, it is noted that DAFNE has been found to be associated with a 
range of benefits in clinical practice. A recent study by Keen et al. (2012)explored 
the  effectiveness  of  DAFNE  with  124  adults  with  Type  1  diabetes  in  a  routine  
clinical practice in the UK. Keen et al. (2012) found that DAFNE resulted in an 
improvement in baseline HbA1c ≥ 81 mmol/mol, a reduced number of reports of 
hypoglycaemia, a total eradication of diabetic ketoacidosisand lower diabetes related 
distress. However, Keen and colleagues (2012) point out that these findings 
underrepresent  the  most  deprived  of  the  clinic  population  and  the  levels  of  clinical  
depression were unusually low for patients with Type 1 diabetes. It is acknowledged 
that this population should be further represented in replicated studies of DAFNE. 
Prior  to  the  implementation  of  DESMOND  within  the  NHS  in  2005  (James  et  al.,  
2005) Type 2 diabetes patients within NHS Lothian received structured group 
education through health professionals at the diabetes clinic. Following on from this 
the conversation map approach to Type 2 diabetes education was applied in NHS 
Lothian from 2007 until 2009when DESMOND replaced it. The conversation map 
approach involved structured group education and was normally facilitated by a 
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nurse and a diabetes specialist who guided the conversation by ensuring that 
participants were challenged to think, learn, set meaningful goals and take action 
(Diabetes Conversations, 2009). This method of diabetes education has currently not 
been audited within the UK, however, it has been audited and supported in other 
countries such as Canada and America (Reaney et al., 2012). However,DESMOND 
has been evaluated in the UK by Davies et al. (2008) to establish its effectiveness as 
an education programme for people with newly diagnosed Type 2 diabetes. Davies et 
al. (2008) carried out their evaluation in 207 general practices in 13 primary care 
sights in the UK. N=824 adults with Type 2 diabetes who had received DESMOND 
were invited to participate. The main outcome measures used to evaluate 
DESMOND were HbA1c levels, blood pressure, weight, blood lipid levels, smoking 
status, physical activity, quality of life, beliefs about illness, depression and the 
emotional  impact  of  diabetes  at  baseline  and  up  to  12  months.  Their  report  
demonstrated that patients benefited from greater improvements in weight loss and 
smoking cessation, and positive improvements in beliefs about illness (mainly SE 
beliefs), however, there was no improvement of HbA1c levels up to twelve months 
after diagnosis. It is evident from this review of the literature that structured group 
education is beneficial to patients with Type 2 diabetes, yet, patients willingness to 
adhere to the goals established during the intervention is not currently assessed prior 
to the education programme. Perhaps if this was assessed this could facilitate 
identification of possible barriers to achieving diabetes self-management goals such 
as having low internal LOC beliefs or low HV.  
2.11 Summary 
The above literature review has outlined the theoretical background to each of the 
constructs of MSLT. This review included studies that investigated the theoretical 
stance of each construct followed by a comprehensive critical review of research that 
has examined the relationships of these constructs and their interactions. The studies 
reviewed were mainly quantitative due to the nature of examining these constructs 
using psychometric scales. It is evident from the literature reviewed that there are 
inconsistencies regarding the role of health locus of control and health value as 
moderators to predicting health behaviour. This analytical review concurrently 
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highlights the impetus for the research questions and provides a justification for an 
investigation into these constructs and testing of MSLT.  
Potential measures that could be used to test MSLT were reviewed in Chapter 2. The 
construct of health value was reviewed in Section 2.3. Lau et al. (1986) health value 
scale is the health value measure of choice for this study. The health value scale has 
been found to have good internal consistency and construct validity. In Section 2.3 
the concept of the instrumental/terminal dichotomy of health value was introduced. 
A mixed methods approach to this research will enable this concept to be explored 
further.  
Scales that measure the construct of self-efficacy were reviewed in Section 2.4. The 
Perceived Diabetes Self-management Scale (PDSMS) developed by Wallston et al. 
(2007)  was  chosen  to  measure  the  construct  of  self-efficacy  in  this  study.  The  
PDSMS is an adapted version of the Perceived Health Competence Scale developed 
by Smith et al. (1995) and has been found to be a valid and reliable scale that 
measures diabetes self-efficacy.  
Form C of the MHLC scales developed by Wallston et al.(1994) was selected as the 
preferred scale to measure the construct of Health Locus of Control,  as it  is  a valid 
and reliable scale that can be adapted to be condition specific to the patient sample 
under investigation. Form C was adapted to be specific to Type 2 diabetes patients in 
this study (see Appendix E). 
To  test  the  interaction  of  the  constructs  of  MSLT  in  a  Type  2  diabetes  patient  
population outcome behaviours need to be examined. The Summary of Diabetes 
Self-Care Activities (SDSCA) measure developed by Toobert et al.(2000) was 
reviewed for suitability to measure self-care activities of Type 2 diabetes patients in 
this study. It was concluded from the review that the revised version of the SDSCA 
measure would be a practical choice as it has been found to be a valid and reliable 
measure that can adequately measure diabetes self-management outcome behaviours.  
Moreover, justification for this research was identified through an analytical review 
of the barriers to diabetes care. It is evident from the literature that a consensus to an 
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approach on the best way to predict outcome behaviours of Type 2 diabetes patients 
is lacking.  
Furthermore, it is clear from this literature review that methods of assessing diabetes 
patients willingness to adhere to goals of behaviour change facilitated through 




The purpose of this study is to test the interactive effects of Modified Social 
Learning Theory (MSLT) in relation to predicting health behaviour in a Type 2 
diabetes population. MSLT states that the interaction of health value and the 
perceived control constructs of internal locus of control and self-efficacy, when taken 
together are better predictors of outcome behaviours than when considered 
individually. A knowledge gap concerning the health value construct was identified 
during the literature review. Literature regarding the meaning of health value to 
people with chronic diseases such as Type 2 diabetes was lacking. Furthermore, 
uncertainty regarding the instrumental/terminal dichotomy of the construct has been 
identified by many(d'Houtaud and Field, 1984, Rokeach, 1973, Schwartz, 1992, 
Smith and Wallston, 1992, Duncan, 2010).  In order to ensure that the constructs of 
MSLT were adequately tested it became apparent that the meaning of the health 
value construct required further exploration. A mixed methods research study 
employing an exploratory sequential design was considered as the best approach to 
facilitate these research requirements.  
An exploratory sequential design allowed for an initial qualitative phase that enabled 
exploration of the health value construct followed by a quantitative phase that 
facilitated testing of MSLT. Furthermore, the exploratory sequential design 
permitted an interim phase during the research whereby findings from the qualitative 
phase were developed to contribute to the methods used in the quantitative phase. 
This design was seen as an advantageous approach as it supported a thorough 
exploration of the construct of health value and ensured that adequate methods for 
testing the constructs of MSLT were identified.  
This chapter begins with a summary of the purpose of the study and of each phase of 
the research design. Following on from this the research questions and hypotheses 
that  were  devised  based  on  the  theoretical  position  of  MSLT  are  presented.  
Succeeding this the implications of the epistemological and theoretical approaches 
taken to this mixed methods research are discussed. Next an in depth discussion of 
the rationale and methods of the research design are provided. Following on from 
 45
this  an  explanation  of  the  research  process  and  ethical  considerations  made  are  
discussed.The sample type and sampling strategy applied in this mixed methods 
research is then discussed.Finally, section 3.11 provides an overall summary of this 
chapter followed by a detailed description of the presentation of the ensuing chapters 
for each phase of the research. The three phases of the research are discussed 
chronologically in relation to methods, findings and results of each phase. 
This chapter is structured as follows: 
· Section 3.2 Purpose of the study 
 
· Section 3.3 Research questions and hypotheses 
 
· Section 3.4 
 
Mixed methods research and the challenges of this research approach 
· Section 3.5 Epistemology  
 
















· Section 3.10 
 
Sample & Sampling strategy 
 






3.2 Purpose of the study 
This study aimed to test the interaction of the constructs of Modified Social Learning 
Theory (MSLT) in relation to predicting health behaviour in a Type 2 diabetes 
population. An exploratory sequential design wasused, in which there were two main 
phases (qualitative and quantitative) and an interim phase of data collection and 
analysis.  Firstly,  the  design  qualitatively  explored  the  constructs  of  MSLT  with  
twelve participants who have Type 2 diabetes and are on insulin. The qualitative 
phase aimed to understand the meaning of health value and perceived control to 
these participants with the intent of using this information to contribute to the testing 
of MSLT. From this initial exploration two new research questions and hypotheses 
were developed which contributed to the interim and quantitative phases. The 
qualitative data also lead to the development of two new items that were added to a 
health value measure used in the quantitative phase,however, the two new items were 
subsequently removed during data analysis as one of the items was deemed 
problematic. The planned quantitative phase included collecting data to test MSLT 
from participants with Type 2 diabetes on insulin using five questionnaires that 
measure diabetes outcome behaviours.  
The following section includes the research questions and subsequent hypotheses 
formulated to explore and test MSLT. 
3.3 Research questions and hypotheses 
The overarching mixed methods research question to be addressed in this study is: 
Is the potential for people with Type 2 diabetes engaging in a set of health 
sustaining behaviours a predictor of health value and perceived control 
(HLOC and SE) as postulated by MSLT? 
To answer this question a series of subsidiary research questions will be used 
throughout the research design. The subsidiary research questions are presented in 
table 3.1 below. Subsidiary research questions 1, 4, 5 and 6 will be addressed in the 
quantitative (Quan) phase. Subsidiary research questions 1, 4, 5 and 6 were 
formulated to address the principle research question that advocates testing of the 
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interactive effects of the constructs of MSLT in relation to predicting Type 2 
diabetes health behaviour. Research question(RQ) 1 will test the three-way 
interaction of health locus of control, self-efficacy and health value. RQ4 will test the 
significance of the locus of control construct as a moderator to predicting health 
behaviour. This result will be compared with the constructs of health value and self-
efficacy as moderators to predicting health behaviour. Therefore the three constructs’ 
significance to predicting health behaviour will be examined individually and as 
interactions. RQ5 was formulated to identify whether health value is a necessary 
predictor of health behaviour in Type 2 diabetes. RQ6 seeks to test the significance 
of the interactive effect of the three-way interaction of health value, self-efficacy and 
health locus of control when taken together.  
Research questions 2 and 3 seek an in-depth understanding of the constructs of 
MSLT and are therefore deemed qualitative in nature. The findings from these two 
questionswill be discussed alongside the quantitative results in Chapter 8.Research 
question 7 seeks to address the impact of mood on predicting behaviour in Type 2 
diabetes. RQ7 is addressed in both the qualitative and quantitative phases of this 
research.RQ 8 was formulated to facilitate the integration of methods, results and 
conclusions of this research in the discussion chapter (Chapter 8).  
The principal research hypothesis is: 
Health locus of control, self-efficacy and health value when taken together 
are more proficient predictors of self-management outcome behaviours 
carried out by Type 2 diabetes patients than when each construct is taken 
individually. 
In order for the researcher to ascertain whether this hypothesis (H) can be accepted 
supplementary hypotheses will be utilized within the research design to support the 
principal hypothesis. The supplementary hypotheses support testing interactions of 
the three constructs when taken together on predicting health behaviour of people 
with Type 2 diabetes and as individual constructs.  
The Subsidiary research questions are presented in table 3.1 in numerical order 
followed by the supplementary hypotheses. Each research phase that each research 
questionis addressed in is represented by denotations for qualitative research (Qual) 
and/or quantitative research (Quan).  
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Does MSLT three-way interaction of HLOC, SE and HV predict the 
outcome of self-care behaviour in a Type 2 diabetes population? 
 
 
How  do  people  with  Type  2  diabetes  value  their  health  and  perceive  
control over their condition? 
 
 
How does having Type 2 diabetes impact on a person’s beliefs and values 
and thus self-management of their condition? 
 
 




Is  the  measurement  of  HV  a  necessary  predictor  of  health  behavior  in  a  
Type 2 diabetes population? 
 
 
Is the measurement of health value and perceived control (HLOC and SE) 
when taken together a more proficient predictor of health behaviour in a 
Type 2 diabetes population? 
 
 
Does mood affect a person with Type 2 diabetes potential of engaging in a 




How do participants’ perspectives of health value and perceived control of 




The greater the value placed on health the greater amount of Type 2 
diabetes self-care behaviours taken. 
 
The greater the perceived control (HLOC & SE) of diabetes the greater 
amount of diabetes self-care behaviours taken. 
 
The greater the perceived control (HLOC & SE) of diabetes and the greater 
the value placed on health (HV) the greater amount of Type 2 diabetes 




Emergent  research  questions  and  hypotheses  that  were  developed  as  a  result  of  the  
qualitative data will be explained in the interim phase (see Chapter 5, Section 5.6) 
3.4 Mixed Methods Research 
In order to address the research questions described in the previous section a research 
strategy must be devised (Bryman, 2008).The research methodology chosen for this 
study is mixed methods research. Mixed methods research adopts a research strategy 
that  employs  more  than  one  type  of  research  method  (Brannen,  2005).   Mixed  
methods research has been defined in several different ways.  A simple early 
definition from Tashakkori and Teddlie (1998:ix) defined mixed methods as  
‘the combination of qualitative and quantitative approaches in the 
methodology of a study’. 
Johnson et al. (2007:123) sought to provide a consensus on a definition of mixed 
methods research based on nineteen different definitions provided by twenty-one 
highly published mixed methods researchers: 
‘Mixed methods research is the type of research in which a researcher 
combines elements of qualitative and quantitative research approaches for the 
purposes of breadth and depth of understanding and corroboration’(Johnson 
et al., 2007:123). 
Creswell and Plano Clark (2011:4) state that this definition incorporates diverse 
viewpoints and relates to the rationale for using mixed methods research. The 
rationale for adopting a mixed methods approach for this research is to allow for a 
more robust explanation of the constructs being investigated.The principal research 
question advocates testing the interaction of the constructs of MSLT. Traditionally 
behavioural theories have been tested using mainly quantitative methods, as 
behaviour is commonly measured by health measurement scales (Conner and 
Norman, 2009). Initially a quantitative method of testing the constructs was 
considered. However,the literature review conducted prior to this research resulted in 
an acknowledgement that the construct of health value requires further investigation. 
Testing of MSLT necessitates the use of a health value measure. The literature 
review identified one such measure developed by Lau et al. (1986). The health value 
measure although deemed a reliable and valid measure consists of only four items. 
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Previous research on values suggests an instrumental/terminal dichotomyof the value 
construct(Rokeach, 1973, Smith and Wallston, 1992). In order to explore this 
conceptfurther prior to testing MSLT it was decided that by employing an initial 
qualitative method a more detailed understanding of the health value construct could 
be obtained. It was envisaged that by qualitatively exploring health value and the 
instrumental/terminal dichotomythis may enableidentification of whether or not a 
new health value measure or new items should be developed to test health value in 
the quantitative phase of this research.  
Furthermore, as the opportunity of subjectively exploring one construct of MSLT 
was made available it was decided that during the qualitative phase the meaning of 
the construct of perceived control would also be explored. This mixed methods 
approach was expected to enhance the understanding and testing of the constructs of 
MSLT and to make a unique contribution to behavioural research and mixed 
methods research.  
3.4.1 Challenges of Mixed Methods Research 
Although mixed methods research has the potential to provide a more holistic 
understanding of findings of a study (Tashakkori and Teddlie, 2010, Creswell and 
Plano Clark, 2011) conducting mixed methods research also raises numerous 
challenges(Mayoh et al., 2011). One such challenge is the feasibility of a mixed 
methods approach as adopting mixed methods in a study may require extensive 
skills,  resources  and  time  on  the  part  of  the  researcher  (Creswell  and  Plano  Clark,  
2011). Research courses were completed in the first year of this research in order to 
ensure that the requisite skills were gained to carry out both qualitative and 
quantitative methods of data collection and analysis. Prior to conducting the research 
a study time plan was developed in order to consider how long it would take to meet 
the  various  targets  of  the  research.  A  timeframe  of  two  years  was  allocated  to  
complete data collection and data analysis. The time plan of the research targets and 
dates achieved are displayed below in table 3.2 to illustrate how this research was 
planned and carried out efficiently to meet the target achievement dates. The 
research processes associated with access, screeningand recruitment are discussed 
from section 3.9.1 to 3.9.4.Chapters 4 to Chapter 7 detail the qualitative, interim and 




Table 3.2 Research Time Plan 2011-2013 














Screening, Recruitment &Data Collection 
Data Analysis 
 
21st of September 2011 
 
3rd of October 2011 
 
 
5th of October 2011 
1st of November 2011 - 23rd of December 2011 
30th of December 2011– 31st of March 2012 
 
15th of March 2012 –6th of May 2012 
 
 
7th of May 2012-31st of August 2012 
3rd of September 2012-31st of January 2013 
 
Another challenge which faces mixed methods research is the incompatibility thesis 
(Howe, 1988) which suggests that qualitative and quantitative methods are 
incommensurate and therefore should not be combined within a single study. These 
beliefs stem from the reality that qualitative and quantitative methods are each based 
on different paradigms, which both have a different set of assumptions concerning 
ontological  and  epistemological  assumptions  (Mayoh  et  al.,  2011).  The  terms  
paradigm, ontology and epistemology are expanded upon in this section followed by 
a discussion on three paradigmatic stances that address the incompatibility thesis. 
The term paradigm originated with Thomas Kuhn (1962). Kuhn described the 
meaning of a paradigm as a worldview that embodied the belief of scientists.Mertens 
et al. (2010) describe a paradigm as an integrated philosophical statement that 
encompasses positions on ontology and epistemology.Crotty (1998) definedontology 
as ‘the nature of being’ and stated how it is concerned with the nature of existence 
and the structure of reality.Bryman (2008) explains how quantitative researchers are 
ontologically concerned with objectivism, which implies that social phenomena 
confront external facts that are beyond human reach or influence.Constructionism is 
the ontological position held by qualitative researchers and rejects objectivism. 
 52
Constructionism asserts that social phenomena and their meanings are continually 
being accomplished by social actors (Bryman, 2008). 
Epistemology is concerned with  
‘providing a philosophical grounding for deciding what kinds of knowledge 
are possible and how we can ensure that they are both adequate and 
legitimate’ (Crotty, 1998:8). 
The  epistemological  assumption  advocated  by  quantitative  research  is  known  as  
positivism. Knowledge is arrived at through the gathering of facts that provide the 
basis for laws (Bryman, 2008). Interpretivism is a term given to the contrasting 
epistemology positivism. This term incorporates the views of qualitative researchers 
and is predicated upon the view that a strategy is required that respects the 
differences between people and the objects of the natural science and therefore 
requires the researcher to grasp the subjective meaning of social action (Bryman, 
2008). 
Melia (1997:29) states that  
‘the link between what a researcher does and the philosophical position set 
out to justify the method is often problematic’. 
Melia’s reflection is a challenge faced by researchers adopting mixed methods 
research as the methodology to their research. Consideration of what philosophical 
assumption is best suited to mixed methods research is difficult due to combining 
elements of two distinct research methods with differing philosophical foundations. 
One important point to consider when deciding on this is that the terms quantitative 
and qualitative denote kinds of data, not the epistemologies, methodologies, designs 
or ontological assumptions that are associated with different research frameworks 
(Biesta, 2010). 
Mertens (2012) claims that there are three paradigmatic stances that answer the 
argument about incommensurability of paradigms.The three paradigmatic 
assumptions are dialectical pluralism (Greene and Hall, 2010), the pragmatic 
paradigm (Biesta, 2010) and the transformative paradigm (Mertens et al., 2010). 
According to Mertens (2012) the three different paradigms address the 
incommensurable argument through their characterisation of mixed methods as a 
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methodological approach that is compatible with different sets of philosophical 
assumptions.  
Greene and Hall (2010:124)describe a dialectical stance as: 
‘A dialectical stance actively welcomes more than one paradigmatic tradition 
and mental model, along with more than one methodology and type of 
method into the same inquiry space and engages them in respectful dialogue 
one with the other throughout the inquiry’. 
This stance enables a researcher to adhere to the post-positivist paradigm when 
conducting quantitative data collection and the constructivist paradigm during 
qualitative data collection and then to converge the two throughout the study to allow 
for a deeper understanding of convergent research findings.   
Pragmatism focuses on the consequences of research and on the importance of the 
research questions asked rather than the methods. Johnson and Onwuegbuzie 
(2004:17) formulate this as the idea that one should  
‘choose the combination or mixture of methods and procedures that work 
best for answering research questions’. 
Biesta (2010) and Greene and Hall (2010) caution against an overly simplistic 
approach to pragmatism and point out how due to its methodological flexibilityit has 
led to researchers adopting mixed method research as a ‘mindless mantra,’ thus 
raising issues of integration methods and the paradigmatic assumptions being used 
when making use of pragmatism. However, Biesta (2010) emphasizes that 
pragmatism offers a very specific view of knowledge claiming that the only way 
knowledge can be acquired is through a combination of action and reflection. This 
approach has implications for the status of knowledge in that knowledge according to 
the pragmatist view is always about relationships between actions and consequences 
never about a world ‘out there’ (Biesta, 2010).Biesta (2010) argues that pragmatism 
does not provide a justification for all forms of mixed methods research but helps the 
field to ask more precise questions about the strength, status and validity of the 
knowledge claims developed on the basis of particular designs. 
The transformative paradigm forms an ethical stance that emphasizes the pursuit of 
social justice and furtherance of human rights (Mertens et al., 2010). The 
transformative paradigm arose partially because researchers and members of 
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marginalised communities expressed dissatisfaction with dominant research 
paradigms and practices and the limitations associated with these paradigms 
(Mertens et al., 2010). Typically, mixed methods designs will be associated with the 
transformative paradigm because of the need to capture experiences both 
qualitatively and quantitatively in order to represent the complexity of social issues 
and solutions to on-going problems(Mertens, 2012).  
The following section provides a rationale for the epistemological assumption upheld 
by this research. 
3.5 Epistemology 
The epistemological assumption of this study is a pragmatic one. The pragmatic 
worldview is problem centred and specifically considers the consequences of actions 
and their role in real world practice (Creswell, 2003).  This research acknowledges 
that pragmatism should not be understood as a philosophical position but rather as 
Biesta (2010) puts it as a set of philosophical tools that can be used to address 
research problems.Freshwater and Cahill (2012) suggest that pragmatism provides 
criteria by which a researcher can judge which methods cohere in the service of 
solving particular problems informed by accepted practice. Approaching this 
research from a pragmatic worldview has enabled a combination of deductive and 
inductive thinking through the mixing of qualitative and quantitative data. Morgan 
(2007) refers to this movement between deductive and inductive thinking as 
abduction. This research practice of abduction enabled the inductive results from the 
qualitative approach to input to the deductive goals of the quantitative approach. 
Pragmatism fosters a relationship to the research process that is subjective, objective 
and inter-subjective, this process emphasizes the interpersonal nature of research 
(Nastasi Kaul et al., 2010). Furthermore,Morgan (2007)highlights a distinction 
between qualitative, quantitative and mixed methods on the basis of the inferences 
drawn from the data. Morgan (2007)emphasizes that with pragmatism the basis of 
inference is context specific, generalizable and transferable.    
Thus pragmatism has enabled this research to identify the commensurability or 
complementarity of qualitative and quantitative methods within mixed methods 
research. 
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3.6 Theoretical perspective 
A theoretical perspective in mixed methods research is a stance taken that provides 
direction for the phases of a mixed methods study (Creswell and Plano Clark, 2011).  
‘A theoretical  orientation  for  a  mixed  methods  study  would  be  the  use  of  an  
explanatory framework from the social sciences that predicts and shapes the 
direction of the study’ (Creswell and Plano Clark, 2011:47). 
MSLT is a social sciences theory and provides a framework to this research that has 
guided the nature of the questions asked and answered in this study. The theory has 
been presented at the beginning of this thesis in Chapter 1 (section 1.4) to 
demonstrate how the theory informed the questions and methods of the study. 
Section 3.7 of this chapter illustrates how MSLT guides the research design of this 
study. Chapters 4, 5 and 6 demonstrate how MSLT guides the qualitative and 
quantitative data collection and analysis methods. 
3.7 Research design 
Research designs are procedures for collecting, analysing, interpreting and reporting 
data in research studies (Creswell and Plano Clark, 2011). Decisions about design 
selection and classification are influenced by considerations of research purpose, the 
researchers  theoretical  perspective  or  worldview  and  concerns  about  inference  
quality (Nastasi Kaul et al., 2010). A pragmatic approach assisted in the decision-
making process on which research design would best address the research questions 
and testing of hypotheses of this study.Creswell and Plano Clark (2011) recommend 
three procedural considerations for choosing a mixed methods design. Thus 
particular attention was paid to the timing, weighting and mixing decision of the 
design.  
The timing decision is also referred to as the sequence of the research and refers to 
the temporal relationship between the quantitative and qualitative components of the 
study (Greene et al., 1989). Timing within a mixed methods design is classified as 
concurrent or sequential. Concurrent timing occurs when both the quantitative and 
qualitative methods are carried out during a single phase of the research. Sequential 
timing occurs when the methods are carried out in two distinct phases by collecting 
and analysing one type of data before collecting and analysing the other type of data 
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(Creswell and Plano Clark, 2011). A decision has to be made on which type of data 
will be collected and analysed first. This decision is based on the research purpose.  
The weighting decision refers to the priority of the quantitative and qualitative 
methods to answering the research questions (Creswell and Plano Clark, 2011). 
Morse (1991) suggested that the theoretical perspective of a study or worldview can 
be  used  to  determine  its  weighting.  Pertaining  to  a  positivist  worldview calls  for  a  
quantitative priority, a natural worldview calls for a qualitative priority whereas a 
pragmatic worldview calls for either equal or unequal weighting depending on the 
research question(Creswell and Plano Clark, 2011).  
The third procedure for choosing a mixed methods design is how the quantitative and 
qualitative methods will be mixed(Creswell and Plano Clark, 2011). Creswell and 
Plano Clark (2011) conceptualise mixing occurring at four possible points during a 
study’s research process: interpretation, data analysis, data collection and design. 
The stage of integration of methods also known as the point of interface is a point 
within  the  process  of  research  where  the  qualitative  and  quantitative  phases  are  
mixed (Morse and Niehaus, 2009).  
1. Interpretation: The interface point of research during interpretation occurs 
when the qualitative and quantitative strands are mixed during the final step 
of the research after data has been collected and analysed for both sets of 
data. This mixing process involves drawing conclusions or inferences that 
reflect a combination of results from both phases of the study such as by 
comparing or synthesizing the results in a discussion (Creswell and Plano 
Clark, 2011).  
2. Mixing during data analysis involves merging the two sets of results together 
through a combined analysis.  
3. Mixing during data collection involves connecting the two phases of the 
research by using the results of the first phase to shape the collection of data 
in the second phase by specifying research questions or developing data 
collection methods or instruments (Creswell and Plano Clark, 2011).  
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4. Lastly, mixing at the design level can involve mixing with a traditional 
quantitative or qualitative research design. This process includes embedded 
mixing, theoretical framework-based mixing, and program objective 
framework-based mixing (Creswell and Plano Clark, 2011). 
There are numerous mixed methods research designs to choose from. In order to 
simplify this choice mixed methods research design typologies were first reviewed.  
Selecting a typology-based design provides the research design with a framework 
and logic to guide the implementation of the research methods to ensure that the 
resulting design is rigorous, persuasive and of high quality (Creswell and Plano 
Clark, 2011). Leech and Onwuegbuzie (2009) provide an integrated typology based 
on a review of published mixed methods research. A three-dimensional typology is 
proposed which considers the potential variations in level of mixing that is whether 
the mixing is partially or fully, time orientation (concurrent or sequential) and the 
emphasis of qualitative and quantitative methods produced (weighting). The 
difference between partially and fully mixed methods is that fully mixed methods 
involves the mixing of methods within or across one or more stages of the research 
whilst with partially mixed methods the phases are not mixed within or across stages 
(Leech and Onwuegbuzie, 2009). Partially mixed methods involves carrying out both 
the qualitative and quantitative methods either concurrently or sequentially in their 
entirety before being mixed at the data interpretation stage (Leech and Onwuegbuzie, 
2009). ConsideringLeech and Onwuegbuzie (2009) three-dimensional typology it 
was decided that this mixed methods researchis fully mixed, the timing is sequential 
and the weighting given to the phases of the research is unequal.  
The research design of this study is considered fully mixed because the point of 
interface is carried out across stages and during interpretation. Integration of methods 
occurs  during  data  collection  as  the  results  of  the  qualitative  phase  are  expected  to  
contribute to the development of a health value measure and thus influence data 
collection methods in the quantitative phase. Additionally, mixing occurs during the 
interpretation  of  results  in  the  discussion  section  of  this  thesis.  The  timing  of  the  
design  is  sequential,  as  the  research  is  carried  out  in  two  distinct  phases.  First  the  
qualitative phase is carried out followed by the quantitative phase. The weighting of 
this study design is considered unequal as the principal research question advocates 
testing of MSLT. For this reason the quantitative phase is deemed the weightier 
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phase  of  the  research.  Figure  3.1  illustrates  the  three-dimensional  typology  of  this  
mixed methods research.  
Considering the typology of the design facilitated the decision making process of the 
specific  type  of  design  that  will  guide  this  research.  The  exploratory  sequential  
design was chosen as it meets the criteria of a fully mixed, sequential, unequal status 
design.  Additionally, this design was specifically chosen because it is based on the 
premise that an initial exploration is required to investigate variables or develop an 
instrument or measure(Creswell and Plano Clark, 2011). 
 
Figure 3.1 Mixed Methods Research Design Typology 
Morse (1991) a nurse researcher developed a notation system for depicting the type 
of methods (Qual,Quan), mixing (sequential, qualèquan) and weighting 
(supplemental method - qual, dominant method - QUAN) given to the methods of the 
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study. The weighting and timing of this research design using Morse’s notation 
system is qualèQUAN.Table 3.3 depicts the exploratory sequential design 
procedure of this study using this notation system.  
The  exploratory  sequential  design  begins  with  the  collection  and  analysis  of  
qualitative data using semi-structured interviews to explore a phenomenon in this 
case health value and perceived control. The design builds on the results of the 
qualitative phase by developing an instrument and by stating research questions that 
have resulted from the qualitative results.  The second phase,  the quantitative phase 
then uses these results to alter or add to data collection and data analysis methods.  
Creswell and Plano Clark (2011:87) argue that  
‘since the exploratory design begins qualitatively the research problem and 
purpose often call for the qualitative strand to have a greater priority within 
the design’. 
However, as previously mentioned the purpose and questions of this research 
advocate a greater weight to the quantitative phase of this study when testing MSLT. 
This change to the traditional approach of the weighting of the design was influenced 
by the pragmatic approach to this research. 
There are several strengths to using the exploratory sequential design. Firstly, the 
phased design adds to the generalizability of the results. Secondly, separate phases 
make the exploratory design straightforward to describe, implement and report 
(Creswell and Plano Clark, 2011). Lastly, a new instrument can be developed 
(Creswell and Plano Clark, 2011) or a current instrument adapted as one of the 
potential products of the research process.  
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Table 3.3 Diagram of Exploratory Sequential Research Design 
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The phase in which the research builds on the qualitative results to develop or adapt 
an instrument is termed the interim phase. During this phase of the researchCreswell 
and Plano Clark (2011) recommend deciding on which data to use from the 
qualitative phase to develop a quantitative instrument orto generate quantitative 
measures. Also procedures should be undertaken to ensure the instrument and the 
scores developed on the instrument are valid and reliable (Creswell and Plano Clark, 
2011). Chapter 5 Section 5.6describes the steps taken to adhere to these 
recommendations and discusses the methods used during the qualitative and interim 
phase. 
Therefore the rationale for adopting the exploratory sequential design is fourfold. 
Firstly, a construct of MSLT, health value requires further investigation prior to 
statistical testing. Secondly, as a result of the first rationale this design provides the 
opportunity  to  subjectively  explore  another  construct  of  MSLT,  perceived  control.  
Thirdly, this method of exploration is expected to enable development of a more 
reliable instrument to measure health value rather than just relying on previous 
research (Creswell and Plano Clark, 2011). Fourthly, this design will contribute to a 
more holistic exploration and testing of the constructs of MSLT. 
3.8 Ethical considerations 
Approval from the Lothian regional research ethical committee and from Lothian 
hospitals research and development department was obtained for the research project 
to proceed. The purpose of the research ethics committee is to safeguard the dignity 
rights and welfare of research participants(COREC, 2005). In order to safeguard the 
rights of participants two important procedures were considered during the research 
process which were obtaining informed consent and maintaining confidentiality and 
anonymity.  
Informed consent involves ensuring that participants have adequate information 
regarding the research, comprehend the information, and have the power of free 
choice, enabling them to consent to or decline participation voluntarily (Polit and 
Tatano Beck, 2010). Participants have the right to privacy through various 
confidentiality procedures and maintaining anonymity (Polit and Tatano Beck, 
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2010). The consent forms and participation information sheets administered during 
recruitment  of  both  phases  of  the  study  included  a  description  of  these  rights  and  
how they would be fully maintained during the research process (see Appendix A). 
Separate consent forms and participation information sheets were devised for each 
phase as both phases differed in research purpose and methods. A signed consent 
form was received from participants prior to their participation in the research. Any 
questions or concerns were also addressed at this point.  
A master list was used to code participants. This method of coding was used to 
maintain anonymity. The master list was kept on a password locked computer where 
the researcher only had access. To protect participant identity pseudonyms were used 
in the qualitative phase whilst numbered codes were used for the quantitative phase. 
Initial demographic data was documented on a demographic questionnaire. This data 
was then transferred to an anonymous coded participant pro-forma (see Appendix B). 
The demographic questionnaires were then disposed of in a confidential manner 
along with the master list.  
3.9 Research process 
3.9.1 Research setting 
The research setting was a diabetes outpatient department (OPD) in an acute 
National Health Service location in Lothian Scotland. The diabetes OPD provides 
specialist diabetes care. Patients attending the department include: 
· Type 2 diabetes patients requiring insulin, 
· Most patients with Type 1 diabetes, 
· Women with diabetes who require pre-conceptual care, 
· Pregnant women with diabetes, 
· Children and adolescents with diabetes, 
· Patients developing complications who require specialist care, 
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· Patients with a complicated risk factor profile (NHS Lothian, 2010). 
The health professionals who provide specialist care to these patients include 
consultant physicians, consultant diabetologists, diabetes specialist nurses, staff 
nurses, dieticians, podiatrists and ophthalmologists.  
3.9.2 Access to outpatient department 
The head consultant physician of the diabetes department grantedaccess to the 
outpatient departmentafter he was given information on the purpose of the research 
and assurance that any patients included in the study would be safe-guarded by 
appropriate ethical considerations. Permission to access the department and begin the 
research was received on the 5th of October 2011. The clinical supervisor of this 
research is a consultant in the department and prior to the commencement of the 
research a blanket email was sent out to all staff informing them of the researcher’s 
impending presence and research purpose. Furthermore, a verbal presentation was 
given to the various health professionals in the OPD to introduce the researcher and 
create staff awareness of the research being carried out. This provided staff with an 
opportunity to ask the researcher questions and leaflets were handed out that detailed 
the research proposal (see Appendix C). 
This introductory presentation enabled the researcher to develop a rapport with the 
nursing  team  who  ran  the  diabetes  clinics.  The  research  nurse  in  the  department  
provided a desk and computer for the researcher to use during data collection. This 
computer was used for screening for participants for both phases of the study.  
The screening, recruitment and data collection processes during the qualitative and 
quantitative phases were carried out concurrently. The screening and recruitment 
processes used for both phases of the research are discussed in this chapter in 
sections 3.9.3 and 3.9.4. The methods of data collection for the qualitative phase are 
discussed in Chapter 4 and for the quantitative phase see Chapter 6.  
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3.9.3 Screening 
Screening of patients was carried out to identify potential participants who met the 
inclusion criteria of the study (see section 3.10 for sample inclusion criteria). 
Screening involved registering with SCI-DC  (Scottish Care Information – Diabetes 
Collaboration) a network used in the OPD which allows for the identification of all 
people with recorded diagnosis in the area and is supportive of the Scottish Diabetes 
Survey (SDS) (The Scottish Government, 2013). Clinic lists were provided at the 
discretion  of  the  OPD  secretaries.  The  clinic  lists  enabled  screening  of  suitable  
participants to recruit on that day. Accessing the SCI-DC network and use of clinic 
lists to screen patients for inclusion in this study was in keeping with the ethical 
considerations discussed in section 3.8. Participants were screened for participation 
in both the qualitative and quantitative phases of this research in the same manner.  
3.9.4 Recruitment 
The researcher is a staff nurse elsewhere not in the department recruited from for this 
study.The researcher’s experience as a staff nurse enabled efficient adaptation to the 
OPD’s clinic routine in order to recruit patients for the study.  Furthermore, the 
rapport developed between the researcher and nursing team was essential to the 
recruitment  process  of  the  research  as  it  was  at  the  nurses’  discretion  to  allow  the  
researcher to intercept the patient during their clinic appointment. Recruitment of 
participants involved initially identifying the patient as they entered the clinic. 
Nursing staff would then ask the patient if they would be interested in speaking to a 
researcher present in the clinic. If interest were shown the nurse would then inform 
the researcher who would then intercept the patient. The researcher agreed a time of 
interception with the nursing team that was least disruptive to the patient and running 
of the clinic. This time for both phases of the study was after the patient had seen the 
nurse for routine checks such as blood pressure, weight, blood glucose test, HbA1c 
test, urine test, and general health assessment. This time to intercept the patient was 
suitable as there was a waiting period after seeing the nurse to see the doctor. In this 
timeframe a verbal explanation of the research to potential participants was provided 
with the necessary information to make a decision on whether they would like to 
partake in the research or not. Potential participants were offered time to consider 
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their participation butgenerally patients approached for both phases would agree or 
disagree to take part in the study at this moment.  
The recruitment process was carried out during clinic times. The outpatient 
department coordinate four morning clinics and one afternoon clinic each week. The 
clinics are usually four hours in duration. The recruitment process for the qualitative 
phase took place over two months between the 1st of November 2011 and the 23rd of 
December 2011. Within this timeframe screening, recruitment and data collection 
took place over ten days and required approximately forty hours of the researchers 
time. The recruitment process for the quantitative phase was carried out over four 
months between the 7th of May 2012 and the 31st of August 2012. Within this 
timeframe screening, recruitment and data collection took place over twenty days 
and required approximately eighty hours of the researchers time. For a clear 
presentation of timeframe dates see section 3.4.1, table 3.2. 
3.10 Sample 
A primary inclusion criterion for the study was that participants were diagnosed with 
Type 2 diabetes (see Chapter 1 for rationale). As diabetes is a heavily researched 
area it was decided that the sample selected for both phases of the research would 
include a group of participants not under research in the OPD at that moment in time. 
A group of patients not under research in the OPD at the time of both phases of this 
study included those who were diagnosed with Type 2 diabetes and were on an 
insulin regime. Choosing this sample ensured that the study was not interrupting 
other research in the OPD at that time. It was also beneficial to this research, as the 
timeframe of recruitment of participants would not be disturbed by other research in 
the OPD. Due to the specific nature of the sample it is acknowledged that this sample 
is not representative of all patients with Type 2 diabetes, however, specifying the 
sample could be viewed as advantageous.Type 2 diabetes is a heterogeneous 
condition whereby patients can receive differing treatments depending on the extent 
of progression of diabetes (see Chapter 1 section 1.2). The rationale for including a 
homogeneous sample of Type 2 diabetes patients who are on insulin may be 
considered a strength for data analysis purposes, as interpretation of results was 
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eased with a clear sample that are at a certain stage of Type 2 diabetes disease 
progression. Other inclusion and exclusion criteria are displayed in table 3.4. 
 
 
Table 3.4 Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
· Type 2 diabetes on insulin 
· Any age is acceptable 
· Length of diagnosis: one year or 
more 
· Speaks English 
· No clinical history of cognitive 
impairment 
· Regular and reliable attendance at 
outpatient clinic 
· Does not have Type 2 diabetes or 
is not on insulin 
· Length of diagnosis less than one 
year 
· Does not speak English 
· Has clinical history of cognitive 
impairment 
· Does not attend clinic 
 
The rationale for including patients who are diagnosed for one year or more is that 
the interviews and questionnaires will involve questions about diabetes self-
management behaviours. Allowing for one year since diagnosis anticipated that 
participants had substantial experience of managing Type 2 diabetes. It was expected 
that this experience would contribute to answering the research questions.  
The nature of the interview questions and questionnaires required participants to 
recall previous personal experiences. This can introduce recall bias to the study. 
Recall depends entirely on memory which can often be imperfect and therefore 
unreliable (Hassan, 2006). According to Sackett (1979) recall bias can be introduced 
in the data collection stages of investigation.Thus it was deemed necessary to try and 
reduce the introduction of recall bias to this study.  An approach used in this study to 
reduce  recall  bias  was  the  exclusion  of  any  person  with  a  clinical  history  of  a  
cognitive impairment from the study. Luis et al. (2003:438) define cognitive 
impairment as  
‘impairment in one or more cognitive domains (typically memory), or an 
overall mild decline across cognitive abilities that is greater than would be 
expected for an individual’s age or education, but that is insufficient to 
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interfere with social and occupational functioning as is required for dementia 
syndrome’.  
This definition was kept in mind during screening of participants for both phases of 
the study. Other approaches used to reduce recall bias will be discussed in the 
interim and quantitative phase of this research. 
3.10.1 Sampling strategy 
The sampling strategy for this study considers the type of sampling used for both the 
qualitative and quantitative phases, the relationship between the samples, the time 
orientation of the samples and the size of both samples. 
The exploratory sequential design generally uses two different samples within its 
phases of data collection (Creswell and Plano Clark, 2011). Onwuegbuzie and 
Collins (2007) assert that if the objective of the research is to gain an insight into a 
phenomenon then the researcher purposefully selects individuals for the research that 
maximizes understanding of the underlying phenomenon. Both phases of this 
research share a common objective that is to understand the phenomenon of 
predicting health behaviour in a Type 2 diabetes population using MSLT. Thus 
purposive sampling is the sample method of choice for this research. It can be used 
in both qualitative and quantitative research and it is a practical approach to 
obtaining a sample as participants are chosen that will best contribute to the 
information needs of the study (Polit and Tatano Beck, 2010).  
Determining the relationship between samples in a mixed methods study is important 
as  it  can  highlight  the  objective  and  differences  of  the  two  samples.  According  to  
Onwuegbuzie and Collins (2007) these relationships can either be identical, parallel, 
nested or multi-level. The relationship of the samples used in both phases of this 
research can be considered parallel. A parallel relationship indicates that the samples 
for the qualitative and quantitative components of the research are different but are 
drawn from the same population of interest (Onwuegbuzie and Collins, 2007). A 
sampling design in mixed methods research considers time orientation and 
relationship of the samples (Onwuegbuzie and Collins, 2007). Thus the sample 
design for this study can be described as sequential with a parallel relationship. In 
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addition  to  selecting  the  type  of  sampling  and  sampling  design  of  this  research  the  
size of each sample for each phase needs to be determined.  
3.10.2 Qualitative sample size 
There are no rules for sample size in qualitative research, sample size is usually 
determined based on informational needs (Polit and Tatano Beck, 2010). A guideline 
in sampling for qualitative research is known as data saturation. This is sampling to 
the point that no new information is obtained and redundancy is achieved (Polit and 
Tatano Beck, 2010). Data saturation was sought in this study in relation to the a 
priori themes of health value and perceived control (Health Locus of Control and 
Self-Efficacy). Furthermore, data saturation was sought in relation to the emergent 
themes that influence participants’ health value and perceived control and impact on 
diabetes self-management behaviour (See Chapter 5, Section 5.1, p89). Data 
saturation in this study became apparent following the tenth interview. It was evident 
that no new themes were emerging and repetition in relation to the deductions made 
from the a priori themes was occurring. In order to validate that data saturation was 
reached the researcher carried out two further interviews. The data from the final two 
interviews did not create new information and it was concluded that redundancy of 
themes was achieved. Data saturation was reached following sound sampling 
techniques, data collection decisions, reflexivity and through a thorough thematic 
analysis (Polit and Tatano Beck, 2010).  
Other factors that may impact on qualitative research sample size have been 
suggested by a number of researchers (Morse, 2000, Ritchie et al., 2003, Mason, 
2010). Morse (2000) suggests that the scope of the study, the nature of the study 
topic and the quality of the data obtained are factors which also contribute to the 
decision on sample size in a qualitative study whilstRitchie et al. (2003) consider the 
types of data collection methods used as a factor. Mason (2010) investigated sample 
size and saturation in PhD studies using qualitative interviews. Mason (2010) found 
that  many PhD students  do  not  fully  understand  the  concept  of  data  saturation  and  
purposely chose large samples to be able to defend their research. In order to fully 
ensure that the data saturation concept was understood and applied 
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appropriatelyquality criteria for evaluating qualitative research was utilised. The 
following four criteria proposed byYardley (2000:215) were considered in this study.  
1. Sensitivity to context: sensitivity not just to the context of the social setting in 
which the research is conducted but also to potentially relevant theoretical 
positions and ethical issues. 
2. Commitment and rigour: substantial engagement with the subject matter, 
having the necessary skills and thorough data collection and analysis. 
3. Transparency and coherence: research methods clearly specified, clearly 
articulated argument and a reflexive stance.  
4. Impact and importance: importance of having an impact on and significance 
for theory, the community on which the research is conducted and the 
practitioners (Yardley, 2000:215). 
See  Chapter  4  for  details  of  reflexivity,  data  collection  and  analysis  methods  used  
and Chapter 5 for the qualitative findings on the a priori and emergent themes.   
3.10.3 Power analysis 
Through power analysis the researcher estimated the sample size necessary to test the 
research hypotheses in the quantitative phase(Cohen, 1988, Clark-Carter, 2004). 
Knowledge gained from an extensive literature review carried out on behavioural 
research informed the researcher that the typical response rate for participants was 
20%, to name but a few(Endler et al., 2001, O'Hea et al., 2005, Jerant et al., 2008, 
O'Hea et al., 2009). Due to time and resource limitations it was anticipated that 
access would be given to at least 400 patients in the clinic. Therefore with a response 
rate of 20% the estimated sample size would be 80 people.  
Based on power analysis, a sample size of 80 will produce 80% power at the 0.05 
level  of  significance  to  detect  an  effect  size  of  0.3.  A computer  program known as  
Gpower3 developed byFaul et al. (2007) was used to carry out power analysis. 
Gpower3 is recommended by statistics textbooks in the social, behavioural and 
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biomedical sciences as being a reliable power analysis program(Clark-Carter, 2004, 
Bryman, 2008).  
The  type  of  power  analysis  used  was  sensitivity  analysis  where  the  critical  
population effect size is computed as a function of alpha (level of significance), 1-β 
(power),  and  n  (sample  size)  (Faul  et  al.,  2007).  This  type  of  power  analysis  was  
deemed appropriate as it enables the researcher to answer questions on what effect 
size a study can detect with a power of 0.8 given its sample size and alpha as 
specified by the researcher(Faul et al., 2007). This allowed the researcher to 
determine that a minimum effect size of 0.3 is sufficiently sensitive for research and 
the size of n is realistic (Faul et al., 2007).  
Dodeen (2003) recommends increasing the sample size, as suggested by power 
analysis, as it can be anticipated that missing data will occur. AdditionallyEdwards et 
al. (2002) found that non-response to postal questionnaires reduces the effective 
sample size and can introduce bias. In order to reach the target sample and to avoid 
reducing the effect size and introducing bias 148 participants were recruited for the 
quantitative phase. The response rate was 72.2% at 107 returned questionnaires. The 
non-response rate was 27.8% at 41 non-returned questionnaires. It is not known why 
41 participants did not return the questionnaires that came with a stamped envelope. 
It  could  have  been  for  a  number  of  reasons  such  as  many  of  the  participants  were  
elderly and may have had problems getting to a post box or the fact that completing 
the questionnaires could be time consuming may have been an issue. Due to 
researcher resources incentives to return the questionnaires were not offered. The 
non-response rate could not be followed up by the researcher as regulations for the 
study set out by the research ethics committee did not enable this. 
3.11 Summary 
This chapter has highlighted the research design and methods of this mixed methods 
research study.The research process and sampling strategy for both the qualitative 
and quantitative phases was discussed.  
Chapter 4 presents the qualitative methods of data collection and analysis followed 
by an analytical presentation of the qualitative findings in Chapter 5. Additionally 
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Chapter 5 presents a discussion on the methods used during the interim phase to 
develop and enhance the qualitative findings that contribute to the quantitative phase. 
The results of the statistical methods chosen to test the outcomes of the interim phase 
are also presented in Chapter 5. Chapter 6 provides a discussion on the quantitative 
methods  of  data  collection  and  analysis  used  in  the  quantitative  phase  of  this  






4 Qualitative phase 
4.1 Introduction 
Silverman (2011:17) asserts that the main strength of qualitative research  
‘is its ability to study phenomena which are simply unavailable elsewhere’. 
According to Payne and Payne (2004) the core concern of qualitative research is to 
seek out and interpret meanings that people bring to their own actions, rather than 
describing any regularities or statistical associations between variables. Qualitative 
research seeks to answers questions about the what, how or why of a phenomenon 
rather than questions about how many or how much (Green and Thorogood, 2004). 
Thetheoretical perspective of this study has guided the research questions of the 
qualitative phase which ask: 
· How do people with Type 2 diabetes value their health and perceive control 
over their condition? (RQ2) 
· How does having Type 2 diabetes impact on a person’s beliefs and values 
and thus self-management of their condition? (RQ3) 
These questions aim to facilitate the exploration of the constructs of MSLT. By 
exploring the constructs in this manner it is anticipated that the underlying rationality 
for diabetes outcome behaviours can be identified. Green and Thorogood (2004) 
highlight the importance of an approach such as this to public health and health 
promotion interventions as they are often associated with changing behaviour.  
‘Without an empathetic understanding of why people behave as they do, we 
are unlikely to identify the possibilities for change’ (Green and Thorogood, 
2004:25). 
It is difficult to refer to qualitative research as a distinctive research strategy 
(Bryman, 2008). Many qualitative studies acknowledge a link to one of the 
qualitative research traditions of inquiry such as ethnography, phenomenology, 
grounded theory, case studies and narrative analysis (Polit and Tatano Beck, 
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2010).There are differing methods of data collection and data analysis that are 
associated with the various traditions of qualitative research. This mixed methods 
research has adopted a pragmatic approach of inquiry to the qualitative phase that 
does not fit into a traditional qualitative inquiry typology. Polit and Tatano Beck 
(2010) assert that a qualitative study such as this can be referred to as a descriptive 
qualitative study and is based on the premise of naturalistic inquiry. Gubrium and 
Holstein (1997)describe naturalism as an inquiry which seeks to understand social 
reality in its own terms and provides rich descriptions of people and interactions in 
natural settings. Naturalistic inquiry has two preferred methods of data collection, 
observation or interviews (Silverman, 2011). Interviews were chosen as the data 
collection method for the qualitative phase. This decision was made as interviews 
were seen as a sufficient method to enable exploration of the constructs of health 
value and perceived control. Silverman (2011:166) asserts that the decision on which 
data collection method to use in a research project depends upon the research topic,  
‘as methods in themselves have no intrinsic value’. 
Qualitative researchers Holloway and Todres (2003:347) suggest that it is important 
to choose a method that is appropriate to the research questions rather than  
‘being too attached to a method for method’s sakewhere you are 
committed  to  method  rather  than  the  topic  of  the  research  and   
questions posed’ (Holloway and Todres, 2003:347). 
This approach to choosing a method was consistent not only for the data collection 
method of the qualitative phase but also for the data analysis method. Thematic 
analysis is the data analysis method of choice as it is a flexible approach that can be 
used across a range of epistemologies and research questions (Braun and Clarke, 
2006). 
This chapter is structured as follows: 
· Section 4.2 
 
Reflexivity 
· Section 4.3 
 
Qualitative participants 




· Section 4.5 
 
Data analysis 
· Section 4.6 Summary 
 
4.2 Reflexivity 
Although this research is a mixed methods study during the qualitative phase the 
researcher pertained to the qualitative tradition of reflexivity. Reflexivity focuses 
upon the researcher’s subjectivity of  
‘what I know’ and ‘how I know it’ and entails an on-going conversation 
about experience while simultaneously living in the moment(Hertz, 
1997:viii). 
Thus  reflexivity  requires  the  researcher  to  be  critically  conscious  through  personal  
accounting of how the researcher’s self-location, position and interests influence all 
stages of the research process (Pillow, 2003). As a result of the processes involved in 
reflexivity it has become associated with or used as a measure of legitimacy and 
validity in qualitative research to guard against personal bias in making judgements 
(Pillow, 2003, Alvesson and Skoldberg, 2009, Polit and Tatano Beck, 2010). 
Reflexivity  was  used  during  the  qualitative  phase  of  this  research  to  facilitate  a  
process of reflecting critically on the self and of analysing and making note of 
personal values that could affect data collection and interpretation (Polit and Tatano 
Beck, 2010). The various methods of reflexivity employed during the qualitative 
phase include identifying presuppositions prior to data collection, adopting a 
reflective routine after each interview and the use of memo’s during data analysis 
(see section 4.5 for a detailed description of the use of memos).  
The presuppositions and reflection made prior to beginning the qualitative phase is 
displayed below. The reflection highlights the researcher’s critical reflection of the 
self and the role of the self in her research. It also identifies any biases she may have 
and how she may deal with those during the research process. In order to think about 
possible presuppositions the researcher questioned her own beliefs on health value 
and how health behaviours are experienced in her life.  
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Reflection dated: September 30th 2011 
LN: ‘When thinking about health behaviour and how I value health I believe 
that I actively engage in health behaviours solely for the purpose of being 
healthy. I like to think I eat healthily and take regular exercise and go for 
regular health check ups. I wouldn’t agree with people who do not see health 
as an important value in life, as without health we wouldn’t be here. Perhaps 
health value is influenced in my situation by being a nurse and experiencing 
how certain lifestyle choices can have detrimental effects on your quality of 
life later in life. However, at work on a daily basis I care for patients whose 
lifestyle choices may not be the most socially desirable and could impact 
hugely on their health, yet, I would never judge them for this. I would only 
want to assess where the problems are and identify how their behaviour can 
be changed to benefit them. By doing a holistic assessment of the patient you 
can see their motives for carrying out such behaviours, their reasoning for 
having such values and the influences in their life which can lead to poor 
health such as social deprivation which can affect health value.  
Although I am biased in my thoughts on living a healthy life I do not think 
my bias will affect the way I view and or interpret other peoples outlook on 
health and its importance during my research. Every individual will have a 
different view for differing reasons and the importance of understanding 
these viewpoints is essential to gaining an appreciation of their valued goals 
in life. This may enable me as a health professional to see the whole patient 
and possibly integrate their viewpoints into planning care and work around 
these to achieve what are considered good health outcomes’. 
Having identified presuppositions prior to beginning the qualitative phase the 
researcher decided that she would be introduced to the qualitative participants as a 
health researcher and not as a nurse. The rationale behind this was twofold. Firstly, 
the researcher was not acting as a staff nurse within the OPD but as a researcher. 
Acting as such was in keeping with the ethical considerations of the study. Secondly, 
by introducing herself as a nurse may have lead to acquiesced responses from the 
participants in regards to theirself-management of Type 2 diabetes. It was anticipated 
that by introducing herself as a health researcher she may reduce the acquiescence 
response bias of participants by being viewed as a health researcher rather than as a 
nurse doing research. The researcher was clear about her role as a health researcher 
in the OPD to participants. If participants required information outwith the remit of 
the study they were referred to an appropriate health professional working in the 
OPD. This process worked effectively.  
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The reflective routine adopted after each interview involved writing in a reflective 
diary. Gibbs (1988) model of reflection was used to facilitate the reflective process. 
Gibbs’s reflective model is clear and precise and allows for description, analysis and 
evaluation  of  the  experience.  This  process  of  reflection  highlighted  areas  for  
improvement during the interview process such as the researchers interview skills of 
probing and listening. Gibbs’s reflective model prompted the researcher to create an 
action plan to improve her practice in each ensuing interview. Reflection was also 
carried out following transcription of each interview and documented in the 
reflective diary and in memos during the data analysis. This part of the reflective 
process resulted in an enhanced interview guide prior to the succeeding interviews 
(see section 4.4.2).  
The ensuing sections include a description of the participants of the qualitative phase 
followed by the qualitative methods of data collection and data analysis. 
4.3 Qualitative participants 
Twelve participants took part in the qualitative phase of this study. Originally there 
were thirteen participants, however one participant’s interview was removed from 
the data analysis due to cognitive impairment. This participant was screened for 
cognitive impairment prior to recruitment, yet there was no documentation to suggest 
this patient was cognitively impaired, thus that is why he was approached. The 
patient verbally agreed and consented to interview. During the interview it became 
apparent that the participant was cognitively impaired through his way of speech and 
recall. The researcher continued the interview, as the participant was keen to 
contribute to the research and the researcher wanted to show gratitude for his 
participation and time. The interview was continued to the point where the researcher 
thought that the participant felt he had contributedsubstantially to the research. The 
participant was then thanked for his time but the data collected was deemed void and 
not included in the analysis.  
Table 4.1 depicts characteristics of the twelve participants who took part in the semi-
structured interviews. These characteristics are displayed in this section rather than in 
the qualitative results chapter, as it was deemed necessary to introduce the 
participants  of  the  qualitative  phase  prior  to  the  analytic  discussion  of  a  priori  and  
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emergent themes in Chapter 5. The characteristics displayed include individual 
characteristics (pseudonym, gender, age and the presence of comorbidities) and 
clinical parameters (medication regime, BMI and HbA1c result). 
Pseudonyms are used to protect participants’ identities. Ten males and three females 
participated in the qualitative phase of this research. Ages ranged from the youngest 
participant being 46 years old to the oldest participant who was 77 years old. The 
average age of the participants was 61. All participants had Type 2 diabetes and were 
on insulin.However, some participants’ medication regime included an oral anti-
hyperglycaemic adjunct therapy. Participants on a medication regime such as this are 
described in table 4.1 as insulin+ and those without are described as insulin-. The 
average length of time since diagnosis of Type 2 diabetes was 13 years and all 
participants reported having one or more comorbid conditions. Participants’ average 
body mass index (BMI) was 32 .8. This level of BMI is considered obese by the 
NHS BMI Calculator (2012). HbA1c is a blood test that indicates blood glucose 
levels for the previous two to three months. Details of participants’ HbA1c result 
taken at the clinic on the day of interview were documented for descriptive purposes. 
The average HbA1c result was 69mmol/mol which is out with the optimal range of 
HbA1c 48-58 mmol/mol, as recommended by(Diabetes UK, 2013a). 
Table 4.1 Characteristics of qualitative participants 






Comorbidities BMI HbA1c 
Mary  F 60 Insulin- 10 Years Yes 33.43 75mmol/mol 
Charles  M 71 Insulin+ 20 Years Yes 29.61 77mmol/mol 
Harry  M 57 Insulin- 9 Years Yes 34.27 87mmol/mol 
Roger  M 64 Insulin- 13 Years Yes 29.39 48mmol/mol 
Harriett  F 46 Insulin+ 12 Years Yes 43.5 99mmol/mol 
John  M 75 Insulin- 24 Years Yes 27.83 52mmol/mol 
Rosie  F 62 Insulin- 3 Years Yes 38.69 75mmol/mol 
Garry  M 70 Insulin- 10 Years Yes 31.32 55mmol/mol 
Tom  M 50 Insulin- 14 Years Yes 33.78 92mmol/mol 
Sean  M 47 Insulin+ 4 Years Yes 39.45 77mmol/mol 
Paul  M 77 Insulin- 16 Years Yes 23.53 53mmol/mol 
Adam  M 55 Insulin- 23 Years Yes 28.91 49mmol/mol 
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4.4 Data collection 
4.4.1 Semi-structured interview 
As previously mentioned the data collection method of choice for the qualitative 
phase was the semi-structured interview. Mason (2002) affirms that qualitative 
research operates from the perspective that knowledge is situated and contextual. 
Therefore the role of the interview is to ensure that relevant contexts are brought in 
to focus so that situated knowledge can be produced(Mason, 2002). This was 
demonstrated through the use of a semi-structured interview format. Within this 
method of interview, interviewers refer to a prepared guide that includes a number of 
questions (Roulston, 2010). These questions are usually open ended, and after posing 
each question to the interviewee the interviewer follows up with probes seeking 
further detail and description about what has been said (Roulston, 2010). 
Similarly to other interview structures, researchers using semi- structured interviews 
must have highly developed listening skills to be able to both ascertain whether the 
research topics have been addressed by the interviewee and when and how it is 
appropriate to follow up on accounts given (Arksey and Knight, 1999, Rubin and 
Rubin, 2005, Roulston, 2010). 
4.4.2 Interview guide 
Arksey and Knight (1999)maintain that the greater our understanding is in an area 
whether through extensive literature searching or through our own experience, the 
better we can connect with the interviewee. An extensive literature review on the 
research topic was carried out (see Chapter 2). As a result a sophisticated knowledge 
base on the research topic was acquired enabling the development of a semi-
structured interview guide.The constructs of MSLT were considered a priori issues 
that required exploration. Questions included in the interview guide were composed 
to address these constructs and included associations to self-management behaviours 
of Type 2 diabetes. Therefore the interview guide was developed to elicit responses 
about how health value and perceive control impact on Type 2 diabetes patients’ 
outcome behaviours. In this instanceSrivastava and Thomson (2009) recommend 
maintaining an open mind and to not force the data to address the a priori issues.  
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Bryman (2008)presents some basic elements in the preparation of an interview guide. 
Following Bryman’s (2008) recommendations a certain amount of order was created 
on the topic area of the questions to allow a continuous flow of conversation during 
the interview. As the interview questions were mainly open broad parameters were 
provided within which the interviewee’s could formulate answers in their own words 
concerning topics specified by the researcher.  
An early version of the interview guide, which was considered a pilot guide, was 
developed and tested on the first four interviews. Ideas for improvement for the 
follow up guide were developed after transcribing the first four interviews. The final 
interview guide is displayed in Appendix D. 
4.4.3 Recording equipment 
Arksey and Knight (1999) recommend audio-taping as the method of choice for 
recording an interview. This creates a permanent record that captures the whole of 
the interview conversation verbatim, as well as the tone of voice, emphasis and 
pauses(Arksey and Knight, 1999). Whilst recording the interviewer considered some 
disadvantages to this method, one in particular is that the idea of taping might 
increase nervousness and dissuade franknessand also transcribing can be a lengthy 
process(Arksey and Knight, 1999, Willis, 2005).In order to reduce these 
disadvantages a hand held digital recording device with an omni-directional 
microphone was used. This device is small in size thus its physical presence is 
notably reduced in comparison to some recording devices, this may have reduced 
interviewee nerves. Furthermore, this device interfaces well with computers though a 
USB connection where interviews can be transferred for ease of transcription. 
4.4.4 Interview setting and timing 
Interviews took place in the OPD in a consulting room conducive to interviewing. 
Comfortable seating was available and seating was arranged so that the researcher 
and interviewee were sitting opposite each other. The recording device was placed 
near both speakers in order to pick up the best possible sound. During each interview 
a sign was placed on the interview room door in order to ensure that the interview 
would not be disturbed. The timing of the interviews ranged between thirty minutes 
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and one hour. This depended on the individual being interviewed and how much they 
wanted to share or discuss. The total data collection time for the interviews including 
screening and recruitment was 40 hours over ten days. However, in addition to this 
many other hours were spent screening and recruiting for other possible participants 
but who subsequently did not agree to take part. Recruitment for the qualitative 
phase began on the 1st of November 2011 and ended on the 23rd of December 2011 
(See Chapter 3 section 3.9 for further details). 
4.5 Data analysis 
The purpose of data analysis regardless of the type of data or underlying research 
tradition is to organise, provide structure to and elicit meaning from the data (Polit 
and Tatano Beck, 2010). Qualitative data analysis can be particularly challenging as 
there is an absence of standard analytic procedures(Polit and Tatano Beck, 2010). 
However, Braun and Clarke (2006) assert that qualitative analytic methods can be 
identified under two divisions. The first division includes those who are tied to a 
particular theoretical or epistemological position and the second includes those that 
are independent of theory and epistemological position and can be applied across a 
range of traditions. A shared skill of data analysis amongst the two divisions is the 
generic skill of ‘thematizing meanings’ (Holloway and Todres, 2003).Boyatzis 
(1998:4) supports this assumption when he describes thematic analysis as a  
‘process that can be used with most, if not all qualitative methods’. 
Thematic analysis was chosen as the analytic method of choice for the qualitative 
phase due its theoretical freedom that can therefore be considered compatible with 
mixed methods research. The term thematic connotes the analysis of verbal material 
and the use of relatively comprehensive units of analysis such as themes (Smith, 
1992).Braun and Clarke (2006) describe how a theme can enable a researcher to 
capture something important about the data in relation to the research question and 
represents some level of patterned response or meaning within the dataset.  
Thematic analysis is widely used but there is no clear agreement on its analytic 
procedures (Boyatzis, 1998, Tuckett, 2005, Braun and Clarke, 2006). Braun and 
Clarke (2006) attempted to clarify this gap in the literature by providing 
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recommendations for carrying out thematic analysis and offer a phased guide on the 
steps which should be undertaken to achieve an effective thematic analysis.  
The recommendations include identifying whether the thematic analysis is inductive 
or deductive as themes or patterns can be identified by either method. As previously 
mentioned in section 3.5 a process of abductive thinking was adopted for this 
research. Therefore an abductive approach to the thematic analysis process was 
carried out, as the theoretical framework of MSLT requires a deductive exploration 
of the constructs of health value and perceived control and an inductive approach is 
required to ascertain whether these constructsinfluence Type 2 diabetes patients self-
management behaviours. The deductive approach to this thematic analysis involved 
identifying the constructs of MSLT (health value and perceived control) as a priori 
themes for exploration.Ryan and Bernard (2000) affirm that themes can be a priori 
theoretical constructs identified by the researcher prior to thematic analysis. Any 
other themes identified through the inductive approach to thematic analysis are 
considered emergent themes. In order to assist this thematic analysis a computer 
assisted qualitative data analysis software (CAQDAS) was used. 
4.5.1 Computer Assisted Qualitative Data Analysis (CAQDAS) 
CAQDAS software packages were initially developed to enhance the accessibility of 
qualitative data by overcoming the physical limitations of paper data records 
(Richards, 1999, Richards, 2002). There has been much debate about the use of 
CAQDAS amongst qualitative researchers (Kelle, 1995, Richards, 1999, Weitzman, 
2000, Bringer et al., 2004, Wickham and Woods, 2005). The key issue being debated 
is whether CAQDAS changes the way qualitative data analysis is carried out and to 
what extent it enhances or detracts from the quality of qualitative research (Bringer 
et al., 2004). The quality of qualitative research can be reduced through CAQDAS as 
it has the potential to produce a rigid automated analysis of text that in actuality 
requires human interpretation (Kelle, 1995, Bringer et al., 2004). In order to avoid 
detracting from the quality of qualitative research CAQDAS was used in this study 
to assist in the undertaking of qualitative data analysis and considered as a tool that 
enables a more efficient organisation of data and its  analysis.  Interpretation of data 
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was understood to be a process undertaken by the researcher and not CAQDAS this 
understanding helped to maintain the context and nature of the data during analysis. 
The CAQDAS used in this study was NVivo 9 developed by QSR 
International.There are five principal ways in which NVivo supports analysis of 
data(Bazeley, 2011): 
· Manage Data: Data was managed in NVivo by first creating a project and 
then devising differing files to store raw data from interviews, the transcribed 
interviews  and  reflections  on  each  interview.  The  memo  function  in  NVivo  
helped to maintain an audit trail of key points and issues arising from the 
data, thoughts about the meaning or significance of themes and reflections 
during analysis. 
· Manage ideas: Ideas for themes were managed through the use of coding. 
Boyatzis (1998) describes coding as the disaggregation of data into text units 
that can be categorized within a thematic classification system. A code in 
NVivo is stored in a node which provides access points for storing coded text. 
A node structure of the a priori themes was inputted into NVivo before 
coding began. Contrasting codes to a priori codes are those that are derived 
directly from the data and are termed in vivo codes. These codesare used to 
develop emergent themes. Codes can be highlighted within text in NVivo and 
there  are  coding  stripes  that  can  allow  you  to  select  which  nodes  are  most,  
least or recently coded. These functions helped to manage the coding process. 
The tree structure in NVivo was also used to manage nodes. The tree 
structure is a classification system that enables the researcher to identify the 
relationships between categories and subcategories of themes. 
· Query data: NVivo provided a flexible way to gather an explore subsets of 
the data through the query function. Queries provides a search function which 
enables an efficient way of finding words or phrases within nodes and when 
required assisted in identifying patterns of coding.  
· Graphically model:Simple graphic models were used in NVivo to build on 
ideas and concepts when developing themes. These models are considered 
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thematic maps in this study and will be displayed in the phased discussion of 
the methods of thematic analysis below.  
· Report from the data: The ideas and knowledge developed in NVivo from 
the original data sources were used to report the rationale for the development 
of themes and the process by which this rationale was reached. 
The following section discusses the phased steps of the methods of thematic analysis. 
4.5.2 Phases of Thematic Analysis 
Braun and Clarke (2006) phased guide on the steps of thematic analysis was adopted 
in  this  study  to  illustrate  the  phases  of  thematic  analysis  in  a  logical  and  coherent  
manner. 
Table 4.2 Phased Steps of Thematic Analysis adopted from Braun and Clark (2006) 
Phase Description of the process 
 
1. Familiarizing 
yourself with your 
data:  
 
2. Generating initial 
codes:  
 
3. Searching for 
themes:  
 
4. Reviewing themes:  
 
 
5. Defining and 
naming themes:  
 
6. Producing the 
report 
 




Coding interesting features of the data in a systematic fashion 
across the entire data set, collating data relevant to each code. 
 
Collating codes into potential themes, gathering all data relevant 
to each potential theme. 
 
Checking if the themes work in relation to the coded extracts and 
the entire data set generating a thematic ‘map’ of the analysis. 
 
Ongoing analysis to refine the specifics of each theme, generating 
clear definitions and names for each theme. 
 
The final opportunity for analysis. Selection of vivid, compelling 
extract examples, final analysis of selected extracts, relating back 
of the analysis to the research question and literature, producing a 
scholarly report of the analysis. 
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Phase 1: Familiarising yourself with the data 
Transcription is the written representation of speech. The transcription process was 
arduous yet valuable as it facilitated what Bazeley (2011) called ‘building knowledge 
of your data’. The goal of the transcription process was to be as true to the interview 
conversations as possible. The interviews were transcribed in full. On average each 
interview took four to five hours to transcribe. During transcription reflections on 
each interview, ideas of emerging themes and thoughts on the a priori themes were 
documented using memos in NVivo.  
Silverman’s (2011) Simplified Transcription Symbols were used to demonstrate the 
interaction process between the interviewer and the interviewee. The symbols enable 
ease of reading as they identify features of natural conversation during the interview 
such as pauses, overlaps or emphasized wording. Not all of Silverman’s symbols 
were used as too many symbols could impede reading effectively. Symbols deemed 
important to facilitating the interpretation of qualitative data were kept and are 
displayed in table 4.3 below. 
Table 4.3 Silverman's (2011) Simplified Transcription Symbols 
Symbol Transcription 
[ Point at which speech is overlapped by other speaker. 
 
(.4)    Numbers in parentheses indicate elapsed time in silence in tenths of a 
second. 
 
(.) A dot in parentheses indicates a tiny gap, probably no more than one-tenth 
of a second.  
 
Word Underscoring indicates some form of stress via pitch and or amplitude. 
 
WORD Capitals indicate especially load sounds relative to the surrounding talk. 
 
((      )) Double parentheses contain author’s descriptions rather than 
transcriptions. 
 
- Hyphen indicates end of speech by participant. 
 
Other symbols used include:LN: Linda Nugent (Interviewer).Each Participants age is 
included once onintroduction in the qualitative results chapter e.g.  (60) = 60 years 
old. 
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Phase 2: Generating initial codes 
Transcriptions were read countless times to begin the coding process andgenerate 
initial  codes.Codes  were  theory  driven  and  data  driven.  Theory  driven  codes  were  
derived from the a priori themes of health value and perceived control whilst data 
driven codes included common subjects on self-management behaviours described 
by Type 2 diabetes patients. The process of initial coding enabled the sorting of data 
into meaningful groups using nodes in NVivo. Tree nodes further classified these 
codes into categories where related concepts were gathered. Each code was explored 
for meaning in relation to MSLT or Type 2 diabetes in keeping with the theoretical 
perspective and research questions of the qualitative phase. This process of 
exploration  generated  an  awareness  of  the  richness  of  the  data  and  the  detailed  
attention to the text helped maintain focus on the text rather than on the 
preconceptions of the researcher (Bazeley, 2011). 
Phase 3, 4 and 5: Searching reviewing and defining and naming themes 
Phase three included searching the coded transcripts for relationships of codes and 
possible themes. Phase three resulted in the conclusion that data saturation had been 
reached with twelve participants when no more relationships between themes could 
be identified. During phase four and five all codes were reviewed and collated by 
topic under the related a priori themes or emerging themes.This process of collation 
included the use of thematic maps to organise the data into named themes.An initial 
a priori thematic map was developed, as other new themes emerged these were added 
to the map. Themes and sub-themes were defined during this phase and definitions 
for each theme are presented in Chapter 5. The developed thematic map from NVivo 
is displayed in figure 4.1 to demonstrate the relationships between the main a priori 
themes and emergent themes.The sub-themes of the a priori themes are also 
displayed in this map.The a priori themes include perceived control (health locus of 
control and self-efficacy) and health value. Health locus of control has two 
subthemes internal locus of control (LOC), external LOC and an emergent subtheme 
internal versus external LOC beliefs. Health value has two subthemes that are 
instrumental health value and terminal health value beliefs and an emergent 
subtheme change in health value. The emergent themes are listed in figure 4.1 under 
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the emergent theme heading.Figure 4.1 demonstrates that the a priori themes and 
emergent  themes  are  both  associated  to  people  with  Type  2  diabetes  and  these  
themes can lead to interactions that can result in varying outcome behaviours. These 
findings are discussed in more detail in Chapter 5.  
Phase 6: Producing the report 
The final step to the thematic analysis involved producing a report that provides 
sufficient evidence of the themes within the data and an interpretation of the meaning 
and significance of the themes. Using extracts from the data as evidence reinforced 
any analytical claims made. It is important to note that the use of extracts in the 
report went beyond description. Relevant literature and knowledge was accessed to 
review the underlying meaning of the themes and this process enhanced their 
interpretation. Furthermore, the interpretation of the data made arguments 










This chapter has described how mixed methods research questions and the 
theoretical position of this study influenced the data collection methods and data 
analysis methods chosen for the qualitative phase.A process of reflexivity was 
adopted throughout the qualitative phase that assisted the researcher in becoming 
aware of how her sense of self may impact on the data collected and analysed. The 
data collection method of choice for the qualitative phase was semi-structured 
interviews. An interview guide focused the interview process to ensure that relevant 
and situated knowledge was produced. A thorough thematic analysis using NVivo 9 
was carried out. The qualitative findings are presented in Chapter 5. The data from 
the qualitative phase contributed to the development of an adapted health value 
measure and two new research questions and hypotheses. Chapter 5 section 5.6 
details the interim phase and discusses the methods used to address the qualitative 





5 Qualitative findings 
5.1 Introduction 
Chapter five, section 5.2 to 5.5presents the qualitative findings that stemmed from an 
in-depth thematic analysis of 12 semi-structured interviews. The data in this chapter 
reveal how subjective data on generally objectively measured psychological 
constructs can show how beliefs and values influence behaviour. Quotations are used 
throughout the following chapter to highlight this. The transcribed data is presented 
using Silverman’s (2011) simplified transcription symbols to ease reading. A tabular 
representation and explanation of these symbols is presented and explained in 
Chapter 4 section 4.5.2. Explanations on abbreviations are provided in the Glossary. 
Pseudonyms are used to represent participants and the initial ‘LN’ is used for the 
interviewer. 
The present chapter discusses results of the a priori themes Health value and 
Perceived Control (Health Locus of Control and Self-efficacy). When exploring the a 
priori themes new themes arose such as ‘Values in Life’, ‘The Meaning of Health’, 
‘Change in Health Value’, ‘Internal versus External Locus of Control beliefs’, and 
‘Acceptance-Adjustment and Adaptation (AAA)’. These themes are discussed in 
connection with the appropriate a priori and emergent themes throughout Chapter 5.  
The semi-structured interviews identified a number of emergent themes that 
influence participants’ health value and perceived control and impact on diabetes 
self-management: 
· Comorbidities and Type 2 diabetes 
· Reasons for Type 2 diabetes: hereditary and age. 
· Medication Management 
· Stigma of Insulin 
· Blood Glucose Monitoring 
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· Type 1 or Type 2 Classification Issues 
· Low Mood, Anxiety and Depression 
The discussion on the qualitative findings ends with a summary of the qualitative 
findings in section 5.5 and indicates how these findings contribute to answering a 
number of the proposed research questions. The data from the qualitative phase that 
contributed to the interim phase is detailed in section 5.6.The chapter ends with a 
summary on the interim phase. 
This Chapter is structured as follows: 
· Section 5.2  
 
Ascribing Meaning to Values 
Values in life 
Health and its meaning 
Health value 
Changes in health value 
Acceptance-Adjustment-Adaptation 
 
· Section 5.3 Perceived Control: Beliefs and their impact 
Health Locus of Control and Self-efficacy 
Internal LOC versus External LOC 
Beliefs, values and outcomes 
 
· Section 5.4 Emergent Themes 
Comorbidities and Type 2 diabetes 
Hereditary reasoning 
Age as a reason 
Medication management 
Stigma of insulin 
Blood glucose monitoring 
Type 1 or Type 2 diabetes: Importance of classification 
Low mood, anxiety and depression 
 
· Section 5.5 Summary of qualitative findings 
 
· Section 5.6 Interim phase 
Adapting the health value scale and item development 
Adapted health value scale: Structure and scoring 
Validity and reliability of adapted health value scale 
Examining changes in health value 




5.2 Ascribing meaning to values 
5.2.1 Values in life 
To be able to infer causal sequences from values to other constructs such as locus of 
control beliefs and self-efficacy it is important to identify whether a value or value 
system is present prior to or simultaneously with the explanation given by the person. 
According to Rokeach (1979) if the value is present it is possible to hypothesize that 
there is a theoretical connection present with other items. In order to identify whether 
health value is a value held by people with Type 2 diabetes participants were asked 
questions which prompted them to think about ‘what is most valuable to them in 
their life’.  
For John (75) one such value is ‘Life itself’. Harris (1987:120) asserts that  
‘our own continued existence is the ‘sine qua non’ of almost everything and 
what we want or value depends upon our own continued existence’.  
John tells of how his existence is valuable not only to himself but also to his wife,  
‘Well  at  the moment I  have got my wife who is very ill.  She’s had a stroke 
and  a  seizure  and  she’s  got  a  heart  problem  now.  So  if  I  am  not  healthy  I  
don’t know who is going to look after her. So I have got to make sure that I 
keep as fit as I possibly can, and make sure I can look after her’.  
Rosie  (62)  and  Harriett  (46)  express  similar  thoughts  to  John  on  the  value  of  their  
lives to their families. For Rosie ‘keeping healthy’ is imperative to maintaining her 
quality of life so she can ‘see her grandsons growing up’. Harriett’s comments show 
how preserving her health is valuable to her life because if ‘you’re not well it can 
affect your family members and they can worry’. These comments highlight the 
commonalities in human value systems and also the individual differences in the 
arrangement of their value priorities. Here the relationship of health and family 
within a value system is apparent. The reasoning for valuing and maintaining health 
for all three participants is seen primarily as a benefit to their families for differing 
reasons.  For  John  it  was  so  he  could  ‘look  after’  his  wife.  For  Rosie  it  was  so  she  
could see her ‘grandsons growing up’. For Harriett it was not to ‘worry’ her family. 
Paul (77) was unsure of how to differentiate between the importance of different 
values to him.  
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‘I have never given any thought about it. I mean family is important, career is 
important and everything is important you know I don’t think that I can tell 
you that one should pay more attention to one and neglect the other’. 
The above quote highlights Paul’s value system as he describes his values as having 
equal importance along a continuum. His values may enable him to choose between 
alternatives and resolve conflicts in life. Rokeach’s (1968:551) seminal paper  asserts 
that  
‘Given any situation a person may find himself in, it is all but impossible for 
him to behave in a manner that is equally congruent with all of his values’.  
Charles (71) likePaul communicates his value system except it is arranged 
hierarchically. Health is ‘most’ important to him in his life and then ‘money and 
other things’ are next on the order of value in his hierarchy. 
Sean is a 47-year-old male who was diagnosed with Type 2 diabetes in 2007. Sean is 
the only participant to allude to not having any values in life. Although, he professes 
to having no values when asked what is most valuable to you in your life he 
responded: 
‘Living day by day mostly that’s it. A lot of folk will think I am cruel but we 
all come into this world for one thing and we are all going to die some time 
so (.1) that is my outlook. It could take me in the morning (.) it could take me 
next week so it doesn’t bother me’. [ 
LN: [ What is important to you in your life? 
‘Nothing, even though I have got the bairns ((children)) I have got no outlook 
I am getting old so basically I am just waiting on that wee box coming to the 
front door’.  
Here a hopeless picture is depicted. He states that ‘nothing’ is valuable to him in his 
life that he has no interest in maintaining his health and ‘basically’ he is waiting to 
die. This statement is inconsistent with his actual behaviour as if he truly did not 
value his life or his health why was he attending a health appointment at the diabetes 
clinic? 
Sean was then probed with: 
LN: Is your health important to you? 
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‘No just as I said I am waiting on that wee box coming for me and that’s it. I 
have been suffering for too long until I get sorted out (.) there is no outlook. I 
have been trying to get into detox again for about the 5th time. I don’t know 
for how many years’.  
Although Sean’s outlook on life is morbid and his value appreciation is low his 
comments are contradictory. He states that his health is un-important but perhaps this 
is because he feels he has been ‘suffering for too long’ and he has not been able to 
resolve his situation ‘until I get sorted out there is no outlook’. Sean’s case 
emphasizes how his values despite his ‘hopeless’ attitude are still present. Perhaps 
his values are being constrained by his external reality (alcoholism)1. 
Like Sean, Tom’s values appear to be constrained by his external reality.  He found 
the question on values in life ‘difficult’. Tom is 50 and has recently divorced. He was 
diagnosed with Type 2 diabetes in 1997 and developed pneumonia in 2002. An 
admission to hospital for treatment resulted in nephro-toxicity due to an overdose of 
the antibiotic Gentamycin, and he was left with chronic kidney failure and balance 
problems.  
‘The most valuable things in my life have been taken away from me. My wife 
was one and I think my health and my mobility was another. That’s not the 
easiest question to answer’.   
Tom feels his values have been taken away from him. However, it is apparent that he 
still values life, his wife and his health but due to his current situation he is not able 
to act in accordance to those values. 
‘I  have  had  a  major  blow  to  it  ((health))  (.)  it  effects  my  ability  to  live  
everyday life’. 
Tom conveys how his quality of life is reduced as a result of his condition  
‘I am pretty much resigned to the fact that I am going to be disabled if you 
like for the rest of my days’. 
Both Sean and Tom are concurrently similar and different. What is similar is the 
process by which attitudes affect a value system and vice versa. Their value systems 
                                               
1Throughout this thesis text in brackets within passages represent explanatory comments. 
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are repressed by the aetiology of their ill health and their current lived experience. 
Possibly their values have been influenced by their attitude (hopelessness) due to 
their experience with ill health. Another comparison is the way health is now valued 
by both men. They view health as enabling them to do things in their life but now 
that neither have optimal health Sean now has no ‘outlook’ and Tom is ‘resigned to 
the fact’ that he is going to be ‘disabled’ for the rest of his days. The difference is 
evident in their lived experiences. 
Health as a value was described by many participants as an overarching value that 
contributes to the quality of that life.  For instance, Charles’s interview highlights 
this point. 
LN: Can I ask which statement you agree with the most and why?  
Without good health I cannot do the things that I want to. 
My goal is to be as healthy as I can be. 
Charles: The first statement.  
LN: And can I ask you why you went with the first statement? 
Charles: Well I mean I can’t walk as much. I used to walk a lot (.) I used to 
quite like walking and I can’t do that now. And general working about the 
house and things like that ah jobs to be done. I feel in some cases I am not fit 
to do them you know (71).  
Charles expresses how he has valued his heath as he ‘used to walk a lot’ and ‘how he 
can’t  do  that  now’  due  to  ill  health.  Again  apparent  here  as  with  Tom  and  Sean’s  
case is the restriction and changes suboptimal health places on the self and thus 
values. These findings echo the results of a study by Sagiv and Schwartz (2000) who 
examined the relations of value priorities and subjective well-being of students from 
Israel and Germany. They found that people are likely to experience a positive sense 
of  well  being  when  their  situation  allows  them  to  attain  their  goals  to  which  their  
values are directed (Sagiv and Schwartz, 2000). This is relative to the participants 
discussed above as the restrictions they face such as ill health and alcoholism affects 
their ability to attain their desired goals and impacts on ‘subjective’ well-being.  
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The following sections will focus on the meaning of health to the person with Type 2 
diabetes, health value and how health value is influenced by a change in health 
status.  
5.2.2 Health and its meaning 
The word ‘health’ means different things to different people. This was clearly 
evident throughout the interviews. Participants were asked questions that probed 
them on the meaning of health to them such as ‘how important is valuing your health 
to you’ and ‘how would you define health’. All twelve participants’ provided 
comments that highlight the dynamic and subjective nature of health. This finding is 
consistent with existent qualitative literature that health is defined in a range of 
different ways but also that these varying definitions of health have implications for 
behaviour (Bishop and Yardley, 2010, Williams, 1983, Herzlich, 1973, Hughner and 
Kleine, 2004). A review carried out by Hughner and Kleine (2004) identified three 
main ways health was viewed by lay people which were ‘health as the absence of 
illness’,  ‘health  as  the  ability  to  carry  out  daily  tasks’  and   health  as  ‘maintaining  
equilibrium’. The participants’ views on health in this study reflect these results.  
Roger (64) when asked ‘What meaning does the word health have for you’ answers 
with  
‘Generally  health  for  your  body  and  how  you  feel,  and  also  how  it  affects  
your daily life’. 
Roger then goes on to define health as  
‘Just  how you feel  ah how your bodily functions function and if you can do 
things you normally do when you were a bit younger which you can’t 
generally’. 
Rogers’ definition resonates with The World Health Organisation (1948) who 
defined health as a 
‘state of complete physical, mental and social well-being and not merely the 
absence of disease or infirmity’.  
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A definition from Tom (50) on the meaning of health defines health as the absence of 
disease but does not fully incorporate the holistic aspect of health to the same extent 
as Roger. 
Tom defined health as 
‘being free from any inherent immediate problems and I do have one and I 
won’t be able to get rid of it so that’s how I would define it’ (M, 50).   
Four other participants were in agreement with Roger’s holistic view of health. 
Health to Roger encompasses his mental well-being ‘how you feel’, his physical well 
being ‘how your bodily functions function’ and it incorporates the psychosocial 
aspect whereby the psychological, physical and social aspects of health can enable 
him to do things ‘normally’.  
Participants perspectives on the meaning of Health are comparable to a proposition 
by Rogers (1990) that an individual is a unitary human being in which there is a 
mind-body interrelationship. This interrelationship is evident through a statement 
from Harriett ‘I am talking about the mental and physical’. Furthermore, within this 
proposition a holistic orientation to health is advocated and as a result the ‘absence of 
illness’ is no longer the fundamental condition for health(Hwu et al., 2001). This 
proposition encompasses the bio-psychosocial model instead of the traditional 
biomedical model. The bio-psychosocial model is seen as the model of choice today 
when  treating  patients  with  a  chronic  illness  such  as  Type  2  diabetes  as  it  
incorporates the biological, psychological and social factors of health (Peyrot et al., 
1999). SIGN guidelines 116(2010) assert that adults with Type 2 diabetes should be 
offered psychological interventions to improve glycaemic control in the short and 
medium term. These interventions are mostly unavailable or unaffordable and as a 
result not all patients can benefit from this. However, improvements are being made 
in psychological support for people with Type 2 diabetes. In Scotland the 
Psychology in Diabetes and Psychology and Diabetes (PIDPAD) project is expected 
to train NHS staff to improve their skills in psychological support and behaviour 
change (Diabetes Action Plan, 2010). 
Many participants shared the assumption that health enables you to do the things that 
you want to do. This assumption of health as a functionality is supported by 
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McKague and Verhoef (2003) and Hughner and Kleine (2004) who note that the 
functional  definition  of  health  is  that  the  person  can  function  to  his  or  her  
expectations.  Participants expressed how their ‘poor’ health has affected their ability 
to carry out daily tasks and affected the enjoyment of travel. For example John stated 
 ‘Travelling is always usually a problem if you have not got good health’.  
A number of studies have identified that if a person can perform daily functions like 
going to work then he or she may consider themselves healthy (Papadopoulos, 2000, 
Torsch and Ma, 2000, McKague and Verhoef, 2003). Three participants revealed 
how their career influenced their choice to maintain their health.  
John: Oh very much I always tried to be kept healthy. I mean having been in 
the forces I was kept fit. 
Roger:  Quite a lot  because I  was working (.)  I  was in the police at  the time 
and you really had to keep yourself fairly fit and hence the reason I gave up 
smoking and other bits and pieces but ya my health was fairly important to 
me.  
Paul mentions the importance of health and ‘quality of life’ and stated that  
‘if you don’t have health you can’t work and if you don’t have health you 
don’t enjoy your life’.  
Paulis a retired surgeon and described the meaning of health to him as a value and 
emphasized how maintaining his health enabled him to be successful in his career.  
‘As a physician if I am not in good health I can’t give my best to my patients 
you know, I am a diabetic if I am hypoglycaemic or hyperglycaemic I can’t 
think clearly and it not only needs your skill as a surgeon but your brain as a 
surgeon also you know judgement and all the other things that goes with it’.  
Although Paul told of how in his later years he valued his health so he could give 
‘his best to his patients’he also mentioned how in his earlier years he ‘thought that he 
could do anything you know and he wouldn’t fall ill’. Paul’s value priority at this 
point in time was his career. Rohan (2000) suggests that value priorities occupy 
central positions in cognitive networks of attitudes and beliefs. This is apparent in 
Paul’s description at that point in his life as he felt in order to succeed in his career 
he would have to ‘neglect’ other value priorities such as health. Although Paul may 
have been motivated to value his health due to his personal endeavours and 
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environmental constraints he did not behave in a way that was consistent to his value 
priorities.  
‘I used to think health was very important, I probably didn’t look after my 
health as I should have done.’ 
This finding provides an understanding of how value priorities and views of health 
can impact on behavioural choices and thus outcomes. 
The final view of health described by participants incorporated a balance between 
subjective well-being and an understanding of self. Good health was conceptualized 
as  contributing  to  a  positive  sense  of  well-being  and  outlook  whilst  ill  health  was  
seen as causing an imbalance in body and mind. Due to Type 2 diabetes and other 
chronic illnesses the majority of participants described an imbalance between body 
and mind. Lawton (2003) in her review of lay experiences of health and illness made 
the point that being healthy is part of one’s self concept and illness is a disruption of 
balance. 
The meaning of health to numerous participants involved describing how life is 
impacted by ‘health problems’. Extracts from Mary’s (60) interview are presented to 
demonstrate this. 
‘It stands for a lot because I have a lot of health problems. Apart from 
diabetes I have high blood pressure high cholesterol (.1) I’ve got asthma, um 
(.)  a few other things (.) but that’s ‘gynae’ ((gynaecology)) department (.) I 
have a quite a lot of medical problems’.  
LN: How important is valuing your health to you?  
‘Very important (.) I need to keep the diabetes under control to control 
everything else because if that goes to high the blood pressure goes up then 
the chest plays up which means the asthma so you’ve got to keep them on a 
wee steady hopefully on a steady run which I can actually do quite well’. 
Mary illustrates how chronic illness places demand on the self to make concessions 
to accommodate the various imparted restrictions by means of control. The above 
quotes demonstrate how she maintains ‘equilibrium’ by ‘keeping the diabetes under 
control to control everything else’ and this helps her to ‘keep them on a wee steady 
run’. In contrast to Mary, Tom’s ‘equilibrium’ and meaning of health has been 
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totally altered due to his kidney failure, diabetes and other comorbidities. Tom feels 
that ‘it’ is his health now that ‘runs’ him ‘as opposed to’ him running it.  
The findings in this section have illustrated the individuality in meaning of health to 
participants and how life’s inconsistencies can impact on the value priority of health 
at differing points in time in a person’s life.  
5.2.3 Health value 
Participants’ perceptions on partaking in activities important to maintaining their 
health were explored in an attempt to understand how health is valued. 
Roger: I was told by the nurse when I first found out I was diabetic that 
taking insulin was you never skive or you never stop taking insulin you have 
got to take it so and I was told that very early.  
Roger’s reasoning for taking his insulin is ‘you have got to take it’. This behavioural 
activity implies an underlying value that has been understood to be health value. 
Rosie feels that  
‘diet,  it  is  a  way  to  control  it,  you  have  to  watch  what  you’re  doing,  your  
intake and not eat too much sugar (.) not eat much’.  
Adam’s self-management behaviours are also valuable to his health. 
‘well it is just to keep healthy, you have got to watch with diabetes with your 
heart and things like that and watch your eating’ (55).  
In contrast to those expressed above, Sean’s thoughts suggest that he does not 
consider taking part in health behaviours valuable. 
LN: Can you describe any activities you adopt on a daily basis to maintain 
your health and control your diabetes? 
‘I sit and lie on the couch. I have got my beer there and I have got my vodka 
right in front of me. That is what my days are roughly about’.  
Rohan (2000:264)advocates that 
‘although people may be motivated to live the best way possible, a multitude 
of personal and environmental constraints mean that people do not always 
behave in away consistent with their value priorities’. 
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Most participants pointed out how they are ‘motivated to live in the best way 
possible but health restrictions due to Type 2 diabetes can impact on health value.  
Roger: To a certain extent I mean if I had the choice I wouldn’t be diabetic 
because it does restrict you and now you just get on with it and try and 
manage it as much as possible the best you can.  
Adam: I mean I am personally not too bad because I control my diabetes 
quite well and it doesn’t restrict me in a lot of things apart from my work for 
working outside. I work with the rail way and I work in the offices now 
because I can’t work outside in-case I keel over by myself like (.) I have got 
to be with somebody so that restricts me in one way but basically I manage 
fine. 
The above quotes show how diabetes can cause restrictions in life. The restrictions 
are described as not ‘too bad’ and infer how it is important to value your health when 
you have diabetes otherwise it could ‘restrict’ you. This point on health value and 
‘restrictions’ is relative to the themes ‘Change in Health Value’, ‘Acceptance-
Adjustment-Adaptation’ and ‘Co-morbidities and Type 2 Diabetes’. The 
relationships between the themes will be explained in the following appropriate 
sections. 
As previously mentioned in section 5.2.2health was seen to be important to enable 
participants to ‘do things’. This value orientation can be described as a person’s 
mode of conduct or as an instrumental health value. Another value orientation is a 
terminal value that is an end-state of existence (for a more in-depth description on 
value orientations please see the Health Value section in Chapter 2 p14). The 
instrumental and terminal value dichotomy was kept in mind during analysis of this 
data. Rokeach (1968:551) stated that  
‘all men can have two kinds of value systems – an instrumental value system 
and terminal value system’. 
A quote from John (75) highlights an instrumental health value orientation. 
‘Valuing health is important so that you can do things and you are quite 
happy in your life and you can get on with your life and you have no 
drawbacks’. 
For John he maintains his health in order to achieve other goals such as happiness 
and having ‘no drawbacks’, rather than simply to be healthy. 
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Harry’shealth value orientation can be viewed as terminal in nature. He states that 
 ‘health is valuable you have only got one life’ (57).  
Harry values his health as a desirable end-state of existence. As previously 
mentioned many participants valued their health from an instrumental point of view. 
Although the majority of participants reported health value as instrumental some 
suggested that they valued health bothinstrumentally and terminally in their lives. 
Others suggested that their health value orientation was terminal before Type 2 
diabetes but on diagnosis this changed to a more instrumentally oriented value. 
Smith and Wallston (1992) suggest that in all likelihood health is probably both an 
instrumental and terminal goal.  
An extract from Roger illustrates this point.He discusses behaviours he carries out to 
maintain his health and control his diabetes. 
‘Well  I  try  and  exercise  everyday  other  than  my bad  knee  (.)  But  I  try  and  
exercise as much as possible to keep my weight down and also just to give 
myself some exercise because I have generally been active all my life it 
would be very hard to stop’. 
Roger exercises in order to achieve a valued goal that is weight reduction. This can 
be considered instrumental in nature. However, at the same time he also states how 
he wishes to exercise ‘just to give himself some exercise’. His motivation to do this 
is solely to maintain his health. This motivation can be considered as a ‘desired end 
state’ and therefore terminal in nature.  
Additionally a quote from Adam highlights how health value can be viewed as both 
an instrumental and terminal goal. The first sentence of the extract indicates an 
instrumental viewpoint whilst the second demonstrates a terminal health value 
orientation. 
‘Because if you are ill that can restrict you and some work and other things. 
Whether you have got diabetes or not you still need to have good health you 
know because there is no use being really unhealthy’. 
Even though, health can be viewed as an instrumental and a terminal goal most 
participants discussed their reasons for maintaining their health and achieving their 
goals as a means to an end (instrumental) rather than only being equal to having 
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good health (terminal).As a result of this finding it could be suggested that valuing 
your health as instrumental is a value priority. Or valuing your health as terminal is a 
value priority. This suggestion entails that values motivate behaviours but this 
motivation depends on the value priority at that time. The instrumental and terminal 
dichotomy has received mixed reviews in regards to values and health (d'Houtaud 
and Field, 1984, Allen et al., 2002, Schwartz, 1994, Lawton, 2003, Duncan, 2010). 
The significance of this in relation to the findings in this study will be discussed in 
Chapter 8 section 8.5. 
5.2.4 Change in health value 
The change in health value (CHV) theme arose through participants’ answers to 
questions such as ‘can you think back to before you were diagnosed with Type 2 
diabetes’‘how much did your health mean to you then’ and ‘has the amount in which 
you value your health changed since diagnosis’. The CHV theme has three 
dimensions to it and the findings are presented chronologically. Firstly it explains 
participants’ perspectives on how diagnosis of Type 2 diabetes ‘changes’ 
howimportant health is to their functioning in everyday life. Secondly it provides 
insight into how health value is altered overtime as the length of diagnosis of Type 2 
diabetes progresses. Thirdly a ‘sense of regret’ on lack of health value pre-diagnosis 
is described by some post diagnosis.  
Eight out of twelve participants conveyed how prior to diagnosis of Type 2 diabetes 
they had not thought about their health much. Harriett tells how she  
‘was a lot younger and didn’t really think about it. It isn’t until you get 
diagnosed with a condition that you actually start thinking about it ((health)) 
you know and you’re just trotting along (.) you just don’t really think about 
itthen all of a sudden wham it happens to you’.  
Mary described how she ‘never really bothered about it’ ((health)) before diagnosis 
of Type 2 diabetes. Interestingly Mary suggests a value difference between having 
‘high blood pressure’ and diabetes when she states  
‘I had the high blood pressure never bothered me had tablets and that. 
Diabetes is a different thing because you have got to change your life’.  
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Mary’s  comments  imply  that  possibly  she  perceives  diabetes  as  more  serious  than  
hypertension and this has caused her to re-evaluate her value priorities in life.  
‘You’ve got to actually turn right around and look at you have done wrong in 
the last forty years and then learn well you’re not getting many more chances 
so behave yourself (.) so my chances were running out (.) so now I behave’. 
Smith and Wallston (1992)suggest that as a person’s health becomes more threatened 
the value of health to an individual may become more salient and consequently more 
important. Charles feels that as a result of his diagnosis he now ‘wants to look after 
his health more’ as he has ‘more things to look after’. John’s comments concur with 
Charles’s 
‘Well it had become more of an emphasis to keep healthy and keep my blood 
sugar levels controlled and so on’.  
Now that diabetes is an issue health value is understood to be of a higher priority 
than before to these participants. 
As Rosie states  
‘diabetes is not just going to be for awhile this is for life’. 
Sean could be described as a deviant case. Although he has been diagnosed with 
Type 2 diabetes his health value and health behaviours have not changed due to his 
current circumstances with an alcohol problem. His alcoholism has not enabled him 
to address his value priorities as other participants have done on diagnosis of Type 2 
diabetes. 
‘That is a bit difficult that question because the fact that I have been drinking 
for that long. I have never really gave it a thought. I have never sat down and 
thought about it that way. I have just plodded along and thought that’s it’.  
A quote from Harriett  is  used to illustrate the second dimension of the CHV theme 
which acknowledges how being diagnosed with a chronic illness such as Type 2 
diabetes for a period of time can result in becoming a bit ‘blasé about it’. 
‘I started getting a bit blasé about it and saying I’ll not bother and stuff. I 
suppose when you are first diagnosed and that you are maybe more keen to 
sort of go RIGHT but once you have it for so long you kind of go a wee bit (.) 
well I do I get a wee bit blasé about it and go ((Shrugs))’. 
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Seanstates how he feels ‘bored’ of diabetes and ‘how it is doing his nut ((head)) in’. 
He also affirms that ‘you think they could just give you a tablet to cure it’. Harriett 
and Sean’s comments suggest that for them the longer they are diagnosed their health 
value priority may be reduced.  
Some participants mentioned regret in not valuing their health more prior to being 
diagnosed with Type 2 diabetes. Paul expressed that  
‘health is much more important now I wish that I had done a little better’ 
and Adam states ‘I could have done it a lot differently’. 
The next section describes the findings of the multi-dimensional theme ‘Acceptance, 
Adjustment and Adaptation’ (AAA). A brief discussion follows this on the 
connections between the themes reviewed thus far. The reason the findings are 
discussed in this manner is that the AAA theme relates to the overall lived 
experience of the person with Type 2 diabetes andwhen considering AAA as a 
process it enables identification of the relationships between themes which the 
person with type 2 diabetes experiences.  
5.2.5 Acceptance-Adjustment-Adaptation 
Acceptance, Adjustment and Adaptation is an emergent theme. Each of these words 
could be viewed as themes in themselves however it was deemed necessary to 
explain their influence as a single theme with various aspects to it. The various 
aspects relate to the person’s belief and value system. The interviews showed that all 
participants’ belief and value systems were influenced by a person’s mode of 
acceptance, adjustment and adaptation. Each aspect within this theme was viewed as 
an operational factor or attitude. Rokeach (1973:550) defined an attitude as  
‘an enduring organisation of several beliefs focused on a specific object or 
situation predisposing one to respond in some preferential manner’.  
Attitudes are important factors to consider when exploring the meaning of health 
value. The reasoning for this is pointed out by Rokeach (1973:550) 
‘a value unlike an attitude is a standard or yardstick guiding not only attitudes 
but also actions, comparisons, evaluations and justifications’.  
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Consequently what became apparent within the data is how values and beliefs impact 
on the individual with Type 2 diabetes attitudes and how this influenced decisions of 
self-management behaviours. The extracts below came from Garry (70) and Harriett 
(46) interviews and are presented to illustrate this theme.  
LN: Tell me what it is like to have Type 2 diabetes? 
Garry: It is just like say having a cold where you have got set times to take 
your medicine and that’s how I look at it, as I say latter years of it I have got 
to watch (.) likes if I am cutting the grass using energy burning up your 
sugars and you have to be careful you don’t get a hypo and well I get a wee 
reminder I’ll maybe sweat a lot or start to get light headed and I say oh and Ill 
go in and I always carry dextrose and tablets and that brings the sugar back in 
to your body so you are always conscious of that. 
Here Garry demonstrates how he accepts Type 2 diabetes when he says ‘you have 
got to watch’ and shows how he has adjusted in his daily life by giving an example 
of how he uses his knowledge on the condition to manage his diabetes  
‘like if I am cutting the grass using energy burning up your sugars and you 
have to be careful you don’t get a hypo’.  
He describes how he gets ‘a wee reminder’ such as sweating and becomes light 
headed which are two of the symptoms of hypoglycaemia. He then acknowledges 
how he has adapted to this possible situation by ‘always carrying dextrose and 
tablets’ because he knows that this ‘brings the sugar back in to your body’. 
Harriett also comments on what it is like to have Type 2 diabetes. 
‘It’s like somebody who’s become very physically disabled in some way 
when all their life they have been ok and then something happens to them 
they have got to sort of learn to adjust and say as you say well this part of my 
life now I have to get on with it and just do what I have to do sort of thing’. 
Harriett accepts that ‘well this is part of my life now’ and states that she has got to 
‘learn to adjust’ by describing how she has to ‘get on with it’ and adapt to her 
situation by acknowledging that she needs to ‘just do what I have to do’. 
The AAA theme can be linked to the concepts of biographical disruption and 
transition. Charmaz (1983) recognised that living with a chronic illness such as 
diabetes means being challenged by changes in ones daily life and body. The work of 
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Bury (1982) on biographical disruption focuses on the concept of reconstructing 
meaning during illness. Whereas transition has been used within the literature to 
describe the process of change in life’s developmental stages or alterations in health 
and social circumstances (Kralik et al., 2004, Meleis et al., 2000, Meleis, 2010, 
Kralik et al., 2006, Kneck et al., 2011, Kneck et al., 2012). In the present study 
descriptions of experiences of being diagnosed with diabetes demonstrated changes 
in daily living required for disease management and adaptation. Due to the necessary 
adaptation required of participants’ varying means of acceptance and adjustment 
were described. The process to adaptation was an individual experience. This finding 
resonates with previous research (Murphy and Kinmonth, 1995, Idler et al., 1999, 
Corbin, 2003, Mol and Law, 2004, Johansson et al., 2009).  
For many the ‘disruption’ of diabetes to their life caused an ‘evaluation’ of values 
and value priorities. This evaluation was seen to cause a change in the way people 
valued  their  health  and  to  change  priorities  of  health  in  order  to  meet  their  new  
diabetes self-management requirements. This change in health value resulted in 
participants’ viewing their health value as mainly instrumental in nature. Valuing 
health instrumentally can be described as viewing health as enabling functionality in 
every day life. This finding is line with Corbin’s qualitative work on ‘the body in 
health and illness’ (Corbin, 2003). Corbin’s (2003) data suggested that depending on 
the extent of the experience of illness and as a result a person’s ability to carry on 
with daily living activities if one does not experience too drastic a change then the 
person may not necessarily perceive themselves as ill. Olshansky et al. (2008) called 
this experience ‘normalizing the process’ of managing a condition.  
The initial evaluation at diagnosis did not resolve there, as some participants 
commented on how as the timespan since diagnosis progresses a continued struggle 
of maintaining values against the emotional burdens of the condition is experienced. 
This finding is supported by King et al. (2003) who examined the nature of resilience 
of people with chronic disabilities. King and colleagues research identified factors 
that help or hinder people at ‘turning points’ in life. Turning points similar to the 
concepts of ‘transition’ and ‘biographical disruption’ cause a shift in the meaning, 
purpose or direction in a person’s life (King et al., 2003).  
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The qualitative findings have so far highlighted how although health is valued by 
most  and  the  majority  of  participants  wish  to  adhere  to  diabetes  self-management  
behaviours; values are but one of the many factors which impact on behaviour 
(Wallston, 1992).  
5.3 Perceived control: Beliefs and their impact 
The perceived control construct was explored within the qualitative data in keeping 
with MSLT. This involved taking into account the internal/external dimension of the 
locus of control construct and focusing on participants’ accounts of self-efficacy in 
self-managing Type 2 diabetes.  
A recurring theme was noted when participants discussed their locus of control 
(LOC) beliefs. Participants’ described conflicts between their internal and external 
LOC beliefs when discussing their self-management behaviours of Type 2 diabetes. 
This theme will be discussed under the heading ‘Internal Locus of Control Beliefs 
versus External Locus of Control Beliefs’. 
The Acceptance-Adjustment and Adaptation theme will also be referred to 
throughout section 5.3 to acknowledge the relationship this theme has with a 
person’s perceived control, values and the impact this has on self-management 
behaviours. 
The section is completed with a presentation of findings that recognize the 
complexity of the mechanisms by which perceived control and health value operate 
to influence health behaviour. 
5.3.1 Health locus of control and self-efficacy 
Participants’ self-efficacy and locus of control beliefs were understood during 
analysis through descriptions of how and why health behaviours are carried out.  
Harry believes he has sufficient coping abilities (self-efficacy) to manage his 
diabetes when he states ‘my ability is fine’. However, he attributes this coping to  
‘never ever having a hypo’ and ‘just taking life as it goes’.  
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This  suggests  an  external  locus  of  control  belief  orientation  as  he  relates  what  
happens in his life to chance.  
Harriett’s perspective on her perceived control over her diabetes self-management 
differs to Harry. She illustrates internal locus of control beliefs when she states 
‘I know what I need to do to manage it’.  
Nevertheless, she has low self-efficacy in that she does ‘not’ believe that she is 
‘good’ at doing what she ‘should do’.  
John demonstrates how a person can have internal LOC beliefs and external locus of 
control beliefs. 
‘Ithink at the moment it seems to be very good (internal belief) they’re quite 
happy in fact they’re over the moon with it (external belief)’.  
He also shows good levels of self-efficacy here due to his internal/external LOC 
beliefs. The effects of this combination are apparent in his outcome behaviour 
 ‘my blood sugar levels are excellent’.  
Tom’s perception over his condition illustrates low perceived control. 
‘Sometimes I fail to understand what’s going on. Sometimes my sugars will 
be high for no reason and sometimes my sugars will be too low for some 
reason’.   
He lacks self-efficacy in that he has no confidence in his ability to manage his 
diabetes even ‘after all these years’. This situation makes him feel ‘unhappy’ in that 
he doesn’t understand what is going on or why. It is clear that Tom’s perceived 
control is the way it is because of his external locus of control belief when he states  
‘Sometimes things happen and you are not entirely sure. I just don’t know (.) 
but unfortunately I have to deal with it’.  
Sean’s perceived control is ‘bad’. He admits to sometimes ‘forgetting’ to take his 
insulin ‘when I am drinking’. For Sean his low self-efficacy and LOC belief is 
external due to his alcoholism. His unconventional manner of diabetes control is 
apparent when he mentions how 
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‘I’ll waken up in the morning at 5 or 6 o’clock I’ll says in my mind that’s my 
bodies way of telling me I need the tablets or I need the insulin and as soon as 
I have done that then it’s fine and I just go back drinking again’.  
Several participants emphasized how life’s irregularities can impact on perceived 
control beliefs and their ability to self-manage diabetes effectively. John felt his 
perceived control was ‘quite well’ when he was on ‘normal tablets’ he didn’t ‘seem 
to  have  a  lot  of  problems’.  Then  he  felt  his  perceived  control  was  altered  when he  
was  
‘changed on to insulin and started getting into a lot of hypos’.  
As a result of this John ‘felt totally out of control’.John’s self-efficacy in managing 
his new medication was understood to be low. This was perhaps due to his external 
LOC beliefs because  
‘he felt that nobody can actually say this is what you take there is no set ways 
of doing it and it varies very much so on your activities’.  
John went on to elicit how he accepted-adjusted and adapted to the situation  
‘there was no other way to control it so I am coping with it’.  
For Rosie good perceived control ‘involved a ‘healthier diet’. Rosie felt that due to 
being separated from her husband ‘everything went up in the air’. However, her 
internal LOC beliefs outshone her personal problems when she states  
‘but now I am back on track with eating properly and just watching what I am 
doing’.  
Her internal locus of control beliefs and self-efficacy show how they impact on her 
diabetes self-management when she states  
‘instead of ignoring it and feeling sorry for myself (.) when I can’t eat a bar 
of chocolate (.) you know it’s not good for you so you shouldn’t eat it’.  
Paul mentions how although he was a surgeon and  
‘it wasn’t always easy to eat or to exercise you know properly for what is 
needed for diabetes control’ 
he felt he still had ‘good control’ because his‘A1c is always between 6 and 7’.  
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5.3.2 Internal locus of control versus external locus of control 
Extracts  from  various  participants’  interviews  are  used  to  explain  the  internal  and  
external LOC conflict in beliefs experienced and the impact this has on the self-
management of diabetes. 
Mary displays high internal LOC beliefs and ‘good’ levels of self-efficacy when she 
discusses her love for chocolate. 
‘What’s the point in taking it? All I’m doing is putting the sugar levels up. 
It’s not worth the risk. They all know Granny doesn’t get sweeties, but I have 
the odd bit but it’s not worth it’. 
Also apparent within this extract is Mary’s mode of acceptance, adjustment and 
adaptation. The conflicts she faces with self-management can be defined within this 
theme. The struggle within her belief system results in low self-efficacy and 
acceptance ability in her taking the ‘sweetie’ and becoming hyperglycaemic. 
‘You get sweats and you start getting warm and you want to take your clothes 
off but you ken ((know)) fine you took the chocolate and that’s what put it 
up’. 
This quote is interesting as it illustrates how her attitudes conflict with her belief 
system. The internal struggle of her belief that she can avoid ‘sweeties’ impacts on 
her level of self-efficacy when she has ‘the odd bit’ however she realises ‘it’s not 
worth it’. The resultant outcome behaviour is hyperglycaemia. Through observing 
Mary’s perceived control it was possible to identify how she struggles with her belief 
system and self-efficacy in managing her adaptation to control diabetes. 
Charles describes internal locus of control beliefs and ‘good’ levels of self-efficacy 
when he discusses his insulin management. However when he mentions that part of 
his perceived control is due to 
 ‘being told that my readings ((blood sugar)) are satisfactory’. 
It  is  clear  that  there  is  a  conflict  in  his  LOC beliefs.  He  relies  externally  on  health  
professionals  to  inform  him  about  his  diabetes  management.  Roger  faces  a  similar  
conflict in beliefs in regards to his ‘diabetes control’. He feels that it is  
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‘very hard to understand how good it is until you come to clinic and then they 
tell you that your diabetes control is quite good’.  
For Roger knowing and receiving reassurance from the diabetes clinic that his 
control is ‘quiet good’ reinforces his internal LOC beliefs outwith the clinic. The 
following quote describes how outwith the clinic Roger’s internal LOC beliefs take 
precedent over his external beliefs.  
‘Well the thing is if you take your blood on a regular basis its a matter of 
knowing when to decrease it or increase it as the days go on or the weeks go 
on and also where you’re going to go and what you’re going to be doing 
social wise’. 
For  Tom  Type  2  diabetes  is  ‘frustrating’  because  it  has  become  a  ‘problem  that  it  
shouldn’t be’. It is apparent that his external LOC beliefs conflicts with his internal 
LOC beliefs when he states he ‘does not know how he got it’. This implies that he 
does not believe being diagnosed with Type 2 diabetes was a consequence of his own 
actions. However, internally he believes that now  
‘I have got it I have got to deal with it’.  
Although he believes internally that he has ‘got to deal with it’ it is clear that he is 
still in conflict with his ‘situation’ when he states  
‘I am now in a situation where medical conditions run my life as opposed to 
the other way around’.  
 
5.3.3 Beliefs, values and outcomes 
The following section describes the relationships between the a priori themes 
perceived control (locus of control and self-efficacy) and health value. The way in 
which these themes influence diabetes self-management behaviours is reviewed.  
A quote from Mary highlights how she values her health as an instrumental priority. 
She discusses the importance of this to her health when she says ‘it doesn’t stop me 
doing anything’. To Mary her perceived control over her diabetes depends on  
‘sticking to a normal routine and taking tablets and insulin in the morning and 
watching what you’re eating’.  
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Mary’s LOC beliefs were understood to be internal and her levels of self-efficacy 
were thought to be satisfactory. This reflection on Mary’s beliefs stemmed from her 
descriptions of her behaviour. 
‘And basically just watch what your doing you learn over the years what you 
can and can’t do with diabetes and I think I have learnt over the years what 
you can and can’t do’. 
An extract from John’s interview shows how ‘the immediate shock’ of being told 
‘you are not as healthy as you think you are’ caused him to think about his health 
value and accept and adjust to the condition. 
‘I think that’s it and then I mean after a while you have just got to say well ok 
I have got diabetes and I have got to control it’.  
The final sentence in this extract ‘I have got to control it’ points to John’s perceived 
control over his condition. It is suggested that his LOC beliefs are internal here and 
as a result he has confidence in his level of self-efficacy to ‘control it’. John conveys 
his thoughts on insulin management and provides evidence for the above 
interpretation of his beliefs. The quote clearly demonstrates the complexity of 
diabetes management and how internal LOC beliefs influence self-efficacy in 
carrying out the behaviour when he states  
‘I mean you have got a lot of choices to make because as I say there is no laid 
down or written in stone way of doing your insulin because it varies on so 
much you know if you do lots of activity you have got to mind what you are 
trying to do and that burns up your sugar and everything else.’  
John’s value priority is instrumental here as he is carrying out specific diabetes self-
management behaviours in order to attempt to live without problems.   
The subsequent extracts illustrate how various aspects in a person’s life can impact 
on perceived control and ability to self-manage diabetes appropriately. Mary talks 
about how she ‘keeps it all under control now’ but ‘before’ she found it hard to 
‘watch’ her diet because she was buying food for herself and for her husband. 
However her perceived control over her diet has improved because  
‘My husband is now diabetic and now we are on an even keel because he has 
got to eat everything I eat, I refuse to eat what he eats’.  
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Mary’s comments on her spouse influencing her eating habits and subsequently 
impacting on her diabetes control is supported in the literature. A study by Trief et al 
(2003) on ‘Couples Living with Diabetes’ found that a spouse’s eating patterns could 
negatively impact on self-management behaviours of diet by preparing inappropriate 
food and modelling bad eating habits. 
Sean discusses his wife’s input in his diabetes care. His comments highlight how his 
perceived control is poor. His wife manages his medication ‘she takes control of my 
drugs’. Searle et al (2007) study illustrates comparable findings to this. Searle et al. 
(2007) study concluded that partners can mediate the relationship between a person’s 
perspective of their diabetes control and their self-management behaviours. Sean 
asserts that the reason his wife does all his tablets is  
‘because if she didn’t I would have to go to the hospital everyday to get my 
tablets’.  
Sean was probed with the question; do you not feel you could do it yourself? 
‘No because I am on that many tablets I am on about 25 in the morning ah, 3 
in the afternoon and 10 or 11 tablets before I go to bed so I have that many 
tablets in a day’. 
Paul and Harriett refer to diabetes management as ‘annoying’ and a ‘pain’. This 
feeling towards it ‘at times’ can result in lowered perceived control. Paul states how 
it is  
‘very annoying because it is very important to have good control of diabetes 
in order to function well’.  
This point shows that his health value priority is instrumental and his LOC belief is 
internal. However he feels that diabetes ‘limits’ him in that 
 ‘you can’t eat or you can’t drink the way you want to sometimes’.  
And similar to Mary’s struggle with chocolate he likes ‘a single malt in the evening’ 
but then he will ‘forgo something in exchange for the gallows’. He states that he does 
this because he knows ‘diabetes has to be well controlled’ and this indicates his level 
of self-efficacy in managing his condition.  
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Harriett also values her health but feels that it is her way of thinking that impacts on 
her perceived control. She admits to sometimes missing her insulin. However she 
acknowledges that when she does ‘take it’ (insulin) she sees the benefits of her 
positive behaviour ‘because I can see it by my blood sugar results’.  
Tom’s multiple comorbidities impact on his perceived control and health value and 
thus his self-management behaviours. He manages to do ‘a little exercise’ and states 
that his ‘diet is fairly ordinary’. His external LOC beliefs, health value and level of 
self-efficacy is apparent when he discusses how his self-management behaviours are 
impeded by his various ailments. 
‘I used to be able to go swimming and the gym and stuff but I have not been 
for a while since I have had the catheter put in’.  
However, it is clear that he has a good level of self-efficacy in managing his 
condition and values his health but due to uncertainties in his life his perceived 
control is lowered. 
‘I  am  a  bit  scared  to  go  back  ((to  the  gym))  until  I  know  what  is  going  to  
happen I am still finding out what’s happening with possible kidney 
transplant and things’.  
The constructs of Perceived Control and Health Value were explored and understood 
through participants’ perspectives of how they manage Type 2 diabetes. These 
themes were a priori and were incorporated into the interview guide through 
questions that aimed to influence the participant to think about their perceived 
control beliefs and health value. This provided subjective data that highlighted how a 
persons belief system impacts on behavioural outcomes.  
Participants demonstrated how a ‘conflict’ in LOC beliefs could influence self-
efficacy and health value. It was evident that participants with higher internal LOC 
along with lower external LOC beliefs had an acceptable interaction with self-
efficacy and health value and this resulted in a positive influence on outcome 
behaviour. Conversely those with higher external LOC beliefs had lower internal 
LOC beliefs and described having less competence in carrying out effective self-
management behaviours. Chapter 8 section 8.3 provides an analytical discussion on 
the above findings. 
 117
5.4 Emergent themes 
The emergent themes will be presented with reference to the acceptance-adjustment 
and adaptation theme and the a priori themes of perceived control and health value. 
This will enable a more complete discussion of the findings.  
5.4.1 Comorbidities and Type 2 diabetes 
Participants’  descriptions  of  experiences  of  living  with  Type  2  diabetes  were  
associated with other comorbidities. Comorbidity has been defined by Valderas et al. 
(2009:359) as  
‘the presence of additional diseases in relation to another disease in one 
individual’. 
Comorbidities are common amongst people with diabetes and account for much of 
the illness these patients face (Piette and Kerr, 2006). Some participants in this study 
reported having multi-morbidities. Multi-morbidities can be defined  
‘as the presence of multiple diseases in one individual’ (Valderas et al., 
2009:359).  
A related concept is that of complication that can be described as a disease or 
condition that arises during the course of or as a consequence of another disease 
(Ferran, 2003). Participants’ descriptions did not distinguish between comorbidity 
and complication. Therefore it has been understood that both constructs are 
synonymous in meaning to the person living with various comorbidities and/or 
complications.  
The comorbidities and Type 2 diabetes theme has two dimensions with different 
influences on behaviour. Firstly, participants describedperceptions of death or 
deterioration in quality of life due to subsequently acquiring comorbidities or 
complications if they did not self-manage their diabetes appropriately. Secondly co-
morbidities and complications were seen to influence participants’ ability to self-
manage their diabetes. 
Piette and Kerr (2006) examined the impact of comorbid conditions on diabetes care 
and as a result developed a model that identifies the general dimensions of comorbid 
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conditions.  These  dimensions  of  comorbidity  were  observed  for  during  analysis  of  
the qualitative data. Figure 5.1 displays an adapted version of Piette and Kerr (2006) 
model. The model has been adapted to display and explain the typologies of 
comorbidities experienced by participants in this study.  
Dimensions of Comorbid Conditions of Participants n=12 
 
Clinically Dominant Conditions 
Definition: Comorbid chronic conditions that are so complex or serious that they eclipse the 
management of other health problems (in the short term or long term). 
End Stage Disease 







Concordant versus Discordant Chronic Conditions 
Definition: A concordant condition represents parts of the same overall pathophysiologic 
risk profile and relate to the same disease and self-management plan. Discordant conditions 
are opposite to concordant. 
Concordant with diabetes 
Hypertension, Cardiovascular Disease, Peripheral Vascular Disease and Retinopathy 
Discordant with diabetes 
Alcoholism, Asthma, Hypertension 
Figure 5.1 Adapted General Dimension Model of Comorbid Conditions Piette and Kerr 
(2006) 
Mary revealed that her biggest fear is eye complications due to Type 2 diabetes. She 
is afraid that this may affect her quality of life in the future. Diabetes can affect sight 
by causing glaucoma, cataracts or damage to blood vessels in the eye known as 
retinopathy (Tortora and Grabowski, 2003). 
‘my only fear is what the diabetes can do to my eyes’. I was at the opticians 
and I was told that I have got the start of cataracts in both eyes’. 
John and Tom also worry about the possible complications associated with Type 2 
diabetes. 
John: The trouble is the longer you have diabetes the more problems you start 
getting. You get problems with your feet and you get problems with your 
eyes.  
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Tom: When done in conjunction with the other medical conditions it 
probably can exacerbate if it is not controlled so it is something I have to deal 
with.  
Even  though  Harry  has  had  a  heart  bypass  in  the  past  that  caused  him  to  re-
evaluatehis health value he does not think complications or comorbidities associated 
with Type 2 diabetes will affect his quality of life in the future. 
‘I  don’t  think so if  I’m doing as well  as I  am doing the now it  shouldn’t  be 
any difficulty in the future’. 
Harry appears to have a conflict in his belief system. He is aware that his health 
issues are a consequence of his own actions yet he attributes some of the blame to 
external factors such as ‘drinking’ and ‘going through a divorce’. 
‘I would say partly it was through myself because I was a heavy drinker and 
that so I think that might have escalated it’.  
Extracts from Rosie and Roger demonstrate how awareness of the possible 
complications  of  Type  2  diabetes  can  influence  perceived  control  and  health  value  
and thus outcome behaviours. 
Rosie:  It  could,  hopefully  not  with  taking  safe  guards  it  shouldn’t  be  more  
than what it is just now if I am careful with my diet if I take care of my feet 
and my blood pressure and anything like that. 
Roger: Blood sugar, general health, getting your eyes checked every so often 
and  getting  your  feet  checked  every  so  often.  Well  I  think  it’s  all  in  one,  I  
think all in the end if you don’t keep your blood sugar at a reasonable level it 
affects everything else.  
Roger’s perception highlights how he values his health and is aware of the 
complications associated with diabetes. As a result he is influenced to carry out 
diabetes self-management behaviours such as eye care, foot care and blood glucose 
monitoring.  Even though Roger is aware of the complications associated with Type 
2 diabetes and wishes to partake in behaviours to avoid these, his ability to do this is 
at times hampered by his arthritic knee. 
‘Well I try and exercise everyday other than my bad knee’.  
Rosie’s ability to exercise is also affected by arthritis  
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‘I have arthritis in my hip so I try and walk but I have to stop and sit on a wall 
for five minutes and then I can just get up again and carry on’.  
Sanders et al. (2002) study of older people who have arthritic joints suggests that 
these patients experience a poorer quality of life than those without. 
Although it is clear Harriett values her health she suffers from depression and at 
times this affects her ability to self-manage her diabetes appropriately.  
‘I mean I have had depression on and off since I was 16 and that can really 
affect  your  day  to  day.  I  would  say  to  me  that  my  depression  is  more  
debilitating than my physical illnesses because my depression can stop me 
doing things when I am not feeling well’.  
This finding on how depression can dominate self-care is a recurrent topic in 
diabetes research and will be elaborated upon in section 5.4.8. 
From an early age Garry has valued his health. He feels this is because of having 
asthma as child. 
‘I think health always had a place (.) I mean with having the asthma from so 
young’.  
Recently Garry has found his memory ‘slipping’. He finds that it is affecting his 
ability to take his medication safely and on time. 
‘I find with having diabetes my memory is starting to go and I says oh did I 
take that ((insulin))’.  
The following extractillustrates how Garry’s health value, internal LOC beliefs and 
level of self-efficacy have influenced him to act in away to try and overcome his 
problem with memory loss. Garry has devised a strategy of organising his 
medication in advance of the next day, as he is aware that his memory may inhibit 
his management of this. This method of recall has been described as ‘intentional 
memory’ as it is aimed at helping accomplish one’s plan (Purdie and McCrindle, 
2002). 
‘I have got two injections a day. I take the two needles and I put them in my 
wee box and I have seen myself having to go and look in the box and see if 
((laughs)) (.2).The first one is easy because that is first thing in the morning 
but you are away doing things for the second one which is round about the 
evening meal and that’s the one at times I have missed it.That side of it is a 
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bit of a downer. But you can forget and you say am I going doolaly ((crazy))? 
I used to remember loads of things now I have to think really really hard so 
we will just see in future years’. 
The above quote echoes findings of previous research which suggests that self-
efficacy beliefs of older adults are particularly influenced by cognitive functioning 
(Purdie and McCrindle, 2002). Several authors have pointed out that older adults 
with Type 2 diabetes may have difficulty in distinguishing between performed and 
imagined activities of medication taking (Hashtroudi et al., 1991, Purdie and 
McCrindle, 2002). It is important that the development of self-efficacy beliefs in this 
population is explored further and attention given to help them to find ways in 
dealing with the effects of cognitive aging.  
Tomhas multi-morbidities, which affect him in his every day life. Unlike other 
participants Tom’s health is clinically dominated by another condition chronic renal 
failure. 
‘I have got to be conscious of taking various medications. Twice or three 
times a day I have got to take my insulin, I have got to do my blood sugars 
and  I  have  got  to  do  my  dialysis  for  eight  hours  at  night  so  medical  issues  
dominate my day’.  
His self-management behaviours at the moment are being carried out in keeping with 
both  dimensions  of  the  comorbidity  theme.  He  must  carry  out  self-management  
behaviours on a daily basis in order to survive and maintain his quality of life and his 
comorbidities affect his ability to carry out self-management behaviours. 
 ‘I walk if and when I can although that is difficult some days’.  
Sean describes how accounting for various morbidities impact on his quality of life 
and  as  a  result  his  ability  to  carry  out  self-management  behaviours  of  Type  2  
diabetes. 
‘Just you have too many ailments. I can’t take certain foods because it affects 
my  gout,  certain  stuff  affects  my  thyroid,  and  certain  things  affect  my  
diabetes. And it’s having to try and manage if you’re not allowed have one or 
the other for each ailment it is a pain in the back-side’.  
The qualitative data on comorbidities has highlighted the way in which various 
morbidities are perceived and handled by participants in conjunction with diabetes 
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self-management behaviours. Evidently, management of comorbidities are not only 
influenced by disease related characteristics, but by the number of morbidities a 
person has, their severity and by individual behavioural characteristics. This finding 
replicates previous research which has found that the presence of some comorbid 
conditions is associated with poor physical functioning and less adherence to diet and 
exercise regimes (Clark et al., 1991, Bayliss et al., 2003, Brod et al., 2006, Piette and 
Kerr, 2006, Valderas et al., 2009). Furthermore, Tom and Sean’s cases have thus far 
highlighted how the impact of an overwhelming comorbid condition such as alcohol 
addiction and chronic renal failure can take precedent over managing a condition 
such as Type 2 diabetes. The significance of this finding in relation to MSLT is 
discussed in Chapter 8 section 8.8.  
5.4.2 Hereditary reasoning 
Previous research has highlighted the importance of views about causation for the 
meanings assigned to disease and illness and the consequent actions required to deal 
with symptoms (Bury, 1982, Williams, 1983, Charmaz, 1983). Many participants 
commented on the hereditary aspect of Type 2 diabetes as a causation of the illness. 
This theme was seen to influence beliefs and values of participants’.  
Roger used to ‘wonder why me’ when it came to blaming something or someone for 
diabetes. 
‘I haven’t got a clue why no one ever told me. I have diabetes on both sides 
of the family (.) it is maybe hereditary you know’.  
John recounted how he should have expected it. 
‘my grandmother  was  diabetic  and  my mother’s  side  of  the  family  were  all  
diabetic so I shouldn’t have been surprised’.  
Despite the ‘surprise’ John highlights how he accepts and adjusts to Type 2 diabetes. 
‘I was quite active and then all of a sudden you know what’s this? So you just 
have to accept the fact and get on with it'.  
Adam also attributes the cause of Type 2 diabetes to his genetic makeup. 
‘I  am  55  unfortunately  I  have  had  diabetes  since  89  that’s  when  I  was  
diagnosed and basically I would put that down because my mother was 
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diabetic and her sisters were diabetic as well. My sister has diabetes as well 
so that is how the diabetic thing came up’.  
Mary possibly viewed the hereditary aspect of Type 2 diabetes as an advantage as 
she felt she could have looked to her brother for support but unfortunately he died. 
‘My brother had diabetes but he died so I couldn’t ask him’. 
Also important to highlight is how hereditary factors may contribute to self-efficacy 
behaviours in regards to treatment and personal responsibility for the management of 
Type 2 diabetes. Adamwas asked when you were started on insulin therapy did this 
change the way you see your control over your diabetes? 
‘No not at first because I didn’t like it because my mother being diabetic she 
used to take insulin I just couldn’t ken ((know)) at first why my levels were 
going up this was after sixteen years sort of thing (.) because my pancreas 
was still producing it ((insulin)) but not as much. I think it was six months 
until the Doctor persuaded me to go on ((insulin))’.  
Results demonstrate how exploring the constructs of MSLT subjectively can enable 
the discovery of factors that may influence beliefs and values and thus outcome 
behaviours of people who have Type 2 diabetes. These findings show that genetic 
attributions have the potential to negatively influence patient’s perceptions of Type 2 
diabetes. The concept of hereditary factors of Type 2 diabetes influencing health 
beliefs and values needs to be explored further.A recent research proposal by (Cho et 
al., 2012) aims to assess the clinical utility of disclosing the results of DNA. Cho et 
al. (2012) anticipate establishing whether providing type 2 diabetes patients with 
genetic risk information can help improve patient’s clinical outcomes, risk 
perception and their engagement in health behaviour change.  
5.4.3 Age as a reason 
Some participants attributed age to the reason why they have Type 2 diabetes and/or 
how they self-manage their diabetes. Garry mentioned the difference in his attitude 
from when he was younger to now and finds that having morbidities is acceptable 
due to his age.  
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‘I am beginning to feel it now as I get older fitness wise when you’re young 
and you’re up and your full of energy, whereas in old age it just comes on 
ya’. 
Charles  makes  reference  to  how he  ‘used  to  be  able  to  do  things’  that  he  can’t  do  
now and he puts it down to ‘getting older’. Charles general practitioner (GP) 
reinforces his belief that this is not unusual for his age. 
‘I  go to my GP he says well  you’re getting older we can’t  expect you to be 
doing too much’.  
Younger participants did not attribute age to their reasoning to why they have Type 2 
diabetes. Type 2 diabetes was viewed as an ‘inconvenience’ for some. 
Harriett: I totally blame myself I keep saying to myself if you had got control 
of it ((health)) quicker you wouldn’t be having this.  
Furthermore, younger participants ‘didn’t really think about diabetes’ until diagnosis. 
This point is demonstrated by Tom when he states how his health value  
‘wasn’t  an  issue,  well  it  wasn’t  a  major  one,  I  wasn’t  as  conscious  of  any  
problems before this happened’.  
Bury’s (1982) influential work on ‘biographical disruption’ drew attention to the 
concept that chronic illness is a stereotype of older people. Older people use this 
stereotype as an explanation to the onset of illness. Additionally, Bury (1982:171) 
highlights how younger participants in his study described a ‘biographical shift’ from  
‘a perceived normal trajectory through relatively predictable chronological 
steps to one fundamentally abnormal and inwardly damaging’.  
The view of illness as synonymous with older age could possibly disguise the needs 
of those with Type 2 diabetes. This study exemplifies this through participants’ 
experiences of discussing their ailments with health professionals and when 
‘normalising’ their individual experiences of symptoms. Similarly, Pound et al. 
(1998) found that patients who experienced a stroke also ‘normalised’ their 
symptoms in an effort to reduce its impact and to maintain stability in their lives. The 
way in which an illness is ‘normalised’ is important to consider for young and old 
patients. Olshansky et al. (2008) recommends that patients’ should view the lifestyle 
changes required by diabetes as ‘healthy living changes’ that are carried out by 
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people with and without diabetes. Olshansky and colleagues (2008)assert that this 
will have positive implications for interventions encouraging healthy lifestyles 
among people with diabetes rather than emphasising that people with diabetes are 
different from the general population. 
5.4.4 Medication management 
Medication management was a recurring theme amongst participants for various 
reasons. Harriett described how ‘the medication side’ of diabetes self-management is 
the most important to her  
‘I know there is other aspects to it but if I am not taking my medication it sort 
of counter goes against anything else I do so I have got to do it all’.  
Although Harriett states that this is the most important aspect of self-management to 
her it is the one she is least competent in due to her depression. 
Roger suggests why medication management is the most important aspect of diabetes 
care to him. 
‘Well  if  you  don’t  do  it  you  die  so  you  don’t  really  have  much of  a  choice  
you know it’s a matter of if you do it or you don’t you are going to be ill so 
there was no choice’.  
Participants’ comments on medication management suggest that their health value 
priority is terminal. They all valued this behaviour in that it enabled them to remain 
healthy.  
Charles discussed how the doctor influences his medication management.  
‘Well if the doctor says don’t do that (.) the doctor she asked me what I felt 
about  one  of  the  tablets  I’m  taking  (.)  I  don’t  think  they  are  doing  me  any  
good  I  honestly  don’t.  I  mean  one  doctor  put  me  on  that  who  am  I  to  say.  
This doctor has taken me off one tablet and put me on another’.  
Charles’ perceived control is affected by this influence. It seems that Charles 
welcomes the doctor’s input but this has created a conflict in his LOC beliefs in that 
they are internal and external in nature.Harry is also aware of the doctors influence to 
his medication management. 
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‘I manage it myself as it goes. But if the doctor tells me something else I’ll 
just go and do it I wouldn’t contradict him’.  
However, comments from Harryand Roger suggest that they possibly feel more 
competent in their ability to manage their condition than Charles. 
Harry:  But  if  I  find  some  sort  of  effects  of  it  ((medication))  I  would  come  
back.  
Roger: I think since I became diabetic my management hasn’t changed that 
much so there is no real reason for them to give me advice. If that changed an 
awful lot I would take their advice.  
The data above shows how individual differences in beliefs and levels of self-
efficacy impact on medication adherence. Earlier research has acknowledged that 
several factors including demographic, patient knowledge and belief variables can 
impact on patient adherence to medication (Donnan et al., 2002, Balkrishnan et al., 
2003, O'Hea et al., 2005). A specific factor identified in this study is the influence of 
health  professionals  input  on  locus  of  control  beliefs  and  self-efficacy.  Some  
participants found this input disconcerting, as they could not appreciate the benefit of 
the medication. Others welcomed advice and described a good balance of 
internal/external LOC beliefs and levels of self-efficacy as a result.  This finding 
supports research by Pound et al. (2005) who advocate that it is not because of 
failings in patients, doctors or systems that medication adherence can be poor but 
because of concerns about the medications themselves. Understanding this may help 
improve adherence to medication. 
Another point on medication management that was apparent within the data is how a 
change in medication type or dose can affect a person’s perceived control. Treatment 
options  may  need  to  change  from  oral  medication  to  insulin  therapy  as  Type  2  
diabetes progresses as the body produces insufficient insulinto maintain glycaemic 
levels within normal ranges (Phillips, 2007). 
John described how he ‘felt totally out of control’ when he was changed on to insulin 
in comparison to when he ‘was on tablets’. He conveyed his worry to the doctor. 
‘Well unfortunately they couldn’t do anything other than that was the tablets 
and that was sort of the end of the regime and I had to go onto insulin’.  
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However, John was not the only person to find the changeover to insulin 
troublesome. As this came up within the interviews it was explored further and 
participants’ reasons for finding the changeover troublesome were acknowledged as 
a recurring theme that was named ‘Stigma of Insulin’. The following section 
discusses the various aspects of insulin management that ‘troubled’ participants’ and 
thus influenced their beliefs and outcome behaviour. 
5.4.5 Stigma of insulin 
Extracts from interviews are displayed in this section to distinguish between the 
various aspects of the theme the ‘stigma of insulin’. Discussing the changeover to 
insulin produced words in the interviews such as worried, apprehensive, serious, 
frightened, unhappy, no problem, needles and injections. The stigma of insulin for 
Charles stemmed from  
‘films and things from the past’  
He described how he ‘had visions of big long needles’.  
Harriett had similar thoughts on commencing insulin therapy. 
 ‘I was a bit frightened you know.The nurse is showing you what to do and 
you think God I have to inject myself it’s a bit frightening’.  
Tomand Garry were also apprehensive about injecting. Garry said how he ‘didn’t 
like jags’ and Tom stated  
‘I don’t like sticking needles in myself unnecessarily but this is necessary so I 
have just got to get on with it’.  
Tom’s comments on how this ‘is necessary’ resonate with John (see below). Both 
men indicate how there is ‘no other choice’ but to accept, adjust and adapt to insulin 
management despite the stigma surrounding the change.  
John:  Well  I  wasn’t  too  happy  at  first  but  unfortunately  I  had  been  on  the  
tablets for something like twenty years and the blood in the body obviously 
was getting immune to them so we had to go for some other treatment which 
unfortunately the only other treatment was insulin.  
Harry in contrast stated how he ‘didn’t have any difficulty at all in the change over to 
insulin’ and how he took to it ‘like a duck to water’.  
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Harriett and Garry explained the difference in being on tablets to insulin. 
Harriett: Taking the tablets is nothing because I have got other medication to 
take anyway so popping a wee pill is nothing really but it is a hassle (.) 
insulin. 
Garry: Oh insulin is a bit serious where you think tablets, you never associate 
too much with tablets health–wise but when the insulin started I suppose I 
looked after myself a wee bit better I watched obviously with having your 
sugar counts that you had ah watch what you weren’t doing.  
Both Harriett and Gary associate tablets as less ‘serious’ than insulin. Other 
participants articulated this too and described how insulin required more 
management than tablets. An extract from John serves as an example to explain the 
complexities of insulin management and lifestyle.  
‘If you are going somewhere and doing certain things then you have got to be 
very careful because that can mean a change in insulin (.) what do I have to 
do (.) am I doing too much? So if you are doing too much then what you have 
actually got to do is reduce the amount of insulin you take. Well you have got 
to have a rough idea. It is quite difficult to plan ahead you know sometimes 
something crops up’. 
Harriett describes how she had trouble adjusting her insulin doses and required 
support from the clinic to help her improve her self-efficacy in doing this. She 
mentioned how she had spoken with the doctor that day about her high blood glucose 
results and he asked her  
‘do you know how to adjust your insulin? I went no ((laughs)) I’m not sure so 
he gave me a wee bit of paper and which kind of explains it but he says 
phone in and speak to one of the nurses and he says we will see if that will 
maybe help get things under control’.  
Participants’ stated how you ‘get used to’ taking insulin. 
Adam: ah eventually I got used to it and accepted it. 
Tom: It is easier now then because I am used to it. I am used to it for a few 
years now so.  
The findings from participants on the stigma associated with insulin are evident 
within the literature. Some research has suggested that patients can be 
‘psychologically resistant to insulin’ and avoid commencing insulin therapy (Peyrot 
et al., 2005a, Brod et al., 2009). Participants in this study however were generally 
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‘psychologically insulin receptive’. Receptiveness towards treatment was described 
as a result of knowing that Type 2 diabetes had progressed to the point where there 
was no other treatment option. Due to this participants were accepting of the idea but 
apprehensive at the same time. These findings support research by Jenkins et al. 
(2010) that explored patients’ and health professionals’ experiences of initiating 
insulin as part of the ‘Treating to Target in Type 2 Diabetes (4-T) Trial’. Jenkins et 
al. (2010)interviewed 45 trial participants and 21 health professionals.Jenkins et al. 
(2010) findings indicate that participants were generally psychologically insulin 
receptive. Insulin receptiveness arose largely from personal experiences such as 
through intensive treatment and through knowledge of deteriorating blood glucose 
overtime that led to engagement with and acceptance that diabetes was progressive 
(Jenkins et al., 2010). Similarly to Jenkins et al. (2010) the findings in this study 
showed that although participants were psychologically receptive to starting insulin 
most participants suggested they were anxious about injecting. The experiences of 
study participants highlighted the difficulties involved with managing insulin and 
how differences in experience can lead to varying satisfaction with treatment.  This 
finding supportsNaegeli and Hayes (2010) study that investigated expectations about 
and experiences with insulin therapy on diabetes treatment satisfaction with Type 2 
diabetes patients. Questionnaires were administered to 240 patients and measured 
expectations and experiences of insulin therapy. Naegeli and Hayes concluded from 
their study that expectations may not independently impact treatment satisfaction but 
the relationship of experiences significantly contributes to it. As a resultNaegeli and 
Hayes (2010) suggest assessing patient expectation of insulin therapy prior to 
initiation of treatment to better understand the individual concerns of patients.  
5.4.6 Blood glucose monitoring 
Self-monitoring of blood glucose is carried out to achieve blood glucose ranges as 
near  to  normal  as  possible  in  order  to  prevent  complications  and  to  make  adequate  
decisions about diet, exercise and medication. Blood glucose monitoring (BGM) 
enables  a  person  to  evaluate  the  effects  of  these  decisions  and  to  detect  hypo  and  
hyperglycaemia (SIGN, 2010). Diabetes UK (2013b) recommends that a blood 
glucose level of less than 4mmol/l can be considered hypoglycaemic. 
Hyperglycaemia can be defined as an excess of glucose in the blood and if not 
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treated can lead to diabetes related complications. The evidence for the benefit of 
self-monitoring of blood glucose in Type 2 diabetes patients is conflicting.Recent 
trials and reviews on the benefits of self-monitoring amongst patient groups not on 
insulin have shown very small effects on glycaemic control (Welschen et al., 2005, 
Farmer et al., 2007, Evans et al., 2012). SIGN (2010) specify certain groups who 
may benefit from self-monitoring such as those on sulphonylureas  and insulin. The 
findings from the interviews of this study suggest that self-monitoring of blood 
glucose was perceived as a beneficial activity by many. Five dimensions of meaning 
to this activity were identified and are presented below followed by an analytical 
discussion. 
1. Some viewed this activity as valuable to health as it assists participants’ in 
making decisions about insulin dosages and diet. 
Harry:  Well  to  me  you’re  looking  after  yourself  with  taking  your  blood  
count and then your regulating how much units of insulin you are going 
to take. 
Garry: I found this taking your blood testing was a great thing to do you 
know like you could have something ((to eat)) and then oh say that had a 
lot of sugar in it so you started say the likes of meals oh don’t put that 
sauce on because there is a lot of sugar in it. 
2. Others articulated how self-monitoring of blood glucose provided them with 
a means of monitoring against possible complications and maintaining 
quality of life.  
Tom: Because it prevents complications and other illnesses stem from it 
((diabetes)) so I have been told so I do it because I have to.  
John: If you are going somewhere and doing certain things then you have 
got to be very careful because that can mean a change in insulin.What do 
I have to do (.) am I doing too much? 
3. Participants described how it reduced worry of hypoglycaemia and 
hyperglycaemia. 
Mary: You don’t have to worry about taking a hypo or anything like that. 
Because if you’re keeping your blood sugars fine you’re keeping 
everything ok’. 
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John: You have got to continually monitor your blood sugar levels if you 
feel anything at all then you have got to go and check and make sure you 
are not going into a really bad hypo because that is the big problem’. 
4. Several participants’ indicated how self-monitoring provided them with a 
‘psychological’ sense of control of their condition in knowing their blood 
glucose ranges. 
Paul: I think that a lot of it is psychological I mean I get anxious if I see 
my blood sugar is high and I feel good when my blood sugar is within a 
normal range. 
Harriett: ‘If I am being really good and trying that motivates me to check 
my blood sugars because I want to (.) I then say to myself look there’s the 
evidence my blood sugars are coming down so there’s the evidence that 
what I am doing is good and it’s working. So you can actually see it there 
in front of you on the screen’ 
5. Two participants suggested that it wasn’t until they experienced a 
hypoglycaemic attack that they realized the benefit of blood glucose 
monitoring. 
Rosie: I just couldn’t function you just collapse. Luckily it was outside a 
chemist and I also had my glucose tablets with me so I took them and 
then  I  sat  for  awhile  and  just  once  it  started  kicking  in  I  was  ok.  It  has  
happened twice but I think it is not eating properly first thing in the 
morning and I think the sugar level is unsettled I mean it was down at 2 
so  I  have  to  be  very  careful  what  I  am  eating  and  when  I  am  eating  
because I don’t want to do that again. It was scary. 
Garry: Now I watch it I don’t do that silly thing again I watch it and I say 
oh well right I will have my meal you can either take your insulin before 
your meal or within ten minutes of finishing your meal for it to be 
effective so I watch. Yes it was a rude awakening.  
BGM provided participants with an objective way of assessing their diabetes control. 
This activity for some improved internal LOC beliefs and levels of self-efficacy as 
participants conveyed how self-monitoring enabled them to manage aspects of their 
diabetes more efficiently. The second dimension of this theme highlights how 
participants  felt  that  BGM  enabled  them  to  maintain  their  quality  of  life.  
Maintenance of quality of life was similar to dimension one however participants 
described how this activity enabled them to have flexibility in their daily living as 
they could adapt their requirements using BGM as a guide. Daily activities described 
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included travel, recreational activities, exercise and job related activities. Using 
BGM as a means of providing feedback on exercise has been implied as limitedby 
French et al. (2008). Additionally, participants’ sought to prevent complications by 
self-monitoring and discussed how frequent measurements were required for the 
detection and prevention of hypoglycaemia. The above findings add to current 
evidence on the benefits of BGM (Heisler et al., 2005, Malanda et al., 2009, 
Hortensius et al., 2012).  
Cryer (1981) originally termed hypoglycaemia as the commonest side-effect of 
insulin treatment for diabetes and described it as the greatest barrier to achieving and 
maintaining good glycaemic control. Hypoglycaemia is higher in those with strict 
glycaemic control as evidenced by the The DCCT Group (1997) and UKPDS (2005) 
trials. Participants described hypoglycaemia as ‘awful’, ‘scary’ and ‘sickening’. 
Symptoms experienced included shaking, nausea, sweating, dizziness, confusion and 
in severe cases unconsciousness. BGM reassured participants that their blood 
glucose ranges were within normal limits and they described feelings of competence 
in avoiding hypoglycaemia as a result. Participants differed in their perspective of 
BGM and the actions they took depending on the reading. Hypoglycaemic readings 
resulted in feelings of panic in some participants. For reassurance some carried 
glucose tablets with them ‘just in case’. Hyperglycaemic readings were met with less 
anxiety but required competence in ability to adjust medication dosages.  
Malanda et al. (2011) found that BGM has the potential to confirm or challenge 
subjective feelings about hypoglycaemia.  This finding was also evident amongst 
participants’  in  this  study.  Dimension  three  of  the  BGM  theme  demonstrates  how  
participants’  levels  of  satisfaction  and  competence  in  their  glycaemic  control  were  
elevated by ‘evidence’ that their blood glucose ranges were within normal limits. 
Peel et al. (2004) suggested that patients with Type 2 diabetes might achieve an 
increased sense of personal control over their condition as a result of seeing the 
impact of their behaviour on blood glucose levels.  
Some participants’ described barriers to BGM that resulted in hypoglycaemic 
attacks. Garry gave a lengthy description of a hypoglycaemic experience. His BGM 
reading was less than 3 mmol/l and he proceeded to take his full dose of insulin. He 
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described in detail how as a result he went unconscious and his wife called the 
emergency services to revive him. Rosie’s account of hypoglycaemia like Garry 
depicts a low level of self-efficacy in glycaemic control. The differing experiences 
have resulted in both participants’ trying to adopt better methods of control to avoid 
a reoccurrence of severe hypoglycaemia.  
The findings discussed above have provided an understanding of how BGM impacts 
on perceived control of insulin-treated Type 2 diabetes patients. Gaining insight and 
discussing all factors involved with BGM may identify personal barriers to diabetes 
care and improve quality of life of this patient group. This finding and implication 
for practice resonates with research by Gonder-Frederick et al. (1997) who 
developed a biopsychobehavioural model that can be used as a guide to assessing 
relevant individual problem areas in patients who experience severe hypoglycaemia. 
Gonder-Frederick et al. (1997) recommend that use of a model such as this can 
determine individual behavioural risk factors of severe hypoglycaemia and 
encourages  health  professionals  to  consider  a  wider  range  of  factors  in  their  
assessments of patients at risk of hypoglycaemia.  
5.4.7 Type 1 or Type 2: Importance of classification 
A notable issue raised by some was what their diabetes type was. This question 
surfaced as a result of being commenced on insulin. This poses serious implications 
as  patients  who  are  unsure  of  their  diabetes  classification  may  seek  out  the  wrong  
information and education material. The shared confusion stemmed from whether 
they should still be identified as Type 2 now that they are on insulin. 
Rosie: When I first got told of thatof course I didn’t know what diabetes was 
or  diabetes  2  or  1  was  so  it  wasn’t  until  I  got  educated  in  that  way I  knew 
what to expect and what I am doing’.  
Adam:  Well  see  it  is  hard  to  say  there  is  still  that  wee  bit  between  Type  2  
although I am classified as Type 2 it is still similar to Type 1 because I am on 
insulin and I am not sort of overweight although they are changing that 
nowadays. 
The importance of classification type to perceived control and health value and 
effective diabetes self-management behaviours is evident here. Rosie implies how 
education improved her perceived control as knowledge on her diabetes type enabled 
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her to identify ways to manage her condition. The issue of diabetes classification on 
patient perspective and subsequent self-management behaviours requires further 
investigation in future research. 
5.4.8 Low mood, anxiety and depression 
Low Mood was not common across all participants’. However, Tom mentioned how  
‘Sometimes you feel unhappy about it all. That’s all. Yes I can be in a bad 
mood from time to time because of the medical things I have got to deal 
with’.  
Garry expressed how he feels he has ‘less tolerance’ due to diabetes. 
‘Well  I  think  it’s  the  diabetes  that  control  the  mood  swings  aye  ((yes))  
because I am short tempered with the children. Well if they are noisy I think 
it possibly is that my blood sugar is starting to get low and your saying they 
are awfully noisy and things like that whereas there is other times they can 
blow away the drums. So sometimes less tolerance’. 
Frier (2008:89) discussed the effects of hypoglycaemia on mood and stated how  
'hypoglycaemia induces a feeling of tense-tiredness, and many people feel 
sad and unhappy with overt pessimism and negative feelings when their 
blood glucose is low’. 
Harriett and Rosie conveyed in their interviews how their lives have been affected by 
clinical depression and gave their perspective on how this impacts their diabetes self-
management behaviour. The self-management aspects of Type 2 diabetes gets 
Harriett down at times which can affect her ability to ‘cope’.  
‘If I feel low I can’t be bothered taking my medication and I can’t be 
bothered taking my insulin and if I can’t be bothered doing that then my 
diabetes gets worse. It’s a vicious cycle’.  
Harriett was asked what helps her to alleviate depressive symptoms? 
‘I  just  need  to  get  myself  into  the  right  place  mentally.   You  know  what  I  
mean I need to get myself right I need to say to myself this is at the moment 
my  number  one  priority  (.)  so  get  some  exercise  eat  better  take  your  
medication and get your health a bit better and that I should be saying to 
myself that is your top priority you need to get that’. 
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Rosie also expressed in her interview how her life has been affected by depression 
and similar to Harriett she mentions how it can affect her diabetes self-management 
behaviours. Rosie at the moment seems to have more control over her depressive 
symptoms and diabetes self-management. 
‘I have to watch my moods because I have got clinical depression because it 
swings very much so but even that I have to control one thing I am actually 
controlling  the  other  to  help  get  it  on  an  even  keel  and  the  psychiatrist  is  
pleased with me doing that. I have had depression for about twenty years so I 
know the pitfalls and the highs of that’. 
Another similarity to Harriett that Rosie highlights is the coping mechanism they 
both share by which they try and overcome the depressive symptoms they have in 
order  to  keep  ‘control  of  one  to  control  the  other’.  Both  women describe  saying  to  
themselves or thinking to themselves about their priority in control and then finding 
personal ways to work this out cognitively and then apply it to action. Heather states 
how she ‘needs to get herself  right’  and Rosie states how she needs to ‘think about 
what she is doing and where she is at’ in order to regain control over depression and 
Type 2 diabetes. 
These findings support previous research that has indicated how depression can 
impact on a person with diabetes ability to self-care effectively (Park et al., 2004, Ali 
et al., 2006, Gonzalez et al., 2007, Egede and Osborn, 2010). Gonzalez et al. 
(2007)recommend that interventions aimed at alleviating depressive symptoms of 
patients with Type 2 diabetes could result in significant improvements in diabetes 
self-care. 
5.5 Summary 
The previous sections on values in life, the meaning of health, health value and 
change in health value have shown how participants’ values can differ in terms of 
their priorities. Although there were differences there were also commonalities 
shared between participants about value priorities, value type and value systems. 
Many participants valued ‘life itself’. As a result life for some of the participants was 
viewed as having precedent over other values within a hierarchical arrangement of a 
value system. For others health was at the top of their value priorities. Participants’ 
descriptions also highlighted the relationships between values and within value 
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systems. These relationships included health and family and health and career, health 
and the ‘ability to do things’. The ‘ability to do things’ value is multi-dimensional 
andwas understood to be describing how various values contribute to behaviour and 
influences on quality of life. One such value priority that contributes to quality of life 
is health value. Prior to discussing the theme ‘health value’ participants’ views on the 
meaning of health and definitions of health were given. Three differing ways of 
defining health was evident within the data and was critically analysed. 
Most participants emphasized how it was only once they were diagnosed with Type 
2 diabetes that health became a value priority. It was evident and consistent with 
seminal literature that health can be valued as an instrumental and terminal value. 
However, post diagnosis of Type 2 diabetes the majority of participants’ indicated an 
instrumental value priority towards health. An apparent reason for this was that 
valuing health instrumentally enables functionality in every day living.  
Participants also described a ‘change in health value’ due to the initial diagnosis of 
the condition. As time progressed participants described how health value can 
change as you can become ‘blasé’ about health and a sense of regret was admitted by 
some who did not value there health as much as they would have liked to pre-
diagnosis of Type 2 diabetes. The theme AAA demonstrates how values and beliefs 
impact on the individual with Type 2 diabetesand mayinfluence their mode of AAA 
and their decisions on self-management behaviours.  
Comorbidity influenced behaviours of participants in different ways. Some 
participants’ described experiencing the various dimensions of the comorbidity 
theme at once. Hereditary influences and age were attributed by some participants’ 
as reasons for ‘getting’ Type 2 diabetes. The self-care activities of medication 
management and blood glucose monitoring highlighted the influence these activities 
have on beliefs and values. The stigma associated with commencing insulin was 
considered and the impact this had on participant beliefs was highlighted. Lastly the 
effects  diabetes  classification  and  mood  has  on  beliefs  and  values  and  outcome  
behaviour was considered. 
The a priori themes and resultant emergent themes contributed to answering research 
questions RQ2 and RQ3. Chapter 8 will defendthis statement and link the data that 
 137
contributes to answering to RQ2 and RQ3 in order to answer RQ8. The qualitative 
data has also addressed research questions RQ7 (see Chapter 3 section 3.3 for detail 
of research questions). 
Moreover, the data resulted in the creation of RQ9 and RQ10 (see section 5.6.4 of 
this chapter). The ensuing section 5.6 details the methods and results of the interim 
phase of this study.
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5.6 Interim phase 
Having carried out an extensive literature review on the health value construct one 
scale  that  measured  current  health  value  was  identified.The  health  value  scale  was  
developed by Lau et al. (1986) and has been established as a reliable and valid scale 
for  use  in  practice.  A  review  of  the  psychometrics  of  the  scale  resulted  in  the  
decision that a new health value scale was not required to measure current health 
value but the scale identified could be adapted to meet the research requirements of 
this study.  
As previously mentioned a priori theme of health value was included in the thematic 
analysis  of  the  qualitative  data  to  explore  how  people  with  Type  2  diabetes  value  
health. The results of this theme were reviewed to consider how it might contribute 
to the adaptation of the health value measure to effectively test the health value 
construct during the quantitative phase. Two qualitative findings in particular 
contributed to the interim phase.  
Firstly, the results of the instrumental/terminal dichotomy of health value contributed 
to the development of the adapted health value measure. The original four items of 
Lau et al. (1986) health value measure were distinguished according to this 
dichotomy.  Following  this  two  new  items  were  added  to  the  already  valid  and  
reliable measure and all six items were then distinguished as either instrumental or 
terminal items. The rationale for adding two new items and distinguishing the nature 
of existing items will be discussed in section 5.6.1. Following this the methods used 
to test validity and reliability of the items and the subsequent results are presented in 
section 5.6.3.  
Secondly, the emergent theme of change in health value resulted in the development 
of two new research questions and hypotheses that contributed to the quantitative 
phase. The methods used to address the new research questions and hypotheses also 
contributed to the development of the adapted health value measure. These 
methodswill be discussed in detail in section 5.6.4: Examining changes in health 
value.  
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5.6.1 Adapting the health value scale & item development 
The instrumental/terminal dichotomy of health value became apparent through 
participants’ descriptions of how health is valued and what health means to them (see 
section 5.2.2 to 5.2.3, of this chapter, for details of the qualitative findings on this 
dichotomy). The qualitative findings on the instrumental/terminal dichotomy suggest 
that participants’ health value orientation is mainly instrumental. The researcher 
decided to examine this result further in the quantitative phase. The principal 
research question thatinvolves testing MSLT was reconsidered at this point in the 
research.  
The testing of MSLT requires a health value measure that measures current health 
value.  In  order  to  allow  for  testing  of  current  health  value  andto  examine  whether  
participants’ health value orientation is mainly instrumental it was decided that the 
items included in the health value measure should allow measurement of current 
health value and the instrumental/terminal dichotomy. The researcher anticipated that 
this method of scale administration would enable sufficient testing of MSLT and 
allow for a concurrent investigation into the instrumental/terminal dichotomy of 
health value.Consequently, the health value measure needed to be multi-dimensional 
in its measurement ability. Thus, the objective of the health value measure for this 
study is to: 
1. Measure current health value, 
2. Measure the instrumental/terminal dichotomy. 
Lau et al. (1986) health value scale has four items that measure current health 
value.In order to proceed with examining the instrumental/terminal dichotomy it was 
deemed necessary to adapt the scale by distinguishing these items using the 
instrumental/terminal dichotomy.Distinguishing whether the items were instrumental 
or terminal involved consulting a definition of each value orientation (see Chapter 2 
section 2.3 for a definition). Items 1 to 4 were then compared with the definitions to 
distinguish each items value orientation. Item 1 and item 4 were distinguished as 
terminally orientated health value items whilst items 2 and 3 were distinguished as 
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instrumentally orientated health value items. This distinguishing of the original four 
items health value orientation resulted in an even number of instrumental and 
terminal health value items.  
To add variability to the testing of the instrumental/terminal dichotomy it was 
deemed necessary to add two more items to the health value measure one that is an 
instrumentally orientated health value item and one that is terminally orientated. The 
researcher developed two new items one of which read as an instrumental health 
value item (Item 5) and one that read as a terminal health value item (Item 6).  
Item development followed a step by step guide provided by (DeVellis, 2003). 
Firstly, the objective of the measure should be identified followed by generating a 
pool of items from a data source provided by a method such as interviews or focus 
groups (DeVellis, 2003). This pool of items should be reviewed by a panel of experts 
for face and content validity purposes (Streiner and Norman, 2008). Face validity is 
an assessment of whether a measurement scale looks reasonable whereas content 
validity considers the extent to which the items measure the relevant subject matter 
(Bannigan and Watson, 2009). The third step is to consider the format and scoring of 
the items in the new or adapted scale (DeVellis, 2003). This includes considering the 
scale type, structure and scoring of items. Other steps recommended by DeVellis 
(2003) include the administration procedures of the scale. These steps are discussed 
under section 5.6.2 ‘adapted health value scale: structure and scoring’ and under 
section 5.6.4 ‘examining changes in health value’. 
The results of the qualitative data influenced the structure of the two new items. A 
pool of items was generated from the theme health value specifically from data 
extracts that referred to the instrumental/terminal dichotomy. A selection ofwords 
that referred to the instrumental/terminal dichotomy was pooled from this data. This 
selection  was  then  narrowed  down  to  formulate  structured  sentences  that  could  be  
used as items. The principal words thatreferred to instrumental health value were ‘to 
do things’ thus item 5 refers to health as valuable in that it enables a person to ‘do 
things’ that they want to. Item 6 was structured using words from participants’ that 
described an end-state of existence thus referring to terminal health value. The items 
were reviewed by an expertin psychometric development and the supervisors of this 
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research to confirm or invalidate the developed items (DeVellis, 2003). The 
objective of the scale was deemed clear by the experts and the new items were 
considered relevant to the specific construct of measurement.  
All six items are displayed in table 5.1. The table includes a description of each item 
in order of its appearance on the health value questionnaire used in this study. Item 
1-4 are the original health value items followed by item 5 and 6 that are the newly 
developed items. The table also depicts the nature of the health value item, whether it 
is instrumental or terminal. Item’s 2, 3 and 5 are considered instrumental in nature 
due to their references to functionality. Item’s 1,4 and 6 are considered terminal in 
nature due to their references to end-states of existence.  
Table 5.1 Original Health Value Scale items (1-4) (Lau et al 1986) & the two new items 
(5 & 6) developed from the qualitative data 
Health Value Scale Items 1 to 6 Instrumental or Terminal 
1. If you don’t have your health then you don’t 
have anything 
Terminal health value item 
2. There are many things I care more about 
than my health 
Instrumental health value item 
3. Good health is of only minor importance in 
a happy life 
Instrumental health value item 
4. There is nothing more important then good 
health 
Terminal health value item 
5. My health is valuable to me mainly because 
it allows me to do other things that I want to 
Instrumental health value item 
6. Without good health my life is meaningless Terminal health value item 
 
5.6.2 Adapted Health Value Scale: Structure and scoring 
The original health value scale developed by (Lau et al., 1986) has a Likert format. 
To reduce impacting on the psychometrics of the scale the adapted health value 
measure  maintained  the  Likert  format  of  the  original  scale.  A  Likert  scale  is  a  
psychometric measure whereby respondents specify their level of agreement or 
disagreement to items on a symmetric agree-disagree scale (Streiner and Norman, 
2008). Likert scales are bipolar which means that items can measure either a positive 
or negative response to a statement (Streiner and Norman, 2008). It is important that 
a Likert scale has a balanced number of positively and negatively worded items to 
reduce acquiescence response bias(Rattray and Jones, 2005). Acquiescence response 
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bias can occur as participants agree with statements as they appear. Having 
negatively and positively worded items should reduce this bias, as acquiescence on 
positively worded items can be balanced with acquiescence on negatively worded 
items (Rattray and Jones, 2005).  
Positively worded items are phrased so that an agreement with the item represents a 
relatively high level of the construct being measured and negatively worded items 
are phrased so that an agreement with the items represents a low level of the 
construct being measured. The negatively worded items of a questionnaire need to be 
reversed scored before computing an individual’s total scale score. Reverse scoring 
the negatively worded items ensures that the items that were originally negative are 
consistent with the positive items in terms of what an agree or disagree implies 
(DeVellis, 2003). As a result of thisitems 2 and 3were reversed scored on data entry 
due to their negatively worded items.  
There were six possibilities for each health value item ranging from strongly disagree 
to strongly agree.The minimum score possible was 6 and the maximum score 
possible was 36. There were three ranges of scores that would allow for 
identification of levels of health value. Scores of 6-16 indicated low health value, 
scores of 17-26 indicated moderate to high health value and scores of 26-36 could be 
considered as very high health value. This scoring system was devised in relation to 
the original scoring system of Lau et al. (1986) health value scale.  
5.6.3 Validity and reliability of Adapted Health Value Scale 
When adapting or developing a new measure it is important that sufficient pilot work 
is carried out (Rattray and Jones, 2005). To test validity and reliability of the health 
value scaleLau et al. (1986) carried out an initial scaling study followed by a larger 
study. The initial scaling study included 47 people and other measures were included 
to validate the measure. The health value scale was found to have good internal 
consistency  with  a  co-efficient  alpha  of  .67  and  a  test  re-test  reliability  of  .78.  The  
larger study included 1,029 people and again results demonstrated that the health 
value measure was a valid and reliable scale. Having considered this method of 
piloting the original health value measure, a pilot study of the adapted health value 
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measure would require at minimum fifty participants along with other measures that 
could be used to validate the measure. This would have set the timeframe for the 
study’s completion back a number of months. Therefore, a separate pilot study for 
the adapted health value measure was considered not possible. Rather the data 
collected from the adapted health value measure in the quantitative phase of this 
study was considered as a method of establishing an initial level of validity and 
reliability. 
Validity in relation to scale development is concerned with the meaning and 
interpretation of the scale (Bannigan and Watson, 2009). There are many ways of 
testing validity and it has been suggested that a variety of approaches should be used 
in testing rather than relying on a single validation measure (Rattray and Jones, 2005, 
Bannigan and Watson, 2009). As previously discussed in section 5.6.1 the adapted 
health value measure was tested for face and content validity. These are two closely 
related forms of validity and are considered the minimum requirements of 
acceptance of a scale (Streiner and Norman, 2008).  Other forms of testing validity 
include concurrent validity and construct validity. Concurrent validity assesses the 
extent to which a measurement correlates with an established measurement scale 
whereas construct validity is tested by assessing to what extent the measurement 
scale under development correlates with the construct under investigation (Bannigan 
and Watson, 2009). Due to the principal purpose of this research to test MSLT the 
researchers resources could not facilitate the testing of concurrent or construct 
validity during the quantitative phase. However, the adapted health value scale was 
tested for reliability. 
Reliability  in  relation  to  scale  developmentrefers  to  the  repeatability  stability  or  
internal consistency of a scale (Rattray and Jones, 2005). Methods of testing 
reliability can be tested through measuring internal consistency including the split 
half technique, Cronbach’s alpha (or co-efficient alpha), item-total correlations and 
the Kuder-Richardson formual (KR-20) (Bryman, 2008, Field, 2009). 
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Item-total Correlations 
Item-total correlations were chosen as the internal consistency method of choice. 
Cronbach’s alpha was considered as an alternative method. However, Cronbach’s 
alpha is influenced by both the number of items as well as the relationships among 
items (Toobert et al., 2000). The adapted health value measure has six items. This 
could  be  considered  as  a  scale  that  has  a  small  number  of  items  (Toobert  et  al.,  
2000). Using item-total correlations to test for internal consistency provides a 
method  that  is  not  influenced  by  the  number  of  items  in  the  scale  (Toobert  et  al.,  
2000). SPSS (statistical package for the social sciences) was the statistical software 
program used to test for internal consistency (for more information on this program 
see Chapter 6 section 6.2).  
The descriptive statistic function was used in SPSS to total each item separately. This 
method of item totalling can enable identification of the variability of the items 
through  observation  of  the  mean  score  and  standard  deviation  of  each  item.  Item-
total correlations were generated using the bivariate correlation function in SPSS. 
This function in SPSS computes the most commonly used correlation index that is 
known  as  the  product  moment  correlation  co-efficient  or  Pearson’s  r  (Polit  and  
Tatano Beck, 2010). This correlation procedure establishes relationships between the 
items. The strength of the relationship can be assessed by the value of Pearson’s r 
(see Chapter 6, section 6.2.7). Kline (1993) recommends deleting any scale item with 
a item-total correlation of <0.3. This method of item-total correlations enables 
identification of weak items that are uncorrelated with the other scale items and 
canresult in their subsequent removal. For consistency and readability results of the 
item-total correlations are reported in the following section. 
Results of item total correlations 
The results of a 6x6 correlation matrix which was produced to test the internal 
consistency of the new health value items (item 5 and item 6) that were added to the 
health Value measure are presented here. Due to missing data (see Chapter 6, section 
6.2.3 for further details) a complete data set and a comparative dataset were included 
in the quantitative data analysis.Dataset 1 (n=78) is considered the main dataset and 
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Dataset 2 (n=107) is the comparative dataset. Correlation matrices of health value 
items  were  produced  for  Dataset  1  and  Dataset  2.  Results  for  both  datasets  are  
reported. For ease of readability the tables for Dataset 2 have been assigned to 
Appendix F.  
Health Value Part 2 was used to test reliability of the items as it measures current 
health  value.  Item 5  and  item 6  were  the  two new items added  to  the  health  value  
measure (see section 5.6.1 table 5.1). Item 5 was distinguished as an instrumental 
health value item whilst item 6 was distinguished to be a terminal health value item. 
The descriptive statistics indicated that item 5 was problematic. There was little 
variability in how participants’ responded to the item as it had the highest mean (5.1) 
and lowest SD (.84) (Dataset 1) (Dataset 2 M = 5.1 SD .81) of all six health value 
items. Furthermore, despite the fact that item 5 reads like an instrumental value 
statement, the item is uncorrelated with the other two items (Item 2 and Item 3) that 
are instrumental in nature.   
Dataset 1 Item 2: r = .1, NS Dataset 2 Item 2 r = .09, NS  
 
Dataset 1 Item 3: r = -.01, NS Dataset 2 Item 3 r = -.04, NS 
Instead it is evident that item 5 is correlated with the three items which are terminal 
in nature (Item 1, 4 and 6).  
Dataset 1 Item 1: r = .30, p<.01 Dataset 2 Item 1: r = .25, p<.05 
Dataset 1 Item 4: r = .5, p<.01 Dataset 2 Item 4: r = .45, p<.01 
Dataset 1 Item 6: r = .28, p<.05 Dataset 2 Item 6: r = .23, p<.05 
Consequently, item five was considered redundant as an instrumental Health Value 
item and  is  now viewed as  terminal  in  nature.  As  a  result  of  this  four  items  of  the  
new health value measure were considered terminal (1, 4, 5, and 6) and two items 
remained instrumental (2 and 3). 
In order that the health value scale remained with an even amount of variability with 
items that were considered terminal and instrumental in nature it was decided that 
item 5 and 6 would be considered redundant and removed from the analysis. Item 6 
was  chosen  as  the  terminal  item  to  be  removed  because  removing  item  5  and  6  
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ensured that the remaining four items were the original items that were found to be 
valid and reliable by (Lau et al., 1986).See Table 5.2 and 5.3 for the descriptive 
statistics and correlation matrix of health value items of Dataset 1. For Dataset 2 see 
appendix F Table 10.2 and 10.3. 
Table 5.2 Descriptive Statistics Health Value Items Dataset 1 
Health Value Items Mean   SD  N 
Item 1 4.42 1.679 78 
Item 2 3.81 1.604 78 
Item 3 4.18 1.569 78 
Item 4 4.82 1.287 78 
Item 5 5.1 0.847 78 
Item 6 3.56 1.702 78 
 
Table 5.3 Correlation Matrix Health Value Items Dataset 1 
Health Value Items Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 
Item 1  .07 .19 .37** .3** .55** 
Item 2 .07  .43** .15 .1 .07 
Item 3 .19 .43**  .07 -.01 -.18 
Item 4 .37** .15 .07  .5** .41** 
Item 5 .30** .1 -.01 .5**  .28* 
Item 6 .55** .07 -.18 .41** .28*   
*correlation is significant at the 0.05 level (2-tailed), ** correlation is significant at the 0.01 level (2-tailed) 
The following section discusses the second qualitative result that contributed to the 
quantitative phase of this research.  
5.6.4 Examining changes in health value 
The rationale for health value item development was to investigate the possibility 
that participants are more instrumentally orientated in regards to their health value. 
This rationale stemmed from the qualitative results.Another qualitative result that 
contributed to new inquiries in this research originated from participants’ 
descriptions of health value and how this influences their diabetes self-management 
behaviours. Participants’ mainly described how pre-diagnosis of Type 2 diabetes 
they valued their health from a terminal point of view but post-diagnosis this was 
mainly instrumental. A terminal health value orientation post diagnosis was viewed 
by many as impractical due to the aetiology of Type 2 diabetes.  Health value 
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was‘changed’ to instrumental as this value orientation enabled participants’ to carry 
on with their daily activities. Health was valued as a functional aspect in daily life.  
The above qualitative findings resulted in new research questions and subsequent 
hypotheses that could be investigated in the quantitative section. It was established 
that the principal aim of the quantitative phase to test MSLT would not be affected 
by the methods included to investigate these two new questions and hypotheses.  













Does health value change from pre-diagnosis to post-diagnosis of Type 2 
diabetes? 
 
Is health valued as an instrumental or terminal value priority post-diagnosis 
of Type 2 diabetes? 
 
Health Value changes from pre-diagnosis to post-diagnosis of Type 2 
diabetes. 
 
Health is valued as an instrumental value priority post-diagnosis of Type 2 
diabetes.  
The method chosen to investigate RQ9 and to test H4 included administering the 
adapted health value measure twice. The first administration of the questionnaire 
involved asking participants to think back to before they were diagnosed with Type 2 
diabetes and think about how much they valued their health at that time. This part of 
the health value questionnaire was called Health Value Part 1 (HVP1). 
The second administration of the questionnaire included asking participants to think 
about how much they valued their health now that they have Type 2 diabetes. This 
part of the health value questionnaire measured current health value and was called 
Health Value Part 2 (HVP2). 
This approach to measuring health value was expected to yield two differing metrics: 
1. Participants’ current health value (as measured by HVP2), 
2. The change in their health value brought about by Type 2 diabetes (as 
measured by comparing scores from HVP1 and HVP2). 
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This method of scale administration asks participants to rate their health value 
retrospectively and can introduce certain biases such as recall bias and social 
desirability bias. Recall bias was defined in Chapter 3 section 3.10.1. Social 
desirability bias is caused by participants’ attempts to construct an account that 
conforms  to  a  socially  acceptable  model  of  belief  or  behaviour  (Bryman,  
2008).HVP1 and HVP2 were strategically placed in the questionnaire booklet. HVP1 
was placed at the beginning of the booklet and HVP2 was placed at the end (see 
appendix E). It was anticipated that this method might contribute to reducing recall 
and social desirability bias.  
During this phase of the research it was acknowledged that it may be impossible to 
ascertaina true depiction of health value pre-diagnosis of Type 2 diabetes in this 
study due to the length since diagnosis of participants’. The average length of time 
since diagnosis was around thirteen years in both phases of this study. A study that 
manages to determine health value of people pre-diagnosis of Type 2 diabetes and 
then again post-diagnosis could possibly be anenhancedsolution to investigating 
changes in health value. This point is further elaborated upon in the future 
recommendations section of this study in Chapter 8 section 8.9. However, this initial 
attempt to measure a change in health value is considered a starting point to 
investigating this phenomenon, as it has not been done before. 
As previously discussed a health value measure was adapted to ascertain whether 
there was variability in the way health value is valued. This resulted in the 
development of RQ10. The methods of investigating this research question and H5 
include reviewing the scoring of these items in the quantitative phase. Answering 
whether participants’ health value is mainly instrumental pre-diagnosis compared to 
post-diagnosis involves comparing the instrumentally scored health value items 
against the terminally scored health value items. If instrumental health value scores 
are higher H5 could be met.  
5.6.5 Summary 
Section 5.6 has detailed the methods used to test the emergent research questions and 
hypotheses that were devised as a result of the qualitative findings. Methods included 
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adapting a health value measure. Items were distinguished depending on the 
instrumental/terminal value dichotomy. Additionally two items were addedto the 
health value measure to add to variability in items for testing of RQ10 and H5. 
Administration procedures for the scale were devised based on the requirements of 
testing RQ9 and H4. The rationale for having two parts to the adapted health value 
measure is discussed. The methods of testing validity and reliability of the new items 
are also highlighted.  
Following  this  the  results  of  the  reliability  test  for  internal  consistency  are  
presented.The results of the item-total correlations of the adapted health value 
measure  resulted  in  the  removal  of  the  two  new  items  developed.As  a  result  of  
removing item 5 and item 6 from the health value data the quantitative data analysis 
only includes items 1 to 4 of Health Value Part 1 and Health Value Part 2 which are 
the four original items developed byLau et al. (1986). To facilitate testing of RQ10 
and H5 items 1 and 4 are still considered terminal in nature and items 2 and 3 are still 
considered instrumental in nature. The methods for testing RQ9 and H4 were not 




6 Quantitative Phase 
Following, the interim phase, the exploratory sequential mixed methods design of 
this research continues to the quantitative phase. The purpose of the quantitative 
phase is to test the interactive effects of the constructs of Modified Social Learning 
Theory (MSLT).  
MSLT for health states that 
‘the three-way interaction between (a) internal health locus of control beliefs; 
(b) self-efficacy for doing the relevant health behaviours; and (c) the value of 
the outcome that follows doing the health behaviours is what predicts (d) 
whether or not the health behaviour(s) will be done’ (Wallston, 
2011:February 2nd, Personal communication). 
Testing MSLT involves testing the interaction of the three main predictor constructs 
on outcome behaviours. The three predictor constructs are internal health locus of 
control, self-efficacy and health value. The predictor constructs are the causal 
variables in this study that are being tested to determine the influence of their 
interaction on predicting outcome behaviours. Causal variables are termed 
independent variables.Outcome behaviours of Type 2 diabetes patients are the 
dependent variable under investigation in this study. A dependent variable is the 
variable in a study that is causally influenced by the independent variables (Bryman, 
2008). 
Research questions and hypotheses for the quantitative phase were formulated based 
on  the  testing  requirements  of  MSLT  (RQ’s  1,  4,  5,  6  and  H  1,  2  and  3).  The  
emergent research questions and hypotheses from the interim phase will also be 
tested during the quantitative phase (RQ’s 9 and 10 and H4 and H5). For readability 








































Does  MSLT  three-way  interaction  of  HLOC,  SE  and  HV  predict  the  
outcome of self-care behaviour in a Type 2 diabetes population? 
 
Does HLOC act as a moderator of predicating health behaviour in a Type 2 
diabetes population? 
 
Is the measurement of HV a necessary predictor of health behaviour in a 
Type 2 diabetes population? 
 
Is  the  measurement  of  health  value  and  perceived  control  (HLOC and SE)  
when taken together a more proficient predictor of health behaviour in a 
Type 2 diabetes population? 
 
Does health value change from pre-diagnosis to post-diagnosis of Type 2 
diabetes? 
 
Is health valued as an instrumental or terminal value priority post-diagnosis 
of Type 2 diabetes? 
 
The greater the value placed on health the greater amount of Type 2 diabetes 
self-care behaviours taken. 
 
The greater the perceived control of diabetes the greater amount of diabetes 
self-care behaviours taken. 
 
The greater the perceived control of diabetes and the greater the value 
placed on health the greater amount of Type 2 diabetes self-care behaviours 
taken.  
 
Health Value changes from pre-diagnosis to post-diagnosis of Type 2 
diabetes.  
 
Health is valued as an instrumental value priority post-diagnosis of Type 2 
diabetes.  
To answer the above research questions and to test the hypotheses quantitative data 
collection methods were reviewed. Quantitative data collection methods vary along 
four dimensions structure, quantifiability, researcher obtrusiveness and objectivity 
(Polit and Tatano Beck, 2010). The research questions dictated which data collection 
method is best suited to the quantitative phase. The data collection method chosen is 
structured data collection. In structured data collection the same information is 
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gathered from all participants in a comparable pre-specified way (Polit and Tatano 
Beck, 2010). A structuredself-report technique of data collection was chosen for the 
quantitative phase. Questionnaires were deemed an appropriate method, as the 
testing of the constructs of MSLT requires the use of social-psychological scales. 
Section 6.1 discusses the various scales used to collect data on the constructs of 
MSLT. 
Data collected was analysed using various statistical procedures. The various 
statistical methods employed during the quantitative phase will be explained in 
section 6.2.Statistical methods were used to organise, test, interpret and report 
conclusions of the quantitative data. Descriptive statistics were used to report 
demographic characteristics of participants and scale scores whilst inferential 
statistics were used to test the quantitative research questions and hypotheses.  
This chapter is structured as follows: 
· Section 6.1 
 
Data collection 
· Section 6.2 
 
Data analysis 




6.1 Data Collection 
Data collection for the quantitative phase began in May 2012 and ended at the end of 
August 2012. The same method of recruitment for participants was used in the 
quantitative phase as the qualitative phase of this research. 
6.1.1 Demographic data 
Data collection methods of the quantitative phase included collecting demographic 
data. Demographic data collected included age, sex, ethnicity, marital status, 
employment  status,  smoking  history  and  years  since  diagnosis  of  Type  2  diabetes.  
Clinical  parameters  such  as  BMI,  blood  pressure,  HbA1c  levels  and  whether  
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comorbidities were present were also collected. Demographic data were gathered for 
descriptive purposes to compare with the statistical results of the questionnaires.  
6.1.2 HbA1c 
HbA1c results were included in this study for descriptive purposes of glycaemic 
control and also within the correlation matrices and block 1 of the hierarchical 
multiple regression (HMR) analyses. See section 6.2 for methods of correlation and 
HMR analyses.  
HbA1c is a blood test that provides a measure of blood glucose levels as an indicator 
of diabetes control over the last two-three months. HbA1c provides a reliable 
measure of actual control over diabetes (Tortora and Grabowski, 2003). Diabetes UK 
(2013a) recommend a cut off for adequate glycaemic control of HbA1c levels at 
between 48-58 mmol/mol. As a result of the compulsory testing of HbA1c at the 
diabetes OPD most recent HbA1c levels of participants were available. Accessing 
these results was in keeping with the ethical considerations discussed in Chapter 3 
section 3.8.  
6.1.3 Questionnaire booklet 
The questionnaire booklet contained five questionnaires (see appendix E). The 
rationale for including this many questionnaires is due to the constructs under 
investigation. In the following sectionseach scale that was included in the 
questionnaire booklet will be explained in relation to the construct it examined. 
Completing this booklet may have been time consuming for many but the response 
rate as discussed in section 3.10.1 was high at 72.2% with 107 returned 
questionnaires.  
Using questionnaires to collect quantitative data can be advantageous. 
Questionnaires  can  be  less  costly  and  require  less  time and  effort  in  comparison  to  
other methods such as interviews(Polit and Tatano Beck, 2010). However, a 
disadvantage of the self-completion questionnaire is that there is no one present to 
help participants if they are having difficulty completing the questionnaire (Bryman, 
2008). At the time of obtaining informed consent from a participant the researcher 
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explained in detail the structure of the questionnaire booklet and the completion 
procedure. This provided participants with an opportunity to address any concerns 
prior to completing the questionnaire. Additionally, a contact number was provided 
to participants on the information sheet to contact the researcher if they had any 
problems filling in the questionnaire outwith the OPD. All participants were supplied 
with a prepaid stamped envelope to return the questionnaire. However, some found 
time to complete the questionnaire whilst waiting in the OPD and handed it in to the 
researcher there and then. 
6.1.4 Adapted Health Value Measure AHV 
The adapted health value (AHV) measure was developed during the interim phase of 
this research. The measure is multi-dimensional as it aims to test current health value 
and value orientation of participants in this study. The AHV is administered in two 
parts in this study. HVP1 aims to measure health value pre-diagnosis of Type 2 
diabetes and HVP2 measures current health value. This method of administration 
addresses RQ9 and H4. The measure consists of 6 items. Items 1 to 4 are found to be 
valid and reliable (Lau et al., 1986). Items 5 and 6 were added to the measure to add 
to variability in items to test RQ10 and H5. Scores ofItems 2, 3 and5 are considered 
instrumental  health  value  scores  and  scores  of  items  1,  4  and  6  are  considered  
terminal health value scores. These scores will be compared to answer RQ10 and H5. 
This study will assess the adapted health value measure for initial reliability (results 
of internal consistency are reported in Chapter 5, section 5.6.3). The AHV has been 
found to have face and content validity (see section 5.6.3). However, item 5 and item 
6 were subsequently removed from the overall quantitative data analysis, as they 
were deemed problematic. Therefore the AHV results that are reported in chapter 7 
willonly include items 1 to 4 of the health value measure.  
Scores from HVP2 will be used for testing of MSLTas these results measure current 
health value.  
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6.1.5 Scales used to test MSLT 
Scales chosen to measure the independent variables areHVP2 of the AHV measure, 
the  Multi-dimensional  Health  Locus  of  Control  (MHLC)  scale  form  C  and  the  
Perceived Diabetes Self-management Scale (PDSMS). The Self-Diabetes-Self-Care-
Activities scale(SDSCA) will measure the dependent variable.  
MHLC Form C 
The Multi-dimensional Health Locus of Control(MHLC) Scale developed by 
Wallston et al. (1978) was designed to assess a person’s beliefs regarding whether 
his or her health status is determined by the actions of individuals and if so whether 
the locus of that control is internal or external. This study will adopt Form C of the 
MHLC scales as it is designed to be a condition specific measure of locus of control 
and can be used when studying people with an existing health/medical condition 
(Wallston et al., 1994).  
Form C has 18 items and has two independent 3 item subscales doctors and other 
people. Each item is a belief statement about a specific medical condition with which 
the patient may agree or disagree. The word condition in each item of the scale was 
replaced with Type 2 diabetes to make the scale relevant to participants of this study. 
There are six possible answers for each item. Scores range from 6-16 = low IHLC, 
17-26 = moderate to high IHLOC, 27-36 = high IHLC. 
PDSMS 
Self-efficacy will be measured using the Perceived Diabetes Self-Management 
Scale(PDSMS) developed byWallston et al. (2007). To test scale reliability Wallston 
et al. (2007) administered the PDSMS to 398 patients with either Type 1 (n=57) or 
Type  2  diabetes  (n=341).  Cronbach’s  alpha  of  the  8-item PDSMS was  found to  be  
.83 indicating internal consistency. The PDSMS can be considered as a beneficial 
tool for measuring self-efficacy, as it is a short measure with 8 items that includes 
positive and negatively worded items (Wallston et al., 2007). 
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The responses for the PDSMS items range from strongly disagree to strongly agree. 
Four of the items (1, 2, 6 & 7) are worded such that high agreement signifies low 
self-efficacy. These four items are reverse scored prior to being added to the other 
four items. The total PDSMS scores can range from 8 to 40 with higher scores 
meaning more confidence in self-managing one’s diabetes. Scores of 8-18 indicate 
low SE, 19-29 indicates moderate to high levels of SE and scores between 30and 40 
suggest high SE.  
SDSCA 
The Self-Diabetes-Self-Care-Activities(SDSCA) scale developed byToobert et al. 
(2000) will be used to measure the dependent variable, diabetes outcome behaviours. 
The SDSCA measure is a brief self-report questionnaire of diabetes self-management 
and includes items assessing aspects of patients’ diabetes regime such as diet, 
exercise, blood glucose monitoring, foot care and smoking. Toobert et al. 
(2000)claim that self-care is multidimensional and it is necessary to assess each 
aspect separately rather than combine scores across components. Therefore scoring is 
calculated for each of the five regimen areas assessed by the SDSCA. The five 
subscales used to assess regimen behaviours include general diet, specific diet, blood 
sugar, exercise and foot care. Smoking is also included, however, this part of the 
scale will be used for descriptive purposes only and will not be included in the 
testing  of  MSLT.  Each  subscale  asks  participants  to  indicate  on  a  scale  of  0-7  the  
average number of days a week they carry out these diabetes related behaviours. 
The  strengths  of  the  items  of  the  SDSCA include  their  brevity  and  ease  of  scoring  
andmake it a practical tool for research. The SDSCA’s use in past research provides 
valuable information on the reliability and validity of this scale (Toobert et al., 
2000).  
HAD Scale 
A measure of anxiety and depression was included in the questionnaire booklet to 
control for anxiety and depression. The data collected on anxiety and depression will 
not  be  included  in  the  statistical  analysis  that  tests  MSLT.  Results  are  used  for  
descriptive purposes only. Previous research has indicated that anxiety and 
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depression can impact on Type 2 diabetes outcome behaviours, controlling for this 
will enable the researcher to compare these descriptive statistics with results on 
behavioural outcomes. Furthermore, these results will be used for comparison 
purposes with findings from the qualitative phase on depression and anxiety. 
The Hospital Anxiety and Depression(HAD) Scale developed byZigmond and Snaith 
(1983) will be used to measure anxiety and depression of participants. After careful 
consideration of various measures of depression, the HAD scale was deemed an 
appropriate tool for use in this study. The HAD scale was the only scale in this study 
that required permission for use. All other scales are considered to be in the public 
domain and free to use for research purposes.Permission to use the HAD scale was 
obtained from GL Assessment London through an application process that involved 
explaining the research purpose and a small fee.  
The HAD scale consists of 14 questions divided into two subscales. The A-scale 
represents the subscale for anxiety and the D-scale measures depression. Each scale 
has seven questions each. Each question is rated by the patient on a four-point scale 
(0-3).  The  score  for  each  item  indicates  the  amount  of  distress  encountered  by  the  
patient (0= none, 3=unbearable). Items for each subscale are then summated. A score 
of 11+ on either scale indicates a case of moderate to severe anxiety and/or 
depression.  
6.2 Data Analysis 
6.2.1 SPSS 
Statistical software packages were developed during the early 1960s for social 
scientists that wanted to calculate statistics from large data sets (Fielding and Gilbert, 
2009).  SPSS stands  for  statistical  package  for  the  social  sciences  and  is  one  of  the  
main statistical packages in use today. Other programs include Minitab, Stata, 
Statview, Genstat and SAS (Fielding and Gilbert, 2009). SPSS version 20.0 for Mac 
was chosen as the statistical program for use in this study because the researcher has 
had statistical training using this particular software package. SPSS enabled efficient 
data management and data analysis of the quantitative data. 
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6.2.2 Data entry 
A data file was created in SPSS prior to data entry. Individual participants are termed 
cases in SPSS. There was one row allocated to each case in the data window. These 
rows were ordered by the identification code given to each participant. Once cases 
were entered variables were entered next. Each variable entered into SPSS was given 
its own name. A label can be assigned to each variable. This is a practical function 
for describing the variable.Data was entered into SPSS using a coding process. 
Coding is the process of assigning numerical values to the response of a variable in 
order to create a data file for computer analysis(Fielding and Gilbert, 2009). A value 
label was assigned to each code as a reminder of its meaning for ease of analysis.  
In order to reduce errors during data entry to SPSS a data checking process was 
devised.Each questionnaire had been manually coded using a coding scheme prior to 
data collection and data entry to SPSS. The coding scheme detailed the value given 
to each code and indicated when to reverse score. Furthermore, prior to data entry to 
SPSS these codes were manually checked for accuracy against the coding scheme 
devised for each questionnaire. The results from the questionnaires were then entered 
case by case in order of their allocated case number. To ensure further accuracy after 
entry of the results from each case into SPSS the questionnaires were manually 
checked again and compared against the codes given for the data in SPSS and the 
manual codes given on the questionnaire.  
6.2.3 Missing Data 
An important issue of data management is how to deal with missing data. Missing 
data arise when respondents fail to reply to a question either by accident or because 
they do not want to answer a question (Bryman, 2008). After the data of the 107 
cases was entered into SPSS it was noted that 29 cases had missing values from 
differing questionnaires. The percentage of cases with missing data was 27% at 29 
cases. The completion rate details the percentage of cases with no missing values. 
The completion rate for this study was 73% with n=78 fully completed questionnaire 
booklets. The partial completion rate details the percentage of cases that have 
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missing values. The partial completion rate was 27% with n=29 partially completed 
questionnaire booklets. 
Estimating the proportion of missing data and the patterns of missing data is 
important to justify the methods used to overcome this problem. Missing data can 
take one of three forms: missing completely at random (MCAR), missing at random 
(MAR) and missing not at random (MNAR) (Potthoff et al., 2006, Myers, 2011). 
MCAR  is  when  there  is  no  systematic  underlying  process  as  to  why  values  are  
missing for a given measurement. Values MAR are missing because of some 
potential non-random systematic process. Data are MAR if the probability of 
missingness for some variable (y) is predictable based on the value of another 
variable  or  set  of  variables  (x)  (Myers,  2011).  Values  that  are  MNAR  are  missing  
due to the value of the variable being considered (Myers, 2011). If data are not 
missing at random then most of the methods of treating the problem are biased for 
example deleting the missing values might result in a non-representative sample if 
data are MNAR (Dodeen, 2003). The cases with missing values were explored to 
establish whether there was a pattern of missing values or whether data was MCAR, 
MAR or MNAR. The percentages of missing values of scales and the type of missing 
data were established and are displayed below. 
Scales with missing values n=29 
MHLOC: 18/29 cases = 62% 
HVP1: 6/29 cases = 20% 
HVP2: 11/29 cases = 38% 
PDSMS: 4/29 cases= 13% 





Cases with missing values from the MHLOC scale, PDSMS and health value scales 
were MCAR. It is impossible for certain to establish which pattern accurately 
describes the missing data (Myers, 2011). Consequently the conclusion that the 
missing values in this study are MCAR is an assumption.  
Four differing methods of managing missing data were reviewed. 
1. List-wise deletion: involves excluding a case from the data analysis if any 
single value is missing. Values deleted must have been MCAR to use this 
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method. List-wise deletion causes a loss of power to the sample and can 
introduce bias. 
2. Pair-wise deletion: discards cases on an analysis-by-analysis basis and only 
when the estimate requires that variable. Pair-wise deletion was regarded as 
an unsuitable method for this study due to the testing of MSLT that requires 
hierarchical multiple regression analyses. Using pair-wise deletion would 
mean that different participants would be included in the estimation of each 
regression coefficient. This could lead to biased estimates and possibly 
mathematically inconsistent results (Myers, 2011). 
3. Mean substitution: involves imputing the mean of a variable in the place of 
any case which is missing a value for that same variable (Myers, 2011). This 
method results in all cases being included in the final analysis. Although this 
method creates an advantage of a complete dataset it also artificially deflates 
the variation of a variable (Myers, 2011). Furthermore, as mean substitution 
is replacing all missing values with average scores this method of handling 
missing data has the potential to change the value of estimates (Myers, 2011). 
4. Multiple regression replacement(MRR): replaces missing values in a variable 
by regressing it on to several highly related variables(Myers, 2011). MMR 
has been found to be one of the most effective data replacement procedures 
for missing data (Ward and Clark, 1991) and has also been found to perform 
better with highly correlated variables, such as Likert-type data (Kromrey and 
Hines, 1994). 
Having considered all four methods of missing data management a combined method 
of using list-wise deletion and multiple regression replacement was chosen for this 
study. Both methods were chosen to reduce the introduction of bias by having 
missing data. Using both methods resulted in an introduction of the use of two 
datasets to report results of this study. 
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List-wise deletion: Dataset 1 n=78 
The 29-cases with missing values were deleted using the list-wise deletion technique. 
This resulted in a complete dataset with no missing data (n=78). This dataset was 
named Dataset 1. 
Multiple regression replacement MRR: Dataset 2 n=107 
The procedure used for MRR was carried out using SPPS. SPSS uses an automatic 
regression imputation function to calculate values for the missing values in the 
dataset. The type of regression that SPSS uses to do this is linear regression (Dodeen, 
2003). In linear regression data are modelled using linear predictor functions and 
unknown model parameters are estimated from the data (Field, 2009). Having carried 
out the automatic regression imputation method in SPSS a new data file with 
imputed missing values was created and named Dataset 2 (n=107). 
Sensitivity analysis 
The main reason two methods were chosen to manage missing data was due to the 
uncertainty of introducing bias from both methods. A data analysis method that 
addresses uncertainty is called sensitivity analysis(Sutton et al., 2000, Meltzer, 
2001). This method of analysis varies in level depending on the requirements of the 
research.  This research adopts a sensitivity analysis approach whereby two datasets 
are tested in the same manner and compared simultaneously throughout data 
analysis. Dataset 1 and Dataset 2 were compared simultaneously in this study to 
identify any possible bias introduced to the results due to missing data. Results are 
reported on both datasets. For ease of reading when reporting results two procedures 
have been introduced: 
1. Dataset 1 (n=78) is considered the main dataset and Dataset 2 (n=107) is the 
comparative dataset.  
2. All results and tables used to describe Dataset 1 are presented in the 
quantitative results chapter (Chapter 7). However, some tables for dataset 2 
are assigned to appendix E for ease of reading.  
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6.2.4 Scale scores 
Scale scores were produced to describe levels of health value, locus of control, self-
efficacy, outcome behaviours and anxiety and depression. The scale scores for health 
value are testing RQ9, RQ1, H4 and H5. Scale scores are reported for both datasets 
using descriptive statistics such as the mean and standard deviation. The mean is the 
arithmetic average of a set of values (Field, 2009). Standard deviation is calculated 
based on every value in a distribution and summarizes the average amount of 
deviation of values from the mean (Fielding and Gilbert, 2009). A standard deviation 
can be interpreted as an indication of the degree of error when a mean is used to 
describe a value or sample (Polit and Tatano Beck, 2010). The results for mean (M) 
and standard deviation (SD) are reported alongside each other for example M (SD).  
6.2.5 Testing the assumption of normality 
Data distributions can be described by their shapes and are a good way to organise 
data and identify patterns (Polit and Tatano Beck, 2010). Data distributions reported 
in this study were explored through testing the assumption of normality. This 
involves reviewing the data to see if it is normally distributed.A normal distribution 
is  a  function  that  represents  the  distribution  of  many  random  variables  as  a  
symmetrical bell shaped graph (Polit and Tatano Beck, 2010). The bell shaped curve 
has a mean of 0 and a SD of 1. The x axis of the standard normal curve is expressed 
in standard deviation units or z units (Fielding and Gilbert, 2009). 
Testing the assumption of normality is important to this research as regression 
models are used to test MSLT and these models assume that errors in the model are 
normally distributed (Field, 2009). Errors in the model that are not normally 
distributed are termed outliers and can bias statistics (Field, 2009). Three differing 
yet connecting methods of testing normality were employed during data analysis. 
The variables inspected for normality included the independent and dependent 
variables used in the regression analyses. This included scores from HVP2, PDSMS, 
and the internal health locus of control subscale scores from the MHLOC scale and 
all five subscales of the SDSCA. 
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An initial exploration involved a visual inspection for normality of both datasets 
using P-P plots and histograms. These were generated in SPSS using the descriptive 
statistics function.Visually inspecting the P-P plots involved checking where values 
lie on the plot. If values fall on the diagonal of the plot the variable is normally 
distributed, but deviations from the diagonal show deviations from normality (Field, 
2009). Any deviations from normality were described using values of skew and 
kurtosis. The values of skewness and kurtosis should be zero in a normal 
distribution. Positive values of skewness indicate a pile up of scores on the left of a 
distribution whilstnegative values pile up on the right. Positive values of kurtosis 
indicate a pointy and heavy tailed distribution, whereas negative values indicate a 
light and flat tailed distribution (Field, 2009). Due to some outliers being identified 
using this method z-scores were calculated to test the outliers’ significance. 
Various statisticians recommend calculating z-scores to test the significance of 
outliers and comparing them to known values for the normal distribution (Marsh and 
Elliott, 2008, Fielding and Gilbert, 2009, Field, 2009). Thusz-scores were calculated 
to establish the significance of skewness and kurtosis. The following formulas were 
used to establish z-scores(Field, 2009). 
 
As previously mentioned a z-score (z-unit) has a mean of 0 and a SD of 1. Within a 
normal distribution 95% of z-scores lie between -1.96 and 1.96 and are significant at 
p <.05, 99% of z-scores lie between +/- 2.58 and are significant at p<.01 and 99.9% 
of z-scores lie between -3.29 and +3.29 and are significant at p<.001. Z-scores with 
values above 3.29 can be regarded as highly significant outliers(Field, 2009). As a 
result this method of comparing z scores to the known values for the normal 
distribution will enable the identification of significant outliers. Some significant and 
non-significant outliers were identified but not removed from the data. The rationale 
for this is discussed in the z-score results section (7.4.3). 
A final method used to test the assumption of normality is Cook’s Distance. Cook’s 
distance is a measure of the overall influence of an outlier on a model (Field, 2009). 
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Cook’s D will be used in the regression analysis to ensure that the remaining outliers 
are not having a significant impact on the regression model. Cook and Weisberg 
(1982) have suggestedthat values greater than one may be a cause for concern. 
Cook’s D was calculated using the regression diagnostics function in SPSS. 
6.2.6 Assessing the assumption of no multicollinearity 
Various techniques were used to assess whether there was collinearity in the data and 
to  prevent  collinearity  occurring.  Multicollinearity  exists  when  there  is  a  strong  
correlation between two or more predictors in a regression model. High levels of 
collinearity can impact on regression results such as increasing the standard errors of 
the b coefficients,  it  limits  the  size  of  r  and  restricts  assessing  the  individual  
importance of predictors (Field, 2009).  
The risk of multicollinearity is increased when testing the interactive effects of 
variables. Testing the interaction of the constructs of MSLT using HMR analyses 
involves creating interaction terms. Creating interaction terms to test MSLT involved 
multiplying the variables by each other to create two-way and three way interaction 
variables that are included in the HMR analyses.  Multiplying variables by each other 
increases multicollinearity of variables (Aiken and West, 1991). A way of 
overcoming this problem is to mean centre the variables before multiplying them to 
create the interaction terms (Aiken and West, 1991).Scores from HVP2, the PDSMS 
and the internal subscale from the MHLC are the predictor variables that required 
centring prior to HMR.Mean centring involves subtracting the mean score for the 
variable from the participant’s raw score and this then centres the variable around 
zero (Field, 2009).The new centred predictor variables were computed in SPSS and 
named IHLC (scores came from internal subscale of MHLC), SE (scores came from 
PDSMS) and HV (scores came from HVP2).  
The three two-way and one three-way interaction variables were then computed in 
SPSS by using the following formula: 
Two-way Interaction Variables: 
Internal Locus of Control x Health Value (IHLC x HV)  
Health Value x Self-efficacy (HV x SE) 
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Internal Locus of Control x Self-efficacy (IHLC x SE) 
 
Three-way Interaction Variable: 
Health Value x Internal Locus of Control x Self-efficacy (HV x IHLC x SE) 
 
Another method of ensuring no multicollinearity of the data is to scan the correlation 
matrix of the predictor variables. Correlations above .80 or .90 are considered to be 
multicollinear(Field, 2009).  
Collinearity diagnostics such as the variance inflation factor (VIF) and the tolerance 
statistic were used in SPSS when carrying out the HMR analyses to further assess for 
multicollinearity. The VIF indicates whether a predictor has a strong linear 
relationship with the other predictor variables. A VIF value greater than ten is a 
cause for concern (Field, 2009). The tolerance statistic is the VIF statistics reciprocal 
(1/VIF). As such tolerance values below 0.1 indicate collinearity problems.  
6.2.7 Correlation 
Pearson product moment correlations were performed to determine if any of the 
continuous demographic variables and predictor variables were significantly 
correlated with the dependent variable outcome behaviour, which is analysed 
through the SDSCA subscales general diet, specific diet, exercise, blood sugar 
testing and foot care. HbA1c was included within the correlation matrix to ascertain 
whether there were any significant relationships between HbA1c results and the 
demographic, independent and dependent variables. Correlations were generated 
using the bivariate correlation function in SPSS.  
The strength of the relationship can be assessed by the value of Pearson’s r. The 
possible values for Pearson’s r range from -1.00 through .00 to +1.00. Correlation 
co-efficients between .00 and +1.00 express a positive relationship whereas 
correlation co-efficients between .00 and -1.00 express a negative relationship(Polit 
and Tatano Beck, 2010). 
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6.2.8 Hierarchical Multiple Regression (HMR) analyses 
The choice of statistical procedure to test MSLT was based on the principal research 
question and hypothesis of this research that requires testing of MSLT. Multiple 
regression  analysis  is  a  way of  predicting  an  outcome variable  from one  or  several  
predictor variables (Field, 2009). There are three methods of multiple regression to 
review when considering which method is best suited to an analysis of predictability 
of variables.  
1. Hierarchical multiple regression (HMR): Predictors are selected and entered 
into the regression model based on a theoretical stance or hypotheses. 
2. Forced entry: is a method whereby all predictors are forced into the model 
simultaneously.  The  statistical  program  makes  the  decision  of  when  and  
where the predictor is entered into the model.  
3. Stepwise regression: The order in which predictors are entered into the model 
are based on mathematical criteria. The statistical program searchers for the 
predictor that best predicts the outcome variable by selecting the predictor 
that has the highest simple correlation with the outcome (Field, 2009). 
Hierarchical multiple regression (HMR) was the method chosen to test MSLT due to 
the fact that the researcher can choose the entry order of predictor variables based on 
theoretical rationale.The procedure of HMR in SPSS involves entering the predictor 
variables in blocks. Causal relationships amongst predictor variables should be 
considered prior to entering the data into the blocks to respect causal flow of the 
theoretical proposition (Cohen and Cohen, 1983).  As recommended by Cohen and 
Cohen (1983) research questions (RQ’s 1, 4, 5 and 6) and hypotheses (H 1, 2 and 3) 
guided the rationale behind the order of predictor variable entry.  
A hierarchical multiple regression analysis consisting of four blocks was performed. 
Cohen and Cohen (1983) argue that demographic variables are typically good 
candidates for initial block entry. The first block consisted of demographic variables 
including age, BMI, years since diagnosis and HbA1c. The second block consisted of 
the three separate predictor variables, HV, IHLC and SE. This allowed for testing of 
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RQ4, RQ5 and H1. The third block contained the three-two-way interactions which 
enabled  testing  of  RQ4,  5,  6  and  H1  and  H2.  The  three-way  interaction  term  that  
tests MSLT was entered into the fourth block. The fourth block tested the principal 
research question and hypotheses (RQ1 and H3).  
The dependent variable for HMR analysis included the five subscales of the SDSCA. 
Due to sensitivity analysis HMR was carried out on Dataset 1 and Dataset 2 resulting 
in ten HMR analyses outputs from SPSS. A summary of each HMR modelon each 
subscale is provided in Chapter 7 section 7.7. Tables from Dataset 2 have been 
assigned to Appendix F for ease of readability. 
The model summary of the SPSS output of each HMR analysis carried out was 
interpreted. The change in R²(∆R2) statistics and its corresponding change in F and p 
values are the statistics used to interpret the significance of the HMR models. R² is a 
measure of how much variability in the outcome is accounted for by the predictors. 
The p values indicate the significance of the change in F. The standard beta 
coefficients are also reported for the earlier stages of the models as they provide an 
insight into the importance of a predictor in a model(Petrocelli, 2003). Interpreting 
HMR summary models involves focusing on the change in predictability associated 
with predictor variables entered later in the model over and above those entered 
earlier in the model (Petrocelli, 2003). This is the method of reporting of HMR 
results used in Chapter 7 section 7.7.  
6.2.9 Three-way independent ANOVAs 
The  HMR  results  found  support  for  the  three-way  interaction  of  MSLT  on  the  
specific diet (SPD) subscale and the blood sugar (BS) subscale. These results 
required further investigation to determine the significance of the interaction effects 
on these subscales. ANOVA is a statistical procedure used to test differences 
between several means (Field, 2009). Two three-way ANOVA’s were conducted on 
both datasets of the specific diet and blood sugar subscales to observe the differences 
in mean among even groups of participants who scored high on the predictor 
variables and groups who scored low. Three-wayANOVAs were also computed for 
the non-significant subscales: general diet, exercise and footcare. 
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In order to support MSLT further it was important that these means demonstrate that 
the highest means were for participants who scored high on all three constructs 
(Wallston, 2013). If the highest means are for participants who scored high on HV, 
SE and IHLOC then MSLT would be better supported. 
To conduct the ANOVAs the variables HV, SE and IHLC were split at the median 
into two groupings of low and high. This enabled identification of means for those 
who scored low and high for each predictor variable. These groupings of low and 
high groups were then entered into the ANOVA function in SPSS.ANOVA results 
were interpreted by reading the three-way ANOVA tables produced using the 
ANOVA function in SPSS. Means for low and high groups are reported by the sum 
of squares (Ss) which is a statistic that reports an estimate of total variability of a set 
of data (Field, 2009). Following this significance statistics of the three-way 
interaction effects using the F-ratio statistic are reported. The F-ratio statistic 
demonstrates how well a proposed regression model fits the data(Field, 2009).The 
ANOVA tables have been reproduced for presentation in this thesis (see Chapter 7, 
section 7.8).  
To visually inspect these results separate interaction plots of the low and high groups 
of the predictor variables were plotted using the three-wayANOVA plot function in 
SPSS. Interaction plots were produced for all five subscales. Interaction plots from 
both datasets for the significant subscales of SPD and BS are displayed in Appendix 
G.  
6.3 Summary 
Chapter 6 has presented the data collection and analysis methods used in the 
quantitative phase to best test MSLT. Various scales were used to collect data on the 
constructs of MSLT and outcome behaviours. The HAD scale was included in the 
questionnaire booklet to control for levels of anxiety and depression and as a 
comparison measure for findings on anxiety and depression from the qualitative 
phase.  
The data analysis section for the quantitative phase details the specific statistical 
procedures used to manage and test the data. Methods of managing missing data 
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were discussed. Choosing two methods to manage missing data resulted in the 
creation  of  two  datasets.  Sensitivity  analysis  was  carried  out  on  the  two  datasets  
whereby  each  measure  taken  for  one  dataset  was  done  so  with  the  other.  This  
enabled identification of any possible bias introduced to the results due to the 
methods used for managing missing data. 
Descriptive statistics are used to describe scale scores and demographic data. Scale 
scores from the health value measure will be used to answer RQ9, RQ10, H4 and H5. 
Inferential statistical methods were employed to test MSLT. Prior to implementing 
these procedures to test MSLT other statistical methods were employed to ensure 
reliability and validity of the statistical results. These methods included testing the 
assumption of normality, centring the predictor variables prior to the HMR analyses 
and use of collinearity diagnostics.  
The methods used for HMR analyses discussed how causal priority of the predictor 
variables was considered prior to block entry, the methods used to interpret the HMR 
analyses  and  the  way  in  which  these  analyses  were  reported.  Finally,  the  rationale  
and methods for conducting three-way independent ANOVAs and interaction plots 
was discussed.  
Chapter  7  details  the  various  statistical  results  from the  quantitative  phase.  Results  
from the qualitative and quantitative phases of the research are integrated and 





7 Quantitative Results 
7.1 Introduction 
The data in this chapter focuses on the results of the quantitative phase. The 
quantitative data analysis included Dataset 1 and Dataset 2. Sensitivity analysis was 
carried out to increase the robustness of the quantitative findings due to removing 29 
cases with missing data from Dataset 1. Dataset 1 includes n=78 complete cases and 
Dataset 2 contains 107 cases, 29 of which had missing values and were replaced 
using regression imputation.Comparative analysis of both datasets is presented 
throughout this chapter. Dataset 1 is considered the main dataset whilst Dataset 2 is 
thought  of  as  the  comparative  dataset.  Selected  results  of  Dataset  2  will  be  
highlighted in brackets (D2, result) alongside the results of Dataset 1. Several of the 
tables that represent the results of Dataset 2 have been consigned to Appendix F for 
readability. 
The chapter begins with a review of participants’ demographic data. Succeeding this 
scale scores are presented. The quantitative data originally sought to test MSLT, 
however, due to the results of the qualitative phaseRQ9 and RQ10 were formulated. 
These research questions aimed to add to the rigor of the qualitative conclusions on 
whether  there  was  a  change  in  HV  orientation  due  to  the  diagnosis  of  Type  2  
diabetes. HVP1 and HVP2 were thus created to test these research questions. Results 
on these questionnaires are reported in section 7.3 along with the other scale scores. 
The statistical tests for the assumption of normality are then evaluated followed by a 
brief review of the results of the statistical assumptions of no multicollinearity. 
Following on from this results from the correlation matrices of demographic, 
independent and dependent variables are given. Finally the hierarchical multiple 
regression results are presented followed bythe results of the three-way 
independentANOVA’s results.  
This chapter is structured as follows: 
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· Section 7.2 Demographic data 
 
· Section 7.3 Scale scores 
 
· Section 7.4 Testing the assumption of normality 
 
· Section 7.5 
 
Meeting assumptions of no multicollinearity 
· Section 7.6 
 
Correlation results 
· Section 7.7 HMR analyses 
 
· Section 7.8 Three-way independent ANOVA results 
 
 
7.2 Demographic data 
Dataset 1 consists of 39 (50%) males and 39 (50%) females. 93.6% of participants 
described themselves as British and 6.4 % described themselves as other. On average 
the participants from Dataset 1 were 63 years old (SD 10.8)and had been diagnosed 
with Type 2 diabetes for an average of 13.5 years (SD 6.3). Participants from Dataset 
1 mean BMI was 34.1 (SD 7.2). A BMI above 30 is considered obese(NHS BMI 
Calculator, 2012). HbA1c levels averaged at 65.4 mmol/mol (SD 18) which is out 
with the suboptimal range of 48-58 mmol/mol, as recommended by Diabetes 
UK(2013a). 80.8% of participants in Dataset 1 have another chronic illness as well 
as Type 2 diabetes, 19.2% do not. 41% of participants were employed, 3.8% were 
unemployed and 55.1% were retired. 12.8% of participants were single, 55.1% were 
married, 21.8% were widowed and 10.3% were divorced. Participants smoking status 
and blood pressure ranges were also recorded (See Table 7.1).  
Similar descriptive statistics were seen in Dataset 2. Dataset 2 consists of 63 (59%) 
males and 44 (41%) females. 93.5% of participants described themselves as British 
and 6.5% described themselves as other. On average participants from Dataset 2 
were 62 years old (SD 10.7) and had been diagnosed with Type 2 diabetes for an 
average of 13.8 years (SD 6.7). Mean BMI was 34.2 (SD7.2) and participants 
average HbA1c level was (66.3) (SD18.3). Again these levels are out with the 
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suboptimal range of 48-58 mmol as recommended byDiabetes UK (2013a).80.6% of 
participants reported having another chronic illness and 19.6% did not. For other 
demographic data on Dataset 2 see Table 10.4 Appendix F. 
Table 7.1Demographic Data Dataset 1 
Demographic Data Mean SD % N   Mean SD % N 
Sex    78  Smoking Status     
Female   50 39  Smoker   12.8 10 
Male   50 39  Never Smoked   70.5 55 
      Ex Smoker   16.7 13 
Age 63 10.8 50 39       
      Diabetes 
yearsddDiagnosis 
13.5 6.3   
Age Groups      1-5   10.3 8 
30-45   9 7  6-10   24.4 19 
46-55   14.1 11  11-15   25.6 20 
56-65   37.2 29  16-20   19.2 15 
66-75   29.5 23  >20   20.5 16 
76-85   9 7        
86 and above   1.3 1   BMI Range 34.1 7.2   
      <18.5   1.3 1 
Ethnicity      18.5-24.9   6.4 5 
British   93.6 73  25.0-29.9   23.1 18 
Other   6.4 5  >30   69.2 54 
           
Marital Status      HbA1c Levels 65.4 18   
Single   12.8 10  <48 mmol/mol   7.7 6 
Married    55.1 43  48-59 mmol/mol   32.1 25 
Widowed   21.8 17  60-69 mmol/mol   26.9 21 
Divorced   10.3 8  70-80 mmol/mol   17.9 14 
      >81 mmol/mol   15.4 12 
Employment Status           
Employed   41 32  Blood Pressure     
Unemployed   3.8 3  ≥91/65   15.4 12 
Retired   55.1 43  ≥120/80   16.7 13 
      ≥130/85   19.2 15 
Co-morbidity      ≥140/90     48.7 38 
Other Chronic Illness   80.8% 63       
None   19.2 15       
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7.3 Scale Scores 
Participants from Dataset 1 mean score for HVP1 was 17.5 (SD 3.8). A similar mean 
score 17.2 (SD 3.9) was seen in HVP2. Correspondingly, participants in Dataset 2 
mean score in HVP1 was 17.4 (SD 3.8) and their mean score for HVP2 was 17.1 (SD 
3.7). These results demonstrate that participants average health value score pre and 
post-diagnosis of Type 2 Diabetes were the same with very similar standard 
deviations. The standard deviations are low which indicates homogeneity of the 
sample’s answers. The mean scores for HVP1 and HVP2 demonstrate a moderate to 
high health value score. The scoring of the scale was adjusted as required due to the 
removal of items 5 and 6. Thus scores ranged from minimum 6-12, moderate to high 
12-18, very high 18-24. 
Scores for the instrumental and terminal health value subscales were also 
comparable. Dataset 1’s terminal health value scores pre-diagnosis (HVP1) had a 
mean  of  9.5  (SD  2.1)  and  post-diagnosis  (HVP2)  mean  scores  were  9.2  (SD  2.4).  
Respectively, Dataset 2 demonstrated that terminal health value scores averaged at 
9.4 (SD 2.3) pre-diagnosis and 8.9 (SD 2.6) post-diagnosis. Dataset 1’s instrumental 
health value scores pre-diagnosis have a mean of 7.9 (SD 2.8) and 7.9 (SD 2.6) post-
diagnosis. Dataset 2’s mean instrumental health value score pre-diagnosis was 8 
(SD2.7) and post-diagnosis 8 (SD 2.5).  Mean scores were considered moderate to 
high  for  terminal  and  instrumental  health  value  scores  in  Part  1  and  Part  2  and  for  
both datasets. Again scoring for the instrumental and terminal subscales were 
adjusted as required due to removing items 5 and 6. Thus Scores ranged from 
minimum 6-8, moderate to high 8-10, very high 10-12. No significant change is seen 
in either Dataset 1 or Dataset 2 (D2) in regards to how people value their health pre 
or  post  diagnosis  of  Type  2  diabetes.   This  will  be  explored  further  within  the  
discussion section of this thesis.  
Scores from the Perceived Diabetes Self-management Scale (PDSMS) indicate that 
participants mean score 29.8 (SD 5.3) (Dataset 1) (D2 29.3, SD 5.3) have ‘moderate 
to high’ levels of self-efficacy.  
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The Multi-Dimensional Health Locus of Control Scale (Form C) results are reported 
as five subscales. IHLCscores averaged at 28.5 (SD 6.11) (Dataset 1) (D2 27.8, SD 
5.7).  These  scores  demonstrate  High  IHLC.  Scores  range  from  6-16  which  are  
considered low IHLC, scores of 17-26 are a moderate level of IHLC and scores 
between 27-36 indicate high IHLC. Participants average scores for the other four 
scales  were  Chance  15.1  (SD 6.8)  (Dataset  1)  (D2 15.5,  SD 6.9),  Powerful  Others  
25.6 (SD 6.5) (Dataset 1) (D2 25.2, SD 5.2), Doctors 15.3 (SD 2.4) (Dataset 1) (D2 
14.9, SD 2.7) and Other People 10.2 (SD 4) (Dataset 1) (D2 10.4, SD 3.9). These 
scores suggest that although participants are high on IHLC, the powerful others scale 
scores indicate that participants believe that doctors and other people influence their 
ability to manage their diabetes.  
The Summary of Diabetes Self-Care Activities Measure demonstrates how effective 
participants are at carrying out certain health behaviours that influence diabetes 
management. It is reported through 5 subscales, which measure on average how 
many days a week these behaviours are carried out. Participants mean score for 
general diet Dataset 1 was 4.9 (SD 1.7) (D2 4.7, SD 1.8) and for Specific Diet the 
mean scores for Dataset 1 were 4.1 (SD 1.5) (D2 4, SD 1.5). Exercise mean scores 
for Dataset 1 were 2.9 (SD 2.4) and for Dataset 2 2.8 (SD 2.4). Blood sugar testing 
was carried out on an average of 5.7 days (SD 2.1) (Dataset 1) (D2 5.4 days, SD 2.3). 
Foot Care activities were carried out on average 3.4 days a week (SD 2.4) (Dataset 1) 
(D2 3.4 days per week, SD 2.4). The last two items of the SDSCA refer to smoking 
status. 87.2% Dataset 1 (88% Dataset 2) have not smoked in the last seven days. The 
mean number of cigarettes smoked in the last seven days were 1.4 (SD 4.3) (Dataset 
1) (D2 1.7, SD 4.8).  
The  HAD  scale  was  used  to  assess  for  and  describe  anxiety  and  depression  levels  
within the sample. These results will not be included within the regression analysis 
due to the principal aims of testing MSLT that do not necessitate these results. It is 
noted that 57.7% of participants scored within the normal range on the anxiety 
subscale and 65.4% scored within the normal range on the depression subscale 
Dataset  1  (D258.9%  normal  ANX,  65.4%  normal  DEP).  However  a  substantial  
number of people have mild to moderate anxiety Dataset 1 mild: 20.5% (D2 
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20.6%),Dataset 1 moderate: 16.7% (D2 15%) and depression Dataset 1 Mild: 17.9% 
(D2 18.7%) Dataset 1 moderate: 12.8% (D2 2.1%). The percentage of participants 
with severe anxiety (D1 5.1%, D2 5.6%) and depression (D1 3.8%, D2 3.7 %) was 
low. See Table 7.2 for scale scores of Dataset 1 and Table 10.5 Appendix F 
forDataset 2. 
Table 7.2 Scale Scores Dataset 1 
Health Value Scales Mean SD % Yes % No N 
Health Value Part 1  17.5 3.8   78 
Health Value Part 2 17.2 3.9   78 
Health Value Part 1 Terminal Items 9.5 2.1   78 
Health Value Part 1 Instrumental Items 7.9 2.8   78 
Health Value Part 2 Terminal Items 9.2 2.4   78 
Health Value Part 2 Instrumental Items 7.9 2.6   78 
      
PDSMS 29.8 5.3   78 
      
MHLC Subscales      
Internal 28.5 6.11   78 
Chance 15.1 6.8   78 
Powerful Others  25.6 5   78 
Doctors  15.3 2.4   78 
Other People 10.2 4   78 
      
SDSCA Subscales      
General Diet 4.9 1.7   78 
Specific Diet 4.1 1.5   78 
Exercise 2.9 2.4   78 
Blood Sugar 5.7 2.1   78 
FootCare 3.4 2.4   78 
      
SDSCA Smoking Status      
% smoked a cigarette in last 7 days    87.2 12.8 78 
Cigarettes smoked per day 1.4 4.3    
      
      
HAD Range of Scores Anxiety % Depression %    
 0-7 Normal 57.7 65.4   78 
8 - 10 Mild 20.5 17.9   78 
11 - 14 Moderate 16.7 12.8   78 
15 - 21 Severe 5.1 3.8     78 
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7.4 Testing the Assumption of Normality 
7.4.1 Normality Dataset 1 
Normality was inspected visually through analysis of histograms and P-P plots of the 
main independent variables and dependent variables that will be used in the 
hierarchical multiple regression (HMR) analyses. The independent variables include 
the summed scores of HVP2, the PDSMS, the Internal subscale from the MHLC and 
the  dependent  variables  consist  of  the  5  subscales  from  the  SDSCA.  Below  the  
normality assumption is explored within Dataset 1, n=78. 
HVP2 demonstrates a distribution that is negatively skewed  -.364 and kurtosis value 
of -.336. The histogram illustrates a bimodal distribution. 14.1% of participants 
scored 14 and 14.1% scored 20 on the HVP2 questionnaire. The P-P Plot again 




Figure 7.1 Health Value Part 2 Histogram and PP Plot D1 
The Internal subscale of the MHLC is negatively skewed -.831 (kurtosis value of .9). 
There also appears to be an outlier near to 0 which required further investigation (See 






Figure 7.2 Internal LOC Histogram and PP Plot D1 
 
The PDSMS scores are slightly positively skewed .218 (kurtosis value of -.561). This 




Figure 7.3 PDSMS Histogram and PP Plot D1 
The scores for the SDSCA subscales are seen to deviate from the assumption of 
normality except for scores on foot care. General Diet has a negatively skewed 
distribution (skewness -.938, kurtosis .512), Specific Diet has a negatively skewed 
distribution with a skewness of -.899 and kurtosis value of .807. General diet and 
Specific Diet appear to have outliers. Specific Diet is multimodal. 15.4% of 
participants followed a specific diet for four days, 15.4% for 4.5 days and 15.4% for 
5 days out of a week. Exercise is relatively normal with a slight positive skew of .268 
and kurtosis value of -1.198. Blood sugar values are negatively distributed with a 
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skew value of -1.4 and kurtosis value of .874. Foot Care is the most normal 
distribution with a skewness value of .030 and a kurtosis value of -1.198 this is also 
evident from viewing the bell curve of the histogram and the line of values on the P-




























Figure 7.8 Footcare Histogram and PP Plot D1 
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7.4.2 Normality Dataset 2 
HVP2 scores are negatively skewed -.307 (kurtosis -.321) this is indicative of 
Dataset1. The skewness and deviations from normality are apparent in the histogram 
and P-P Plot below. Dataset 2 HVP2 is also bimodal with 14% scoring 14 and 14% 




Figure 7.9 Health Value Part 2 Histogram and PP Plot D2 
The IHLC scores are negatively skewed -.728 and have a kurtosis value of .855. 
Again the histogram as seen in Dataset 1 depicts an outlier close to zero that will be 






Figure 7.10 Internal LOC Histogram and PP Plot D2 
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The PDSMS scores are positively skewed .134 (Kurtosis -.331). This is evident from 
the histogram and P-P Plot. There also appears to an outlier within these scores that 
was not evident in Dataset 1. The significance of this will be tested through 






Figure 7.11 PDSMS Histogram and PP Plot D2 
The SDSCA subscale scores from Dataset 2 demonstrate similar assumptions for 
normality as Dataset 1. This similarity is evident in the skewness and kurtosis of the 
distributions and through visual inspection of the histograms and P-P Plots. General 
Diet is negatively skewed -.776 (kurtosis -.043). From the histogram of General diet 
there appears to be no outlier, this is different to the histogram for Dataset 1. Perhaps 
this outlier was created in dataset 1 due to the deletion of cases with missing values. 
This will be investigated through an examination of z-score significance. Specific 
Diet is negatively skewed -.757 (kurtosis value .682). This is similar to Dataset 1 and 
there are obvious outliers displayed on the histogram, which is also indicative of 
Dataset 1. Exercise is positively skewed .346 (kurtosis -1.217). Blood sugar scores 
deviate from normality and are negatively skewed -1.156 and have a kurtosis value 
of  -.251.  Foot  Care  as  seen  in  Dataset  1  can  be  considered  the  most  normally  
distributed subscale with a skew of .044 (kurtosis -1.213). All histograms and P-P 































Figure 7.16 Footcare Histogram and PP Plot D2 
 
7.4.3 Z-scores 
Table  7.3  and  7.4  demonstrate  the  calculated  z-scores  of  Dataset  1  and  Dataset  2.  
The scales that are included in the tables are the independent and dependent variables 






Table 7.3 Skewness and Kurtosis z-scores Dataset 1 
Scale Skewness zSkewness SIG Kurtosis zKurtosis SIG 
HVP2  -.364 -1.3 NS -.338 -.62 NS 
Internal LOC -.831 -3.05 p < .01  .9 1.67 NS 
PDSMS .218 .8 NS -.561 -1.04 NS 
General Diet -.938 -3.4 p < .001 .512 .95 NS 
Specific Diet -.899 -3.3 p < .001 .807 1.5 NS 
Exercise .268 .98 NS -1.198 -2.2 p<.05 
Blood Sugar -1.475 -5.4 p < .001 .874 1.6 NS 
Foot Care .03 .11 NS -1.148 -2.13 p<.05 
Significance: Value > or < 1.96 sig p < .05, Value > or < 2.58 sig p < .01, Value > 3.29 sig p < .001, NS= Not Significant 
 
Table 7.4 Skewness and Kurtosis z Scores Dataset 2 
Scale Skewness zSkewness SIG Kurtosis zKurtosis SIG 
HVP2  -.307 -1.3 NS -.321 -.69 NS 
Internal LOC -.728 -3.11 p < .01 .855 1.84 NS 
PDSMS .134 .57 NS -.331 -.71 NS 
General Diet -.776 -3.31 p < .001 -.43 -.09 NS 
Specific Diet -.757 -3.23 p < .01 .682 1.47 NS 
Exercise .346 1.47 NS -1.217 -2.6 p<.01 
Blood Sugar -1.156 -4.9 NS -.251 -.54 NS 
Foot Care .044 .18 NS -1.213 -2.61 p<.01 
Significance: Value > or < 1.96 sig p < .05, Value > or < 2.58 sig p < .01, Value > 3.29 sig p < .001, NS= Not Significant 
 
The Internal LOC subscale z-score for skewness Dataset 1 is 3.05, p<.001 and z-
skewness 3.11, p<.001 for Dataset 2. The outlier was identified from the histogram 
and  frequency  output  in  both  datasets  in  SPSS  as  being  a  single  score  of  6.   Data  
entry was reviewed to ensure a mechanical error was not made. This was confirmed 
and  decided  that  the  outlier  would  not  be  removed  or  changed  as  the  z-scores  for  
skewness are below the upper threshold for skewness which is 3.29, p<.001 (Field, 
2009). Additional diagnostic tests such as Cook’s Distance are used during 
regression analysis to justify this decision (see section 7.4.4).  
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General Diet was identified as having outliers with a z-score for skewness in Dataset 
1 of 3.4, p<.001 (D2 z-skewness 3.31, p<.001) and Specific Diet Dataset 1 had a z-
score for skewness of 3.3, p<.001 (D2 z-skewness 3.23, p < .001). The z-skewness 
scores for Specific Diet in Dataset 2 were below the upper threshold of 3.29, p<.001. 
The outliers were identified in the frequency output and histogram from SPSS and it 
was clear that this was due to participants scoring a zero for the amount of days that 
they  followed a  general  healthy  eating  plan  or  a  specific  diet  plan.  For  this  reason  
these outliers will be left unchanged as removing them would bias and alter the data. 
This is further justified when recognising that there was an increase in skewness in 
Dataset 1 as a result of removing cases with missing Data from the dataset. In order 
to ensure the validity of this decision Cook’s Distance will be used in the regression 
analysis to ensure that the outliers are not having a significant impact on the 
regression model(Field, 2009). 
Furthermore, Blood Sugar was found to have a z-score for skewness of -5.4, P < .001 
Dataset 1(D2 z-skewness 4.9 P < .001). Individual blood sugar scores can vary 
immensely and due to the clinical reasoning for carrying out a blood sugar test it 
would be very difficult to obtain a normal curve for this data with a sample 
population. As a result theseoutliers were not changed and as previously stated the 
assumption of normality will be tested within the regression analysis.  
The z-scores for kurtosis of exercise and foot care in Dataset 1 and Dataset 2 indicate 
significant kurtosis at p<.05 and p<.01 however these scores are below the upper 
threshold of 3.29, p<.001 and therefore will be left unaltered.   
7.4.4 Cook’s D 
All cases within each dataset were examined using Cook’s D and were found to be 
<1. This resultfurther justifies the decision not to remove outliers that were identified 
through an inspection of normality and through calculation of z scores, as itindicates 
that the remaining outliers are not significantly impacting on the regression model. 
 186
7.5 Meeting assumptions of no Multicollinearity 
The correlation matrices for all five subscales of the dependent variable were 
examined for multicollinearty. None of the predictor variables correlated highly. 
Correlations above .80 or .90 are considered to be multicollinear (Field, 2009). 
All VIF values for all ten-regression analyses were below ten and all Tolerance 
values were above 0.1. It was noted that the highest average VIF value was 1.3 in 
Dataset 1 and 1.2 in Dataset 2. This indicates there may be some collinearity present. 
Taking into account that the predictor variables were centred and the correlation 
matrices show no multicollinearity this was not investigated further.  
7.6 Correlation 
Table 7.5 Dataset 1 and Table 7.6 Dataset 2 display the correlations among the 
demographic, independent and dependent variables that will be included in the HMR 
analyses.  
Results showed that HbA1c was significantly correlated with age in Dataset 2 (r = -
.26, p<.01) (Dataset 1,  r = -.21, NS) this demonstrates that older participants were 
more likely to have lower HbA1c levels. Age was positively correlated with blood 
sugar testing in Dataset 1 (r = .27, p<.05) and Dataset 2 (r = .29, p<.01). This 
suggests that older participants check their blood sugars more regularly than their 
younger counterparts. Dataset 1 shows a moderate correlation with BMI and general 
diet (r = -.34, p<.01)(D2 r = -.18, NS). This correlation indicates that asadherence to 
a general diet decreases, BMI increases. In Dataset 2 years since diagnosis indicates 
a positive moderate correlation with blood sugar testing (r = .21, p<.05) (Dataset 1, r 
= .2,  NS) and foot care checks (Dataset 2,  r  = .25,  p<.01) (Dataset 1,  r  = .12,  NS).  
This suggests that the longer people are diagnosed with Type 2 Diabetes the more 
regular are their blood sugar checks and foot care checks.  
Health value has a weak negative correlation with blood sugar in Dataset 2 (r = -.21 
p<.05) (Dataset 1 r = -.16, NS). Health Value showed a weak and non-significant 
correlation  with  HbA1c Dataset  1  (r  =  .01,  NS)  Dataset  2  (r  =  -.04,  NS).   Internal  
Health Locus of Control shows a weak relationship with HbA1c Levels (Dataset 1, r 
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= -.01, NS) (Dataset 2 r = -.03, NS). However, Internal Health Locus of Control has 
a weak but significant correlation with exercise in Dataset 2 (r = -.16, p<.05) 
(Dataset 1, r = .1, NS). The construct of self-efficacy is represented by scores from 
the PDSMS and is shown to have a strong positive correlation with general diet 
(Dataset  1  r  =  .51,  p<.01)  (Dataset  2  r  =  .5,  p<.01).  This  correlation  indicates  that  
having good levels of self-efficacy in management of Type 2 Diabetes results in 
greater adherence to a general healthy eating diet. Furthermore, self-efficacy is 
weakly but significantly correlated with specific diet in Dataset 2(r = .19, 
p<.01)(Dataset 1 r = .11, NS). Self-efficacy shows a moderate to strong negative 
correlation with HbA1c levels in Dataset 1 and 2(D1 r = -.42, p<.01)(D2 r = -.38, 
p<.01) which demonstrates that participants who have moderate levels of self-
efficacy are more likely to have lower HbA1c levels. 




Table 7.5 Correlation Matrix of Study Variables Dataset 1 
D1 N=78 General Diet Specific Diet Exercise Blood Sugar Foot Care HbA1c 
Age .15 .13 .13  .27* .15 -.21 
BMI -.34** -.01 -.21   .01  -.05 
Years diagnosed .03 -.13 .11   .2 .12 -.05 
HVP2 .08 .1 -.01  -.16 .11 .01 
Internal LOC .01 .04 .1  -.04 -.13 -.01 
PDSMS (SE) .51** .11 .08   .09 .12  -.42** 
Demographic variables Age, BMI, Date Since Diagnosis, * Correlation is sig at the 0.05 level (2-tailed), ** 
Correlation is sig at the 0.01 level (2-tailed). Independent Variables * Correlation is sig at the 0.05 level (1-
tailed), ** Correlation is sig at the 0.01 level (1-tailed).  
 
 
Table 7.6 Correlation Matrix of Study Variables Dataset 2 
D2 N=107 General Diet Specific Diet Exercise Blood Sugar Foot Care HbA1c 
Age .07 .06 .16 .29** .17 -.26** 
BMI -.18 -.01 -.21* .07 .04 -.02 
Years diagnosed .1 -.02 .09 .21* .25** .01 
HVP2 .03 .07 .04 -.21*  -.04 
Internal LOC -.02 -.02 -.16* -.03 -.07 -.03 
PDSMS (SE) .5** .19** .02 .15 .05 -.38** 
Demographic variables Age, BMI, Date Since Diagnosis, * Correlation is sig at the 0.05 level (2-tailed), ** 
Correlation is sig at the 0.01 level (2-tailed). Independent Variables, * Correlation is sig at the 0.05 level (1-
tailed), ** Correlation is sig at the 0.01 level (1-tailed). 
 
Dataset 1 
Internal LOC and SE (r = .067, NS) 
Internal LOC and HV (r = .003, NS) 
SE with HV (r = -.035, NS) 
Dataset 2 
Internal LOC and SE (r = -.016, NS) 
Internal LOC and HV (r = .052, NS) 
SE with HV (r = -.006, NS) 
 188
7.7 Hierarchical Multiple Regression Analyses 
Each SDSCA subscale used for HMRanalyses is interpreted independently and 
compared with the other Dataset. Collaborative conclusions on all ten subscales are 
then made. The tables of results of HMR analyses of Dataset 1 are presented in this 
chapter. Appendix F contains the tables of results of HMR analyses of Dataset 2 (See 
Tables 10.6-10.10). 
7.7.1 General diet 
The variables BMI and HbA1c have a negative and significant relationship with 
general  diet  (BMI β =  -.334  P  <  .01)  (HbA1c β =  -.242  P  <  .05)  in  block  1  of  the  
HMR General  Diet  Subscale  for  Dataset  1.  This  would  be  expected  because  as  the  
following of a general diet increases, levels of BMI and HbA1c decrease. These 
results are consistent with earlier correlations. Similarly, Block 1 of General Diet 
Subscale  for  Dataset  2  shows  HbA1c  levels  to  have  a  negative  and  significant  
relationship.  However,  this  is  not  the  same  for  BMI  levels.  Block  4  Dataset  1  
demonstrates a negative significant relationship with BMI levels (BMI β = -.231 P < 
.05). 
When the three individual predictor variables were added to the regression analysis 
in  Block  2  self-efficacy  is  seen  to  be  the  only  significant  predictor  variable  of  
General Diet. This is apparent in both datasets. There was a significant increase in R² 
Block 2 Dataset 1(β = .419 P < .01, ∆R2 .137 P < .01) and Block 2 Dataset 2(β = 
.515 P < .001, ∆R2 .201 P < .001). Self-efficacy Block 2 accounts for 32.5% (R² = 
.325) of variance in predicting the outcome variable for maintaining a general diet in 
Dataset 1 and 28.4% (R² = .284) of variance in Dataset 2. Self-efficacy has 
significant beta values for both Datasets in block 2, 3 and 4 (Block 4 Dataset 1, SE 
β= .400, P < .01) (Block 4 Dataset 2, SE β= .499, P < .001).  
The addition of the two-way interaction variables to Block 3 show a non-significant 
change  in  R² in both datasets. Block 4 of both datasets also demonstrates a non-
significant change in R² following the inclusion of the three-way interaction variable. 
However, self-efficacy beta values remain significant throughout all 4 Blocks in both 
Datasets. This illustrates that self-efficacy is the only contributing predictor variable 
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to general diet outcomes.  
7.7.2 Specific diet 
Specific Diet Subscales for Dataset 1 and Dataset 2 show a significant change in R² 
in Block 4 (Dataset 1,∆R2 = .069, P < .05) (Dataset 2, ∆R2 .055, P < .05). The three-
way  interaction  variable  HV  x  IHLC  x  SE  accounts  for  20.8%  (R² = .208) of the 
variance in predicting the outcome behavior of maintaining a specific diet in Dataset 
1 and 16.9% (R² = .169) of variability in Dataset 2.  
The two-way interaction variable IHLC x SE has a positive significant relationship 
with Specific Diet in both Datasets (Dataset 1, β = .274P < .05) (Dataset 2, β = .231P 
<  .05).  IHLC  x  HV  has  a  positive  significant  relationship  with  Specific  Diet  in  
Dataset 2 (β = .224P < .05) (Dataset 1, β =253, NS). Furthermore, it is important to 
point out that the beta values in both datasets for the two-way interaction variables of 
IHLC x SE and IHLC x HV are quite similar in value indicating that as a two-way 
construct  they  are  of  an  equal  level  of  importance  when  predicting  adherence  to  a  
specific diet.  
7.7.3 Exercise 
There was no significant change in R² in any of the four blocks in either Dataset. 
However, it is noted that in Block 3 Dataset 2 (N=107) BMI and IHLC have 
significant  beta  values.  BMI  again  as  with  general  diet  has  a  negative  relationship  
with exercise (β = -.223P < .05). This would be expected because as levels of 
exercise increase BMI would decrease. Interestingly IHLC is the only predictor 
variable  to  have  a  significant  beta  value  (Dataset 2, β =  .228P <  .05).  It  also  has  a  
positive relationship with exercise. The higher the IHLC the more exercise that is 
carried out.  
7.7.4 Blood sugar 
Age appears to have a strong positive significant relationship with Blood Sugar 
measurement. As age increases so does the number of times blood sugar is checked. 
Dataset 1 (N=78) shows age to have a significant beta value in Block 1 only (β = 
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.262,P < .05). However, Dataset 2 shows age to have significant beta values 
throughout all four blocks. 
When  the  three-way  predictor  variable  was  added  to  Block  4  a  significant  change  
was  seen  in  R² Dataset 1(β = -.292P < .05, ∆R2 .055P < .05) and Dataset 2 (β = -
.222.P < .05, ∆R2 .038P < .05). The three-way predictor variable accounts for 20.8% 
(R² = .208) of variance for predicting the outcome of blood sugar checking in Dataset 
1 and 24% (R² = .240) in variability in Dataset 2.  
7.7.5 Foot care 
The foot care subscale shows no significant change in R². The only significant beta 
value seen is years since diagnosis in Block 2 Dataset 2 (β =.212, P < .05) which has 
a positive relationship with foot care indicating that as years since diagnosis increase 
so does regular foot care checks.  
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Table 7.7 HMR General Diet Dataset 1 
Predictors B SE β df R ²  ∆R2 
Block 1       
Sex -.338 .376 -.099    
Age .005 .020 .030    
BMI -.079 .026 -.334**    
HbA1c -.023 .010 -.242*    
Years since diagnosis -.015 .032 -.055 72 .187**  
       
Block 2       
Sex -.174 .361 -.051    
Age -.006 .019 -.040    
BMI -.058 .026 -.244    
HbA1c -.007 .011 -.074    
Years since diagnosis -.006 .030 -.022    
IHLC -.009 .029 .031    
SE -.135 .039 .419**    
HV .048 .044 .112 69 .325** .137** 
       
Block 3       
Sex -.204 .373 -.060    
Age -.006 .020 -.036    
BMI -.058 .027 -.244    
HbA1c -.007 .011 -.072    
Years since diagnosis -.005 .031 -.018    
IHLC .009 .030 .031    
SE .134 .040 .416**    
HV .050 .048 .115    
IHLC x SE .001 .005 .019    
IHLC x HV .005 .007 .066    
HV x SE .001 .008 .008 66 .329 .004 
       
Block 4        
Sex -.114 .374 -.033    
Age -.005 .019 -.034    
BMI -.055 .026 -.231*    
HbA1c -.006 .011 -.063    
Years since diagnosis .000 .031 .001    
IHLOC -.004 .031 -.013    
SE .129 .039 .400**    
HV .069 .050 .160    
IHLC x SE .003 .005 .069    
IHLC x HV .010 .008 .149    
HV x SE -.002 .008 -.027    
HV x IHLC x SE -.002  .001  -.191  65  .353  .024 
* P < .05, ** P < .01, *** P < .001. 
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Table 7.8 HMR Specific Diet Dataset 1 
  
Predictors B SE β df R ²  ∆R2 
Block 1       
Sex .083 .369 .026    
Age .027 .019 .188    
BMI -.003 .026 -.014    
HbA1c -.014 .010 -.155    
Years since diagnosis -.054 .031 -.216 72 .082  
       
Block 2       
Sex .053 .386 .017    
Age .027 .020 .184    
BMI -.002 .028 -.010    
HbA1c -.013 .012 -.147    
Years since diagnosis -.050 .032 -.203    
IHLC .003 .031 .010    
SE .006 .042 .021    
HV .038 .047 .095 69 .091 .009 
       
Block 3       
Sex -.062 .389 -.020    
Age .028 .020 .194    
BMI -.004 .028 -.019    
HbA1c -.012 .012 -.140    
Years since diagnosis -.053 .032 -.215    
IHLC -.003 .031 -.011    
SE .004 .041 .015    
HV .024 .051 .061    
IHLC x SE .008 .005 .187    
IHLC x HV .007 .008 .111    
HV x SE .008 .008 .128 66 .139 .048 
       
Block 4        
Sex .080 .381 .025    
Age .029 .020 .198    
BMI .001 .027 .005    
HbA1c -.001 .011 -.125    
Years since diagnosis -.045 .031 -.182    
IHLC -.022 .031 -.085    
SE -.033 .040 -.012    
HV .055 .051 .137    
IHLC x SE .012 .006 .274*    
IHLC x HV .016 .008 .253    
HV x SE .004 .008 .068    
HV x IHLC x SE  -.003  .001  -.326*  65  .208*  .069* 
P < .05, ** P < .01, *** P < .001. 
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Table 7.9 HMR Exercise Dataset 1 
Predictors B SE β df R ²  ∆R2 
Block 1       
Sex -.644 .560 -.135    
Age .026 .029 .116    
BMI -.056 .039 -.170    
HbA1c .010 .016 .075    
Years since diagnosis -.030 .047 -.079 72 .081  
       
Block 2       
Sex -.715 .583 -.150    
Age .021 .030 .093    
BMI -.066 .042 -.199    
HbA1c .009 .017 .068    
Years since diagnosis -.002 .048 -.057    
IHLC .058 .047 .147    
SE -.063 .063 -.007    
HV .005 .071 .008 67 .101 .020 
       
Block 3       
Sex -.813 .597 -.170    
Age .024 .031 .107    
BMI -.066 .043 -.200    
HbA1c .009 .018 .070    
Years since diagnosis -.019 .049 -.050    
IHLC .057 .048 .145    
SE -.007 .063 -.015    
HV .012 .078 .019    
IHLC x SE .004 .008 .054    
IHLC x HV .014 .012 .147    
HV x SE .001 .012 .010 66 .121 .021 
       
Block 4        
Sex -.647 .594 -.135    
Age .024 .031 .110    
BMI -.060 .042 -.182    
HbA1c .011 .018 .082    
Years since diagnosis -.009 .049 -.025    
IHLC .035 .049 .088    
SE -.016 .063 -.036    
HV .047 .079 .078    
IHLC x SE .008 .009 .121    
IHLC x HV .025 .013 .257    
HV x SE -.003 .012 -.037    
HV x IHLC x SE  -.004 .002  -.252  65  .163  .041 
P < .05, ** P < .01, *** P < .001. 
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Table 7.10 HMR Blood Sugar Dataset 1 
Predictors B SE β df R ²  ∆R2 
Block 1       
Sex .247 .490 .059    
Age .051 .026 .262*    
BMI .025 .035 .084    
HbA1c .002 .014 .017    
Years since diagnosis .040 .041 .120 72 .098  
       
Block 2       
Sex .407 .508 .096    
Age .051 .026 .259    
BMI .034 .037 .116    
HbA1c .006 .015 .053    
Years since diagnosis .031 .042 .094    
IHLC -.028 .041 -.080    
SE .033 .055 .082    
HV -.078 .062 -.145 69 .127 .029 
       
Block 3       
Sex .417 .518 .019    
Age .048 .027 .243    
BMI .036 .037 .122    
HbA1c .008 .015 .068    
Years since diagnosis .039 .043 .116    
IHLC -.022 .042 -.062    
SE .033 .055 .083    
HV -.076 .067 -.141    
IHLC x SE -.007 .007 -.114    
IHLC x HV .008 .010 .090    
HV x SE .001 .011 .013 66 .152 .025 
       
Block 4        
Sex .588 .511 .139    
Age .048 .026 .247    
BMI .042 .036 .143    
HbA1c .010 .015 .082    
Years since diagnosis .048 .042 .145    
IHLC -.045 .042 -.128    
SE .024 .054 .059    
HV -.039 .068 -.072    
IHLC x SE -.002 .007 -.036    
IHLC x HV .019 .011 .218    
HV x SE -.003 .011 -.040    
HV x IHLC x SE  -.004  .002  -.292*  65  .208*  .055* 
P < .05, ** P < .01, *** P < .001. 
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Table 7.11 HMR Foot Care Dataset 1 
Predictors B SE β df R ²  ∆R2 
Block 1       
Sex -.498 .571 -.104    
Age .036 .030 .160    
BMI .026 .040 .078    
HbA1c .016 .016 .117    
Years since diagnosis .021 .048 .054 72 .054  
       
Block 2       
Sex -.376 .579 -.078    
Age .035 .030 .157    
BMI .052 .042 .155    
HbA1c .027 .017 .200    
Years since diagnosis .021 .048 .055    
IHLC -.063 .047 -.160    
SE .089 .062 .197    
HV .092 .070 .151 69 .122 .067 
       
Block 3       
Sex -.418 .583 -.087    
Age .031 .031 .137    
BMI .049 .042 .146    
HbA1c .028 .017 .211    
Years since diagnosis .011 .048 .028    
IHLC -.072 .047 -.181    
SE .093 .062 .206    
HV .048 .076 .078    
IHLC x SE .008 .008 .124    
IHLC x HV -.012 .012 -.128    
HV x SE .016 .012 .172 66 .169 .647 
       
Block 4        
Sex -.381 .594 -.079    
Age .031 .031 .138    
BMI .050 .042 .150    
HbA1c .029 .018 .214    
Years since diagnosis .013 .049 .033    
IHLC -.077 .049 -.194    
SE .091 .063 .201    
HV .056 .079 .091    
IHLC x SE .009 .009 .139    
IHLC x HV -.010 .013 -.103    
HV x SE .015 .012 .161    
HV x IHLC x SE  -.001  .002  -.057  65  .171  .002 
P < .05, ** P < .01, *** P < .001. 
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7.8 Three-way independent ANOVAs 
The results for the three-way independent ANOVAs are reported in this section. 
Descriptive statistics and tests of between subjects effects are demonstrated in table 
format. The tables for the significant subscales from the HMR analyses(blood sugar 
and specific diet) are presented here only. For readability purposes the tables for the 
general diet, exercise and foot care subscales have been allocated to Appendix 
F.Compared means are reported first. Following on from this the F statistic for the 
three way interaction variable (HV*IHLC*SE) is reported for each subscale.  
Means for the blood sugar subscale demonstrated that participants with Low HV and 
Low  IHLC  are  highest  in  blood  glucose  testing  regardless  of  their  level  of  SE  
(Dataset 1 Ss for Low SE 6.65, SD .987High SE 6.50, SD 1.414) (Dataset 2 Ss for 
Low SE 6.46, SD 1.664 High SE 6.50, SD 1.323), while those with High HV and 
Low  IHLC  are  lowest  in  blood  glucose  testing  regardless  of  their  level  of  SE  
(Dataset 1 Ss for Low SE 5.17, SD 2.634High SE 5.06, SD 2.364) (Dataset 2 Ss for 
Low SE 4.21, SD 2.848 High SE 4.31, SD 2.720) (See table 7.12).  There was no 
statistical significance between groups as determined by the three way ANOVA for 
blood sugar (Dataset 1 F(1,70) =.101, NS) (Dataset 2 F(1,99) = .475, NS)(See table 
7.13). 
With specific diet, the High-High-High group had the highest mean score (Dataset 1 
4.88, SD 1.157) (Dataset 2 4.90, SD 1.089) which is what MSLT predicts, this is 
minimally better than the mean score for the Low-Low-Low group (Dataset 1 4.77, 
SD 1.092) (Dataset 2 4.58, SD 1.592), the group that should have the lowest mean 
score(See table 7.14). There was no statistical significance between groups for 
specific diet (Dataset 1 F(1, 70) = 2.032, NS) (Dataset 2 F(1,99) = 2.197, NS) (See 
table 7.15). 
The compared means for the general diet subscale show that participants with High 
HV, High IHLC and Low SE (Ss for Low SE Dataset 1 5.75, SD 1.035, Dataset 2,  
4.82, SD 2.383) score a higher meanthan those with High SE(Ss for High SE Dataset 
1 4.65, SD 1.796, Dataset 2 4.33, SD 1.543) (See Appendix F table 10.11). The Low-
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Low-Low group overall has higher mean scores than the High-High-High group but 
only minimally so. Although the Low group is better than the High Group it is 
important  to  point  out  that  those  with  High  HV,  Low IHLC,  Low SE score  higher  
than those in the Low group. Health value is seen to act as a moderator here. There 
was no statistical significance observed between groups for general diet Dataset 1 
F(1,70)=.876, NS, Dataset 2 (F(1,99) =.309, NS (See Appendix F table 10.12). 
The ANOVA results for the exercise and foot care subscale again show that the Low 
group has higher means (See Appendix F tables 10.13 for exercise and 10.15 for foot 
care). However, it is important to point out here that the general diet, exercise and 
foot care subscales were not significant for MSLT as suggested by the HMR results. 
There was no statistical difference shown between groups for the ANOVAs of 
Exercise and Foot care. Exercise, Dataset 1 F(1,70) = .725, NS, Dataset 2 F(1,99) = 
1.148, NS (See Appendix F table 10.14). Foot care, Dataset 1 F(1,70) = .725, NS, 
Dataset 2 F(1,99) = 1.148, NS (See Appendix F table 10.16). 
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Table 7.12 ANOVA Blood sugar descriptive statistics 
ANOVA   Dataset 1 N=78 
 
Dataset 2 N=107 
Blood 



























  Total 6.6 1.136 21 6.48 1.462 28 
 
High 


















  Total 5.64 2.035 18 5.6 2.198 25 


















  Total 6.15 1.663 39 6.07 1.881 53 
High 


















  Total 5.11 2.429 18 4.26 2.724 25 
 
High 


















  Total 5.4 2.518 21 5.29 2.558 29 
 Total Low SE 5.21 2.840 17 4.81 2.836 26 









  Total 5.27 2.449 39 4.81 2.662 54 
Total Low IHLC Low SE 6.05 1.939 22 5.38 2.534 25 
  High SE 5.74 2.055 17 5.48 2.331 28 
  Total 5.91 1.970 39 5.43 2.406 53 
 
High 









  High SE 5.73 1.901 22 5.67 2.078 26 
  Total 5.51 2.281 39 5.44 2.381 54 
 Total Low SE 5.69 2.322 39 5.29 2.573 53 
  High SE 5.73 1.943 39 5.57 2.194 54 
  Total 5.71 2.127 78 5.43 2.382 107 
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Table 7.13ANOVA Blood sugar tests of between subjects-effects 
Blood Sugar Dataset 1 N=78 Dataset 2 N=107 
Source Sum of 
Squares 
df Mean Square F Sig Sum of 
Squares 
df Mean Square F Sig 
Corrected model 28.567 7 4.081 .894 .516 74.305 7 10.615 1.993 0.63 
Intercept 2430.192 1 2430.192 532.116 .000 3117.047 1 3117.047 585.292 .000 
HV levels 14.108 1 14.108 3.089 .083 44.607 1 44.607 8.376 .005* 
IHLC levels 2.143 1 2.143 .469 .496 .328 1 .328 .062 .805 



































































HV levels * IHLC 





















Error 319.692 70 4.567   527.237 99 5.326   
Total 2892.750 78    3761.750 107    
Corrected total 348.260 77    601.542 106    
 a.R Squared = .082 (Adjusted R Squared) = -.010               * P< .05 a.R Squared = .124 (Adjusted R Squared) = .062                     * P< .05 
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Table 7.14 ANOVA Specific diet descriptive statistics 
 
ANOVA   
 
Dataset 1 N=78 
 
Dataset 2 N=107 
Specific 













Low HV Low IHLC Low SE 4.77 1.092 13 4.58 1.592 13 
  High SE 3.63 1.808 8 4 1.592 15 
  Total 4.33 1.478 21 4.27 1.590 28 
 
High 









  High SE 4.39 1.816 9 4.59 1.814 11 
  Total 3.83 1.978 18 3.8 1.876 25 
 Total Low SE 4.16 1.700 22 3.85 1.786 27 
  High SE 4.03 1.798 17 4.25 1.681 26 
  Total 4.1 1.721 39 4.05 1.730 53 
High 









  High SE 4.17 1.225 9 4.31 1.128 13 
  Total 3.75 1.263 18 3.88 1.160 25 
 
High 









  High SE 4.88 1.157 13 4.9 1.089 15 
  Total 4.48 1.561 21 4.34 1.547 29 
 Total Low SE 3.56 1.580 17 3.6 1.470 26 
  High SE 4.59 1.211 22 4.62 1.127 28 
  Total 4.14 1.460 39 4.13 1.391 54 
Total Low IHLC Low SE 4.18 1.332 22 4.02 1.461 25 
  High SE 3.91 1.502 17 4.14 1.380 28 
  Total 4.06 1.396 39 4.08 1.406 53 
 
High 













  High SE 4.68 1.444 22 4.77 1.416 26 
  Total 4.18 1.771 39 4.09 1.713 54 
 Total Low SE 3.90 1.655 39 3.73 1.628 53 
  High SE 4.35 1.501 39 4.44 1.420 54 
  Total 4.12 1.586 78 4.09 1.561 107 
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Table 7.15 ANOVA Specific diet tests of between subjects-effects 
Specific Diet Dataset 1 N=78 Dataset 2 N=107 









Corrected model 28.420 7 4.060 1.721 .118 35.110 7 5.016 2.224 .038 
Intercept 1226.678 1 1226.678 519.864 .000* 1771.778 1 1771.778 785.529 .000 
HV levels .022 1 .022 .009 .924 .001 1 .001 .001 .981 
IHLC levels .260 1 .260 .110 .741 .023 1 .023 .010 .920 



































































HV levels * IHLC 





















Error 165.173 70 2.360   223.297 99 2.256   
Total 1518.750 78    2047.250 107    
Corrected total 193.593 77    258.407 106    
 a.R Squared = .147 (Adjusted R Squared) = -.061     *P< .05 a.R Squared = .136  (Adjusted R Squared) = .075       * P< .05 
 202
 
8 Main Discussion 
8.1 Introduction 
The number of people with Type 2 diabetes is rising rapidly worldwide. This rise is 
associated with economic development, ageing populations, increasing urbanisation, 
dietary changes, reduced physical activity and changes in other lifestyle patterns 
(WHO, 1994, IDF, 2011). The management of Type 2 diabetes involves a change in 
lifestyle patterns for most. Patients are encouraged to review their lifestyle choices, 
to reduce weight by exercising and to change dietary habits to improve glycaemic 
control. For some these lifestyle changes may not be enough and as the disease 
progresses health professionals will place patients on medication regimes that 
include oral anti-hyperglycaemic agents and/or insulin. Identifying and assisting 
patients that have difficulty in making these lifestyle changes and adapting to 
medication regimes is essential to preventing or delaying the onset of complications 
and/or  comorbidities  associated  with  Type  2  diabetes  to  maintain  quality  of  life.  
Using  a  behavioural  theory  in  clinical  practice  to  identify  and  assess  the  needs  of  
such patients may be a beneficial tool for health professionals and subsequently 
patient care.  
This research has aimed to test Modified Social Learning Theory(MSLT) a health 
behaviour theory that considers the interaction of health value and perceived control 
on behavioural outcomes.Researching how behavioural outcomes of patients with 
Type 2 diabetes are influenced by psychological constructs is not a new concept. 
However, this research has highlighted the benefits of exploring and testing health 
value and perceived control of patients who have Type 2 diabetes and provided 
evidence that could support MSLT’s potential use in practice. By doing so the 
researcher has filled a knowledge gap in the literature that required support for 
MSLT and provided further knowledge on the health value construct and its 
meaning. 
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Traditionally, health behaviour theories have been examined quantitatively rather 
than  qualitatively  due  to  the  nature  of  testing  the  predictability  of  such  theories  
constructs. Consequently, this mixed methods study aimed not only to test MSLT but 
also to understand the meaning of the behavioural constructs of MSLT to the person 
with Type 2 diabetes and how this impacts on their self-management behaviour. This 
study had two separate phases of data collection, whereby the results from the 
qualitative phase of the study directly influenced the quantitative measures in the 
second phase. The associations of both phases’ results will be discussed concurrently 
in this chapter.  
Subjectively exploring health value and perceived control in relation to outcome 
behaviours of patients with Type 2 diabetes on insulin has identified how values and 
beliefs can impact on aspects of diabetes management. Influencing factors included: 
the stigma of insulin, medication management, blood glucose monitoring, 
comorbidities,  beliefs  surrounding  age,  hereditary  aspects  of  the  disease  and  the  
classification of diabetes type. This research has also demonstrated the importance of 
examining the way in which health is valued and whether it is valued from an 
instrumental or terminal point of view. Furthermore, the way in which changes in 
health value were explored in this research can be considered as a unique initial 
attempt at investigating this phenomenon. Finally,the support found for MSLT in the 
quantitative phase has demonstrated statistically significant results. 
This chapter aims to criticallydiscuss the overall study results, their relevance to 
existing theory and literature and make recommendations for future research. To do 
this the research questions are re-introduced and answered in relevant sections to 
present the key findings of the research. The principal research question for this 
study was:  
Is the potential for people with Type 2 diabetes engaging in a set of health 
sustaining behaviours a predictor of health value and perceived control 
(HLOC and SE) as postulated by MSLT? 
To answer this research question a number of subsidiary research questions (RQs) 
were formulated and used at different stages of the research design (See Chapter 3, 




This chapter is structured as follows: 
· Section 8.2 Health Value and Type 2 diabetes 
 
· Section 8.3 Beliefs and Self-management of Type 2 diabetes 
  
· Section 8.4 Support for MSLT 
 




MSLT & Instrumental Health Value 
 
Potential Value and Belief Assessment and Planning 
Framework 
 
· Section 8.6 Significance of the study 
 
· Section 8.7 Implications for practice 
 
· Section 8.8 Limitations 
 
· Section 8.9 Recommended Future Research 
 




8.2 Health value and Type 2 diabetes 
Health Value was explored subjectively and objectively amongst participants with 
Type 2 diabetes. This mixed methods approach has contributed to the understanding 
of the health value construct and facilitated its testing of predictability alongside the 
other behavioural constructs of MSLT. Health value was initially explored through 
an interview technique which observed for instances in which values guided 
behaviour. This method of exploring health value conforms with the contemporary 
method of exploring the values construct from the perspective of the person who 
evaluates the entities in his or her environment and then attempting to understand the 
motivations which underlie people’s responses to their environments (Rohan, 2000).  
RQ2 (Qual): How do people with Type 2 diabetes value their health and 
perceive control over their condition? 
The interviewsprovided data that highlighted participants’ value systems and the 
cognitive  structures  that  it  is  made  up  of.  It  was  clear  that  a  person’s  value  system 
stemmed  from  ‘life  itself’  and  within  that  life  there  were  various  different  aspects  
that motivate that person to distinguish between value priorities. Value systems have 
been defined in the literature as integrated structures in which there are stable and 
predictable relations among values(Schwartz, 1992, Schwartz, 1994, Rohan, 2000, 
Rohan and Zanna, 2001, Bilsky et al., 2010). Participants in this study described 
relationships among values such as family and health, health and career and health 
and the ability to do things. These relationships which include health possibly 
became apparent over other value relationships because of the aim of the interviews, 
which was to understand the construct of health value. 
Furthermore, the way in which value systems are structured amongst participants 
was recognised. Two structures were apparent. Firstly, some participants discussed 
their values as having equal importance along a continuum whereby they chose 
between alternatives to suit their life situation at the time. Secondly, others arranged 
health as a value hierarchically where it was described as having the utmost 
importance  over  other  values.  These  findings  contribute  to  answering  RQ2 as  they  
 206
indicate that patients with Type 2 diabetes can value health hierarchically or along a 
continuum depending on the persons value system. 
The concept of health as a value to an individual is widely considered to be highly 
valued and thus is not commonly thought of as a construct with variability(Lau et al., 
1986, Smith and Wallston, 1992). The qualitative findings in this studypropose that 
there is variability within how the construct is valued by individuals. This proposal is 
synonymouswith literature on value systems and priorities which suggests that values 
reflect underlying motivations and these motivations are associated with people’s 
perceptions of the requirements of their existence(Rohan, 2000, Rohan and Zanna, 
2001). 
RQ3 (Qual): How does having Type 2 diabetes impact on a person’s beliefs and 
values and thus self-management of their condition? 
The variations in health value became clear through the way participants described 
valuing their health. These findings contributed to answering RQ2 and RQ3 as 
individual differences were demonstrated in which health is valued and how this 
influences self-management behaviours of people with Type 2 diabetes. Type 2 
diabetes and its requirements of self-management were seen to influence a person’s 
value system and value priority in that ‘health’ became ‘even more important’ post 
diagnosis. This finding suggested a change in health value post diagnosis of Type 2 
diabetes.  The  results  of  RQ2  and  RQ3  support  Smith  and  
Wallston’s(1992)suggestion that as health becomes threatened the value of health 
becomes more salient and consequently more important. As far as the researcher is 
aware there is currently no evidence within the literature that health value changes 
with health status. 
Health value was described as changing overtime as the length of diagnosis of Type 
2 diabetes progresses.Participants described how ‘diabetes was a different thing 
because you have got to change your life’. Changes in attitude due to length of 
diagnosis and the inconvenience of self-management lead to becoming ‘blasé’ about 
health and its value. Furthermore, the qualitative findings suggest that health value 
was influenced by changes to medication regimes and as a result of having a 
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hypoglycaemic attack. Earlier research has acknowledged that changes to medication 
or condition can impact on belief variables (Donnan et al., 2002, Balkrishnan et al., 
2003, O'Hea et al., 2005).  
The instrumental/terminal dichotomy was kept in mind during the qualitative data 
analysis. It became apparent that participants valued their health as both an 
instrumental and terminal health value. However, a commonality shared between 
participants when discussing health value and diabetes self-management behaviours 
is that health value was considered instrumental in that it enabled participants ‘to do 
things’. This result addresses RQ2 and RQ3 as it suggests how a person with Type 2 
diabetes values their health and it also highlights the importance of observing health 
value as a contributor to health behaviour. Participants who valued their health 
instrumentally also described highly valuing their health and as a result carrying out 
diabetes self-management behaviours.  
The results of RQ2 and RQ3 highlight the importance of health value and how 
instrumental health value can be perceived as a moderator of health behaviour along 
with the construct of health value. Wallston (2005b)stated how no one to his 
knowledge had included the ‘perceived instrumentality’ of the behaviour as a 
moderator of the relationship between health locus of control beliefs and self-
efficacy. The researcher believes that this is still the case in regards to researching 
this concept. The qualitative results of this study provided impetus for investigating 
this concept further, research recommendations addressing this result are discussed 
in section 8.5. 
The qualitative data also contributed to what aspect of health people are referring to 
when they respond to questions on the construct of health value. As described in 
section 5.2.2 the meaning of health was conceptualised differently by participants but 
for most it included the physical, mental and social aspects of health.  
RQ9 (Quan): Does health value change from pre-diagnosis to post-diagnosis of 
Type 2 diabetes? 
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The qualitative data on change in health value was an emergent theme and as a result 
RQ9 was formulated to test the hypothesis H4(health value changes from pre-
diagnosis to post-diagnosis of Type 2 diabetes) within the quantitative phase. HVP1 
and HVP2 were positioned strategically within the questionnaire booklet to test this. 
Despite this attempt the quantitative results do not support H4. No significant change 
in scale score for level of health value was seen from pre to post 
diagnosis.Participants scored high on health value in both scales. This indicates that 
participants’ when answering the questionnaires did not think their health value was 
any lower or higher pre or post diagnosis but remains the same which is moderate to 
high. Results that contributed to answering RQ9 and H4 may have been influenced 
by recall bias, social desirability bias and due to the length of diagnosis of 
participants that was on average 13.5 years. This point is further elaborated upon in 
recommended future research section 8.9. 
RQ10 (Quan): Is health valued as an instrumental or terminal value priority 
post-diagnosis of Type 2 diabetes? 
The qualitative finding that suggested that health is mainly valued from an 
instrumental point of view resulted in the creation of RQ10. The items of the Health 
Value Scale were considered to beinstrumental and terminal in nature. There was no 
observed  difference  in  instrumental  or  terminal  health  value  scores  pre  to  post  
diagnosis. The scale scores demonstrated that terminal health value scale scores were 
higher than the instrumental health value scores pre and post-diagnosis of Type 2 
diabetes. However, these scale scores suggest that a person can hold both terminal 
and instrumental health values at once, which is evident in patients’ perceptions in 
the qualitative data. 
8.3 Beliefs and self-management of Type 2 diabetes 
The  constructs  of  locus  of  control  and  self-efficacy  were  considered  during  the  
interview process in the qualitative phase of this study. Participants were 
specificallyasked to think about their ability in carrying out self-management 
behaviours and about their beliefs that may influence this process.The descriptions of 
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participants’ self-management behaviours provided an understanding of the 
dimensions of the locus of control construct and its effect on self-efficacy. 
RQ3 (Qual): How does having Type 2 diabetes impact on a person’s beliefs and 
values and thus self-management of their condition? 
Descriptions of internal locus of control beliefs highlighted how participants 
acknowledged that taking control over their condition is their responsibility. 
Participants descriptions of external LOC beliefs indicated that a health professional 
was  responsible  for  their  care  or  that  their  health  had  deteriorated  to  the  point  that  
they did not believe they were responsible for control. Searle et al. (2008) examined 
beliefs of patients with Type 2 diabetes and agrees with the latter and highlights how 
differences in diabetic patients’ beliefs are apparent according to their complications. 
Gillibrand and Flynn (2001) also used the LOC framework to explore eighteen 
patients’ perceptions of diabetes and its complications. Their results indicate that 
people with diabetes may inadvertently externalise their control to ‘powerful others’ 
which is contrary to the philosophies of holism and promotion of self-management. 
The qualitative phase of this study also found this but interestingly participants 
described an internal/external dualism of beliefs when it came to them and their 
diabetes management and the health professional and their diabetes management. For 
example participants relied externally on health professionals to inform them of how 
‘good’ their diabetes management is but outwith the clinic their beliefs in internality 
resulted in their ability to take responsibility for their own care. These findings 
contributed to answering the qualitative research question RQ3, as they suggest not 
only how people with Type 2 diabetes perceive control over their condition but also 
how LOC beliefs impact on SM of diabetes. 
The construct of LOC has been found to be valuable but limited (Bennett et al., 1997, 
Bennett et al., 1998, Norman et al., 1997, Steptoe and Wardle, 2001, O'Hea et al., 
2005, Luszczynska and Schwarzer, 2005). O'Hea et al. (2005) highlighted the 
importance of locus of control as a moderator to predicting outcome behaviours. 
They compared the five dimensions of the MHLC scale in 109 patients with Type 2 
diabetes HbA1c results. HbA1c was considered a medical outcome of behaviour in 
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this study. Their study concludes with support for the locus of control construct, 
however, they found that poorer adherence to a diabetic regime was related to 
different combinations of health locus of control beliefs(O'Hea et al., 2005). Findings 
from the qualitative phase of thismixed methods study support this finding as varying 
descriptions of differences in LOC beliefs were reflected in participants’ descriptions 
of diabetes self-management behaviours (RQ3).  
The MHLC and PDSMS questionnaires investigated the constructs of health LOC 
and SE respectively.Additionally, results of the HMR two-way and three-way 
interactions providesupport to previous literature that LOC can be considered a 
moderator of outcome behaviour (RQ4). 
RQ4 (Quan): Does HLOC act as a moderator of predicating health behaviour in 
a Type 2 diabetes population? 
Specifically this study supports the assumption that internal LOC beliefs and external 
locus of control beliefs are independent of each other and a person can 
simultaneously hold both beliefs. This finding is in agreement with previous 
research(Luszczynska and Schwarzer, 2005, O'Hea et al., 2009). The MHLC scale 
scores support this conclusion in that people scored similarly on the internal HLOC 
subscale (D1 28.5, (SD 6.1), D2 27.8, (SD 5.7)) and the powerful others subscale 
(D1 25.6, (SD 5), D2 25.2, (SD 5.2)).  
The qualitative and quantitative data has demonstrated that it is possible to contrast 
people with Type 2 diabetes in terms of their LOC belief orientation and distinguish 
them in terms of health behaviour they may carry out.  
The construct of LOC beliefs appears in the literature to be a less powerful construct 
than  the  construct  of  self-efficacy.  Studies  by  Aljasem  et  al  (2001),  Griva  et  al  
(2000), Hampson(1990) and Hampson (1995)have found that self-efficacy alone is a 
significant predictor of diabetes regime adherence. Results of correlations of 
predictor variables and outcome behaviours in this study are consistent with previous 
research as self-efficacy showed stronger correlations with diabetes outcome 
behaviours  than  IHLC.  IHLC  showed  a  weak  but  significant  correlation  with  
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exercise,whereas self-efficacy showed a strong positive correlation with general 
diet.Gramstad et al. (2001) study that investigated the impact of LOC and SE on 
psychosocial adjustment of 101 epilepsy patients found similar correlation results to 
this study, as self-efficacy and health outcomes were considered more powerful as a 
predictor  than  MHLC  alone  and  health  outcomes.  Scores  from  the  PDSMS  in  this  
study indicated that participants’ levels of SE were considered moderate to high. 
Furthermore, this result is consistent with previous research on LOC and SE beliefs. 
Waller and Bates (1992)study examined 57 healthy elderly participants beliefs 
anddemonstrated that most of them were characterized by high IHLC beliefs and 
high SE and that there were positive relationships amongst the variables.  
RQ7: Does mood affect a person with Type 2 diabetes potential of engaging in 
as set of health sustaining behaviours? 
Subjective descriptions in this present study highlighted relationships anddifferences 
in  level  of  self-efficacy  depending  on  LOC  belief  orientation.  A  person’s  mode  of  
Acceptance-Adjustment-Adaptation (AAA) was influenced by their relationship of 
SE  and  LOC  beliefs  depending  on  the  situation  at  that  time.AAA  to  diabetes  self-
management was affected by numerous themes such as co-morbidities, age, 
hereditary reasoning, stigma of insulin, low mood, anxiety and depression and fear of 
hypoglycaemia. Most commonly participants described the negative effects co-
morbidities, stigma of insulin and low mood had on their self- management 
behaviours. The negative effects were caused by external LOC beliefs and low SE 
due to the influence co-morbidities had on life, the fear of injecting, fear of 
hypoglycaemia or due to depression (RQ3&RQ7). Wu et al. (2004) investigated the 
associations among HLOC, SE and psychological distress in 159 elderly Chinese 
women who have chronic physical illness. Comparable to the qualitative results of 
this studypsychological distress was determined by a low level of self-efficacy as 
well as a high level of external locus of control. 
Naus et al. (2005) examined the relationship between breast cancer LOC beliefs 
(BCLOC) and depression in early-stage breast cancer survivors. Differences in levels 
of anxiety and internal BCLOC indicated variability in level of depression. Low 
levels of anxiety and internal BCLOC indicated low levels of depression, whereas 
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high levels of anxiety and internal BCLOC indicated higher levels of depression. 
These results when considered in context with the qualitative results of this study 
perhaps provide asuggestion as to how participants’ internal LOC beliefs were 
affected by anxieties thus affecting levels of self-efficacy in self-management.  
8.4 Support for MSLT 
The discussion thus far has concentrated on the variability of the individual 
constructs of MSLT and in relation with one another. However, Wallston has argued 
over  the  years  that  ‘the  action  is  in  the  interaction’  (Wallston,  1992,  Wallston,  
2005b).  It  is  not  just  Wallston  who  has  argued  this  point.  Many  other  researchers  
have demonstrated research which has considered a behavioural construct as a 
moderator to predicting behaviour alongside anotherconstruct(Norman, 1994, 
Macrodimitris and Endler, 2001, Laffrey and Isenberg, 2003, Lange and Piette, 2005, 
Jerant et al., 2008).Nevertheless, it is thought that this is the first formal researchto 
test the interaction of the constructs of MSLT on Type 2 diabetes outcome 
behaviours.  
The qualitative phase of this researchcontributed to exploring the meaning of the 
constructs of MSLT to patients with Type 2 diabetes. The qualitative descriptions 
demonstrated how participants in everyday life use the interaction between their 
values and beliefs to inform their diabetes self-management behaviour. Apparent 
within these descriptions was the equal importance attributed to health value, LOC 
beliefs and self-efficacy in carrying out self-management behaviours. 
The  quantitative  phase  was  the  main  contributor  to  the  testing  ofMSLT.  It  was  
expected that the interactions of the perceived control variables would add 
significant variance accounted for (∆R2) in outcome behaviours of general diet, 
specific diet, blood sugar testing, exercise and foot care. Additionally, it was 
expected that the combination of the three-predictor variables would demonstrate the 
strongest relationships amongst the five outcome behaviours.  
RQ5 (Quan): Is the measurement of health value a necessary predictor of health 
behaviour in a Type 2 diabetes population? 
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Correlations between the predictor variables of internal LOC and self-efficacy, self-
efficacy with health value and internal LOC with health value were non-significant. 
These non-significant correlations demonstrate that these constructs are different 
entities. This result offers support to O’Hea et al (2009) whose study on the 
interaction of self-efficacy, locus of control and outcome expectancy demonstrate 
similar findings on the non correlation of these constructs.  
In the hierarchical multiple regression (HMR) analyses Self-efficacy was seen to be 
the only significant predictor for general diet. The individual predictor variable 
remained significant throughout all four blocks. This result supports research that has 
found self-efficacy to be the strongest predictorvariable related to health 
behaviour(Tolma et al., 2006, Frank et al., 2007, O'Leary et al., 2008, O'Hea et al., 
2009).  
The exercise and foot care subscales showed no significant change in R². 
Interestingly the exercise subscale showed that IHLC was the only predictor variable 
to have a significant beta value and it had a positive relationship.This finding differs 
to Laffrey and Isenberg (2003) who found no support for the construct of internal 
locus of control, health value and exercise in a group of 70 women with no defined 
health illness. However, exercise was measured as aleisurely variable and not as 
outcome behaviour for health. Laffrey and Isenberg (2003) stated that perhaps IHLC 
and HV were not perceived to be important by their participants in regards to 
physical activity and leisure.  
RQ1 (Quan): Does MSLT three-way interaction of HLOC, SE and HV predict 
the outcome of self-care behaviour in a Type 2 diabetes population? 
The hierarchical multiple regression analyses were carried out to determine if 
internal locus of control, health value and self-efficacy when taken together would 
have a stronger relationship with outcome behaviours than alone or as two-way 
interactions or as a three-way interaction. Results indicated support for the three-way 
interaction variables and support was seen for some two-way interactions.  
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RQ 6 (Quan): Is the measurement of health value and perceived control (HLOC 
& SE) when taken together a more proficient predictor of health behaviour in a 
Type 2 diabetes population? 
The Specific Diet subscale and Blood Sugar subscale showed a significant change in 
R² when the three-way interaction variable of HV x IHLC x SE was added to Block 
4 of both datasets HMR analyses. Furthermore the two-way interactionsof IHLC x 
SE and IHLC x HV had positive significant relationships with Specific Diet in both 
Datasets and Dataset 2 demonstrated a positive significant relationship for IHLC x 
HV. The beta values for the two-way interactions are quite similar in value indicating 
that as two-way constructs they are of an equal level of importance when predicting 
adherence to a specific diet. These results supportO'Hea et al. (2009)research as they 
also found support for the two-way interaction of IHLC x SE, IHLC x Outcome 
Expectancy.  
The  HMR  results  are  considered  to  show  support  for  MSLT  and  have  been  
interpreted to suggest that health value, internal health locus of control and self-
efficacy are more proficient predictors of health behaviour when taken together. This 
result is seen to contribute to answering the principal research question and RQ1, 
RQ5, RQ6, H3. Although support was demonstrated for MSLT through the Specific 
Diet  (SPD)  and  Blood  Sugar  (BS)  subscale  it  is  evident  that  the  percentage  of  
variability for SPD (D1, 20.8%, D2 16.9%) and BS (D1, 20.8%, D2, 24%) in 
predicting these outcome behaviours is low. This finding is further discussed in the 
Limitation section of this chapter(section 8.8) where considerations are made as to 
what is accounting for the other 80% of variability in predicting these behaviours. It 
is not known why specific diet and blood sugar subscales showed significant 
interaction effects or why the exercise, foot care and general diet subscales did not. 
However, a potential cause could be that the constructs of health value, LOC and SE 
may not be relating to the perceptions of the participants in this study in regards to 
the self-care behaviours of exercise, foot care and general diet.It  could  also  be  
suggested that this finding reflects the priorities of health care professionals in the 
outpatient clinic. For example for patients with comorbidities, health care 
professionals may view improving diet as more realistic than increasing exercise.  
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Additionally, an emphasis on HbA1c testing and results is placed at every 
consultation while feet checks are only reviewed once a year if there are no known 
foot complications. Therefore it seems intuitive that specific diet and blood sugar 
might feature more importantly than general diet, foot care and exercise in this study.  
This finding highlights the complexities of predicting behaviour and how further 
replication of research is needed to ascertain other predictors of Type 2 diabetes 
patients self-management behaviours (see section 8.9 for recommended future 
research). 
Principal research question: Is the potential for people with Type 2 diabetes 
engaging in a set of health sustaining behaviours a predictor of health value and 
perceived control (HLOC and SE) as postulated by MSLT?  
The significance of the interaction effects of the Specific Diet and Blood Sugar 
subscales were investigated further. Two three-way ANOVA’s were conducted on 
both datasets to observe the differences in mean among even groups of participants 
who scored high on the predictor variables and groups who scored low. In order to 
support MSLT further it was important that these means demonstrate that the highest 
means were for participants who scored high on all three constructs(Wallston, 2013).  
Participants  with  Low  HV  and  Low  IHLC  were  highest  in  blood  glucose  testing  
regardless of their level of SE while those with High HV and Low IHLC were lowest 
in blood glucose testing regardless of their level of SE. With specific diet, the High-
High-High group had the highest mean score, which is what MSLT predicts. 
However, this is just minimally better than the mean score for the Low-Low-Low 
group.There was no statistical significance between groups as determined by the 
three-way ANOVA for blood sugar or specific diet. 
A factor that may account for this lack of support for MSLT within the ANOVA 
results for blood sugar testing is the sample that was used to test this theory. All 
participants in both phases were on insulin and from the qualitative data it is clear 
that being commenced on insulin lowered participants’ IHLC beliefs. Furthermore, 
participants’ average age was 63 (SD 6.3)and had been diagnosed with Type 2 
diabetes on average 13.5 years (similar demographics were reported for D2). 
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Participants’ HbA1c levels were out with the suboptimal range as recommended by 
Diabetes UK (2013a) with levels averaging at 65.4 mmol (SD 18).Age was 
positively correlated with blood sugar testing (r = .27, p<.05, D1and r = .29, p<.01 
D2). Taking these demographics and correlations into account it is being suggested 
that low IHLC, low HV and low or high SE resulted in more frequent blood glucose 
testing due to the medication regime, length of diagnosis and age of these 
participants. The qualitative data supports this conclusion in that being started on 
insulin was seen to change HV, lower IHLC and effect self-efficacy ability. 
Other factors might have contributed to frequent blood glucose testing. For example 
people with low self-efficacy and low IHLC may engage in regular testing of blood 
glucose at the request of doctors but may not understand why they are doing so or 
they understand the reasoning behind the task but do not understand how to adjust 
their insulin dosages independently. This point is reflected in the qualitative findings 
of this research. In contrast those who test less frequently may have higher levels of 
self-efficacy and IHLC and test their blood glucose in a more purposeful way for 
personal reasons such as before exercise or when driving. This finding has 
implications for patient education and is further elaborated upon in section 8.7.  
Additionally, although the qualitative and quantitative data have determined that 
health was highly valued by most participants perhaps the reason that participants 
with high HV, low IHLC and low or high SE were lowest in blood glucose testing is 
the way in which health value was measured. The HV scale used measured current 
health value but perhaps if it had been measured with just instrumental health value 
items it may allow a clearer measurement of HV for this sample. This is being 
proposed because of the qualitative results on instrumental health value that 
suggested that HV of participants with Type 2 diabetes is valued instrumentally. The 
proposal raises the question; if HV is measured or explored instrumentally in a 
sample  such  as  this  would  it  allow  a  clearer  understanding  as  to  the  value  of  self-
management activities being carried out? This will be discussed more 
comprehensively in section 8.5, which critically explores MSLT and instrumental 
health value. 
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8.5 MSLT and instrumental health value 
Wallston (2005b:629)stated that 
‘not only does the value of health theoretically moderate the relationship 
between HLOC and health behaviour but so does self-efficacy as well as 
perceived instrumentality, an outcome expectancy that doing the behaviour 
will lead to good health’. 
The concept of perceived instrumentalityand task value have been defined as an 
individual’s understanding of the incentive for a present behaviour (Husman et al., 
2004). If these two concepts are combined with health it gives instrumental health 
value. The qualitative data has implied that diabetes self-management behaviours are 
carried out as task values in that the aim is to maintain health in order ‘to be able to 
do things’. This finding is consistent with Macrodimitris and Endler (2001) study 
where the relationships of both coping strategies and perceived control to 
psychological and physiological adjustment were investigated in 115 adults with 
Type 2 diabetes living in Canada. Macrodimitris and Endler used a variety of 
psychometric measures to examine these relationships such as the Coping with 
Health Injuries and Problems Scale, the Event Perception Measure and anxiety and 
depression scales. Macrodimitris and Endler (2001)found that problem-focused 
(instrumental)  coping  was  related  to  better  psychological  adjustment  and  overall  
outcomes. However, the cross-sectional nature of their study may be perceived as a 
limitation. An investigation of the processes of coping over time in Type 2 diabetes 
patients would have been beneficial. Furthermore,Marrow et al. (2008) explored the 
life and health goals of 24 older adults with Type 2 diabetes from outpatient clinics 
in Houston, Texas. The study was qualitative and used in-depth interviews to explore 
life  and  health  goals.  Marrow et  al.  (2008)  results  concur  with  this  research  in  that  
their  participants  expressed  their  goals  of  diabetes  self-management  in  terms  of  
functional activities. AlthoughMarrow et al. (2008) study allowed for an in depth 
exploration  of  preferences  and  expectations  of  diabetes  treatments  the  findings  are  
limited, as they cannot provide quantitative estimates for the patterns and 
associations they observed.  
A series of studies carried out bySimons et al. (2000) investigated the effect of 
perceived instrumentality on goal orientation of 81 adults and 229 high school 
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students from Leuven, Belgium. In studies one and two participants were asked to 
complete a questionnaire aiming at assessing participants’ orientation toward task 
and performance goals. Study three aimed to differentiate between goal orientations 
using  a  scale  specifically  devised  to  test  these  differences.  Results  showed  that  
emphasizing the future consequence of achieving personal goalsenhanced task 
orientation and decreased performance orientation both in daily life and in study 
contexts. Future time perspective theories stress the importance of personal future for 
motivation and learning(Husman and Lens, 1999). Simons et al. (2000) results 
indicate that being future orientated or perceiving the instrumentality of a present 
task for future goals is said to enhance future motivation performance and 
persistence.  
8.5.1 Instrumental Health Value 
The qualitative results of this study have demonstrated how participants perceive the 
outcome of their future as a consequence of their self-management behaviours. This 
perception came fromtopics of how quality of life may be influenced by Type 2 
diabetes in the future. The possible negative effects from resultant co-morbidities due 
to poor diabetes self-management resulted in a re-evaluation of health value and a 
more instrumentally orientated view of this value. 
8.5.2 Potential Value and Belief Assessment and Planning Framework for 
People with Type 2 Diabetes using MSLT as the Theoretical Basis of 
Development 
In section 8.4 it was proposed that measuring or exploring instrumental health value 
of this group of patients may provide a clearer picture of how health value influences 
self-management outcome behaviours, this point will be addressed in this section.A 
potential framework for assessment and planning of patient centred care of people 
who have Type 2 diabetes is presented which incorporates the theoretical basis of 
MSLT and instrumental health value as a moderator to behaviour management. 
Thisframework takes into consideration the assertion of Simons et al. (2000) as 
stated above, the suggestion of Wallston (2005b) on perceived instrumentality as a 
moderator to health behaviour and also the overall results of this study.The 
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framework is presented diagrammatically followed by an explanation of how it could 
potentially be applied in the clinical setting. It should be noted that this framework 
has not been tested in this study or supported in practice but is presented here to 
demonstrate how the research results have supported MSLT and contributed to 
thedevelopment of this theory as a potential assessment and planning tool for patients 
with Type 2 diabetes. This potential framework will be suggested as a future research 
recommendation in section 8.9.Figure 8.1 illustrates how this framework could be a 
follow on research proposal from this thesis. 
8.5.3 Findings that contributed to framework development 
The potential framework incorporates MSLT as the theoretical basis for assessment 
and planning of patient treatment goals. The potential framework begins with 
considering a person’s belief and value system. It advocates ascertaining whether a 
person’s beliefs surrounding self-management are internal and/or external and 
whether they are competent in engaging in diabetes related activities. The results of 
this study highlight the variations in LOC belief and SE of people with Type 2 
diabetes  and  could  provide  a  possible  guide  to  assessment  and  evaluation  of  these  
beliefs towards planning of self-management behaviours. For example patients who 
described high internality and had ELOC beliefs had sufficient competence in 
carrying out diabetes self-management behaviours. However, those with low IHLC 
and higher ELOC beliefs had a greater reliance on external factors and thus poorer 
levels of self-efficacy. The framework supports MSLT in that the relationships 
between IHLC and SE should only hold for individuals who value their health.  
On the basis of the findings from the qualitative and quantitative phase of this study 
it  was  evident  that  participants  valued  their  health  as  a  terminal  value  and  
instrumental value. However, the qualitative data indicated that participants’ 
subjective view of health value was mainly instrumental and was described by most 
as a moderator of behaviour of diabetes self-management behaviours. As a result of 
this the concept of perceived instrumentality is included in the model as it enables 
assessment of an individual’s understanding of the incentive of a behaviour.  
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When the constructs of MSLT and perceived instrumentality have been considered 
the potential framework guides the professional towards using this information to 
consider the person’s beliefs and values and how this may impact on self-
management behaviours. The framework then advocates planning appropriate self-
management behaviours for the individual patient and re-evaluating these behaviours 
if there is a change to a medication regime or to the person’s health status. This stage 
of the framework is supported by the qualitative results of this study whereby 
changes in health status and medication indicated a change in beliefs and values that 
can have a negative or positive impact on self-management behaviours depending on 
the person. In this situation re-evaluation directs the professional back to the 
beginning  of  the  model  again  to  reassess  the  patient’s  needs  by  exploring  their  









8.6 Significance of the study 
When considering the impact of the findings of this study the significance is 
threefold. First, the research hasadded to existing knowledge and understanding of 
the behavioural constructs health value, locus of control and self-efficacy. Second, 
the methodology of this study enabled an enhanced investigation of research aims 
through exploring MSLT subjectively and objectively.Third, the research has added 
to the theoretical underpinning of MSLT and possibly enhanced MSLT by providing 
evidence that supports the assumption that instrumental health value is a moderator 
of health behaviour. 
The  first  contribution  of  this  study  is  that  it  adds  to  existing  literature  on  three  
important health behaviour constructs. Mixed reviews on each construct as 
moderators to health behaviour have appeared in the literature throughout the last 
twenty to thirty years to name but a few(Hampson et al., 1990, Hampson et al., 1995, 
Waller and Bates, 1992, Bennett et al., 1997, Bennett et al., 1998, Laffrey and 
Isenberg, 2003, Steptoe and Wardle, 2001, Wu et al., 2004). The results of this study 
provide evidence which supports the tenet that health locus of control beliefs 
moderate but do not mediate health behaviour (Wallston, 1992, Norman et al., 1997, 
Wallston, 2005b, Luszczynska and Schwarzer, 2005, O'Hea et al., 2005, O'Hea et al., 
2009). The finding that health was highly valued by most in both the qualitative and 
quantitative phase was consistent with previous literature on the construct (Lau et al., 
1986, Smith and Wallston, 1992). Individual differences of health value when 
considered with value systems and value priorities point to the variability of the 
construct this offers a unique contribution to knowledge on the construct. The 
concept of viewing health as functional is synonymous with the literature (McKague 
and Verhoef, 2003, Hughner and Kleine, 2004) and was described as a value held by 
most participants. This was understood to be instrumental health value and provides 
evidence that perceived instrumentality may act as a moderator to health value and 
thus influence health behaviour. Self-efficacy was considered to be the strongest 
individual predictor of health behaviour among the HMR results and participants’ 
descriptions also contributed to this conclusion, which is consistent with previous 
research (Frank et al., 2007, O'Leary et al., 2008, O'Hea et al., 2009). 
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Althoughthe mixed methods methodology of this study presented numerous 
challenges it provided data that was holistic in terms of the experiences of patients 
with  Type  2  diabetes  and  testing  MSLT.  The  discussion  section  of  this  thesis  
highlights the contribution of results from both phases and demonstrates how 
integration of these findings enabled transferability, generalizability and 
identification of the practical significance of the results. Findings from the qualitative 
phase were transferred to the quantitative phase to add rigor and also to attempt to 
answer resultant research questions. Data analysis of both phases and integration of 
results provided results that were either supported or opposed. For example a 
supporting result was that participants can simultaneously hold internal and external 
LOC beliefs. An opposing result was that subjectively participants’ described their 
health value orientation as instrumental but objectively it was measured to be more 
terminally orientated. This comparative analysis of results of both phases enabled 
identification  of  the  practical  significance  of  MSLT and how it  can  be  generalized  
for  use  to  explore  beliefs  and  values  of  people  with  Type  2  diabetes.  Furthermore,  
this mixed methods study makes a methodological contribution to mixed methods 
research as it provides an example of the opportunities of this method. 
Lastly, this study makes a unique contribution to the testing of MSLT. It is thought 
that no one has yet formally tested MSLT. The HMR results of this study provide 
support for the significance of the three-way interaction of the constructs of MSLT. 
The way in which these constructs were measured is also thought to be unique. As 
far  as  this  researcher  is  aware  no  one  to  her  knowledge  has  tested  MSLT  using  a  
health value measure, Form C of the MHLC scale, a measure of SE and a measure of 
diabetes outcome behaviours. Additionally, the qualitative andquantitative phase’s 
attempt to observe for the instrumental/terminal dichotomy and changes in health 
value could be viewed as a distinctive method. The qualitative phase’s approach to 
exploring MSLT theoretical underpinning could also be considered as a distinctive 
research approach. 
The implications of this knowledge for practice are discussed in the following 
section. 
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8.7 Implications for practice 
Nurses and health professionals in diverse practice settings assist people to cope with 
the change that illness causes to people’s lives (Kralik et al., 2006). This assistance 
specific to diabetes patients is provided through education by imparting the 
knowledge and skills required to self-manage the condition (Walsh et al., 2011, 
Trend-UK, 2011). SIGN guidelines (2010:9) recommend that 
‘helping patients to modify certain behaviours should take account of other 
factors such as the patient’s willingness to change, their perception of their 
diabetes, and factors which may be indirectly related to their diabetes, such as 
depression and adverse effects on quality of life’.  
Although this is a sound recommendation there is no evidence to suggest that this 
takes place within Lothian Scotland’s health care setting (NHS Lothian, 2010). 
Currently patients’ illness perceptions and willingness to adopt ‘good’ health 
behaviour is not assessed or included in patients’ individualised management plans 
(NHS Lothian, 2010). This research provides evidence to suggest that MSLT could 
benefitcurrent  health  assessment  practice  of  patients  with  Type  2  diabetes.  This  is  
being suggested becausesubjective and objective assessment of beliefs and values 
using MSLT provided information on individual capability in self-managing 
diabetes. By adopting MSLT as a theoretical framework to clinically assess beliefs 
and values information acquired could be used to understand patients ‘willingness’ 
and ability to partake in effective self-management behaviours.  
This implication provides impetus for the development of nurse education when 
assessing the psychological needs of patients with Type 2 diabetes. Diabetes Action 
Plan (2010)emphasizes that one way of improving the spectrum of psychological 
support for people living with diabetes in Scotland is to enhance the skills of clinical 
staff. Furthermore, Walsh et al. (2011) makes an important point that the person with 
diabetes should be confident that healthcare staff are at the required level of expertise 
of their profession to provide quality care. Currently there are interventions 
underway to support this such as PIDPAD as discussed previously in section 5.2.2. 
The qualitative and quantitative results on blood glucose monitoring recognise that 
low health value, low IHLC and low or high SE can result in more frequent blood 
glucose testing. This may be because of numerous factors depending on the person as 
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discussed in section 8.4. This finding has implications for clinical practice and 
patient education, as it highlights that frequent blood glucose testing does not 
necessarily suggest that the patient will have good glycaemic control.  
8.8 Limitations 
While this study contributed to the theoretical underpinning of MSLT and existing 
knowledge of beliefs and values of patients with Type 2 diabetes it is not without 
limitations. The sample for this study consists of patients who attend the diabetes 
clinic for diabetes treatment. This is not a representative sample of all patients with 
Type  2  diabetes,  especially  those  who are  non-adherent,  which  could  be  evidenced  
by not seeking treatment for diabetes. Additionally this sample does not represent 
those who do not wish to go on insulin despite there being a clinical need for it. A 
typical population sufficed for the purpose of this study. This limitation should be 
addressed in future research, as it is important to ascertain how health behaviour can 
be predicted in a non-adherent population or those who do not wish to follow clinical 
recommendations.However, it is unlikely that individuals unwilling to engage with 
care would be willing to participate in a detailed study such as this one and any 
future research may therefore be subject to similar sampling bias. 
The sample consisted only of patients who have Type 2 diabetes and are on insulin. 
It was evident from the qualitative data that being commenced on insulin lowered 
perceived control and changed health value of these patients. Furthermore, the 
quantitative data supports this assumption through the ANOVA results on blood 
sugar testing. These results illustrate how the sample influenced the results of testing 
MSLT. Perhaps MSLT would benefit from being tested with a ‘healthy sample’ as 
this may provide data that is not influenced by the experiences of illness. 
The hierarchical multiple regression analysis demonstrated minimal support for 
MSLT. It is important to acknowledge here the limitations of this result in relation to 
the complex area of predicting health behaviour. Although, the Specific Diet and 
Blood Sugar subscales were found to be significant the variability expressed in 
predicting these two Type 2 diabetes self-care behaviours accounted for only 20% of 
the variance of the outcome behaviour. Other factors of predicting health behaviour 
contributed to the additional 80% of variability. Other factors could be defined as 
numerous entities in a person’s life such as social influences, economic and financial 
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factors and even individual life events. It is evident from the literature reviewed in 
Chapter 2 and from the results of this research that there may never be one 
behavioural construct that explains every behaviour a person exudes. However, 
finding a construct or a combination of constructs that explains a reasonable 
proportion of behavioural factors at play with a person may contribute to predicting 
some aspects of their health behaviour. Therefore, a limitation resulting from this 
research is that the constructs of MSLT could be suitable to predicting health 
behaviour in some patients but not others.  
Furthermore, patients with comorbidities or multi-morbidities may not have 
responded based on their experience of Type 2 diabetes. Due to Type 2 diabetes 
being a disease that contributes to comorbidities it would have been incorrect to 
exclude  patients’  with  comorbidities,  as  it  would  not  be  a  true  depiction  of  this  
population. Duringdata collection participants were directed to respond based on 
their experience with Type 2 diabetes to try and overcome this limitation as much as 
possible. It is also possible that these comorbidities may have contributed to the 
additional 80% variability in outcome behaviour discussed above. 
However, the inclusion of patients with comorbidities and specifically dominant 
comorbid conditions such as alcoholism and chronic renal failure has highlighted a 
possible limitation of using MSLT in practice. Findings from participants with 
dominant comorbid conditions in the qualitative phase demonstrate the 
overwhelming influence a condition such as this can have on health value, IHLC and 
SE. The significance of managing diabetes is thus reduced in comparison to the 
dominant condition. It is evident from the results of the qualitative phase that MSLT 
may have applicability to diabetes but it may not be relevant to patients who have a 
dominant comorbid condition such as addiction or chronic renal failure or even 
cancer. 
Finally, the health value items adapted to Lau et al. (1986) health value measure in 
the interim phase of this research were removed from the data due to item 5 being 
problematic.Although, the items were examined for face validity the time constraint 
for completing this research resulted in the decision not to pilot the adapted health 
value measure prior to administering it. As a result ofnot pilotingthe adapted health 
value measure prior to its administration some disadvantages were introduced to the 
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research. If the measure had been piloted it would have provided the researcher with 
an advanced warning that the new items added to the measure were problematic. 
Additionally, if the measure had been piloted practical problems such as the 
administration procedure used to investigate changes in health value could have been 
pre-determined. The way in which the Adapted Health Value measure was 
administered may have introduced recall bias. A pilot study would have foreseen this 
and could have provided an early solution.These disadvantages limited the variability 
of examining the instrumental/terminal dichotomy of health value in the quantitative 
phase of this research. Carrying out a pilot study prior to a main study provides 
accountability to the research and can ensure the best possibility of research results 
(Crosswaite and Curtice, 1994). However, conducting a pilot study does not 
guarantee success in the main study, but it does increase the likelihood of success 
(van Teijlingen and Hundley, 2002). Therefore, researchers should be encouraged to 
conduct pilot studies, report issues arising from the pilot study and report in detail 
the actual improvements made to the study design and the research process as a 
result of conducting the pilot (van Teijlingen and Hundley, 2002). 
While this study was not without limitations these limitations did not negate the 
value of this study. Rather these limitations provided an impetus for future research 
in the area of beliefs and values. Further directions for future research in these areas 
are discussed in section 8.9. 
8.9 Recommended future research 
Several possible future directions for research became apparent during this study. As 
mentioned in the limitations section of this study further replication of testing of the 
interaction  of  the  constructs  of  MSLT  is  necessitated.  Perhaps  with  a  ‘healthy’  
sampleas this could avoid the influence of illness on beliefs and values and provide a 
clearer picture of the interaction of the constructs of MSLT.The individual constructs 
themselves would benefit from further investigation.There is a significant gap in the 
literature on health value as an individual construct and its impact on health 
behaviour. This research has contributed to filling this gap and raised new questions 
about the construct of health value and its variability. Although these questions were 
initially tested in the quantitative phase of the study further examination of change in 
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health value as a result of change in health status and change to medication regime is 
required.  
Other research methods that allow for testing of changes in health value with people 
with diabetes need to be considered. Methods that reduce the possibility of recall and 
social desirability bias would be preferential. Perhaps a suitable research proposal 
considering this type of research would include a longitudinal study whereby health 
value is measured with participants who are pre-diabetes and consider themselves 
healthy (pre-diabetes is the state in which some but not all of the criteria for 
diagnosing diabetes is met) and then measured again some time later to ascertain 
whether diabetes was diagnosed and if so measure health value again. This method 
of investigating health value may enable identification of changes in health value 
overtime.  
This research raised questions about instrumental health value/perceived 
instrumentality as a moderator to health behaviour. Viewing health instrumentally 
when considering patients with a chronic illness such as diabetes may support an 
individual’s conception of health as a function in everyday living. Supporting this 
ideal may be beneficial to interventions that advocate adoption of certain self-
management behaviours. Duncan (2010) argues that viewing health care as 
instrumental may support the purpose and methods of health care delivery. Future 
research addressing this concept may benefit from a new health value measure with 
variability in items to examine the instrumental/terminal dichotomy.  
The potential value and belief assessment and planning framework requires testing 
and identification of its applicability to practice. Research of this nature could 
demonstrate how to translate complex research of interacting variables into practice. 
Guck et al. (2008) study of using patient reports of psychosocial variables to cluster 
diabetic patients provides an example of research findings applied to clinical 
practice. Guck et al. (2008) found that identification of unique psychosocial patient 
profiles using the MDQ may help busy care providers match patients with practical, 
beneficial and cost effective interventions that improve patients’ ability to meet the 
demands of diabetes. It is hoped that future research of MSLT may enable this form 
of holistic care for patients with Type 2 diabetes. 
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Further research investigating the impact of hereditary factors and the classification 
of  diabetes  type  is  required  to  understand  the  implications  these  concepts  have  on  
self-management of diabetes. The influence of comorbid and multi-morbidities on 
self-management of Type 2 diabetes requires further examination to determine the 
complex experience of management of multiple conditions and complications and 
devise suitable interventions to help people deal with such difficulties. 
Finally, the possibility that health care professionals perceptions of self-management 
of Type 2 diabetes influence patient perceptions and thus outcome behaviours 
requires further investigation. 
8.10 Summary 
The Scottish Diabetes Survey (SDS, 2011) estimate that the number of people with 
diabetes continues to increase by about 10,000 people each year, presenting greater 
organisational and resource pressures. In 2011 217,514 (88%) of all people 
registered with diabetes had Type 2 diabetes(SDS, 2011). This research has sought to 
test a psychological theory to demonstrate how beliefs and values impact on patients’ 
with Type 2 diabetes outcome behaviours. The findings have drawn attention to the 
ways in which patients’ with Type 2 diabetes value their health and perceive control 
over their condition and the influence this has on self-management. The findings 
provide a unique contribution to the testing of MSLT and demonstrate its relevance 
and possible benefits of use with patients’ who have Type 2 diabetes. 
The findings may be considered interestingby professionals working with patients’ 
who have Type 2 diabetes as it provides anunderstanding of how such patients’ 
process a change in health status, a change in medication regime, and overall the 
difficulties of managing diabetes. 
Finally, this research is significantfor researchers and health professionals interested 
in intervention planning for patients with Type 2 diabetes. As discussed in section 
8.7 there is currently no assessment procedure to assess patients ‘willingness’ to 
adopt certain self-management behaviours. MSLT requires further testing yet it may 
provide a means of assessment of psychosocial variables of people with Type 2 
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Appendix F: Tables of Quantitative Results for Dataset 2 and ANOVA 
tables for Dataset 1 & 2 General Diet, Exercise and Foot care 
Tables 10.2 to 10.10 include selected tables of results for Dataset 2. Tables 10.11 to 
10.16 display ANOVA results for General Diet, Exercise and Foot care subscales for 
Dataset 1 and Dataset 2. 
Table 10.2 Descriptive Statistics Health Value Items Dataset 2 
Health Value Items Mean SD N 
Item 1 4.36 1.671 105 
Item 2 3.86 1.579 104 
Item 3 4.29 1.53 105 
Item 4 4.64 1.414 104 
Item 5 5.12 0.812 99 
Item 6 3.51 1.718 104 
 
Table 10.3 Correlation Matrix Health Value Items Dataset 2 
Health Value Items Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 
Item 1   .09 .47** .25* .48** 
Item 2   .36** .08 .09 .08 
Item 3 .09 .36**  -.03 -.04 -.25** 
Item 4 .47** .08 -.03  .45** .34** 
Item 5 .25* .09 -.04 .45**  .23* 
Item 6 .48** .08 .25** .34** .23*   
*correlation is significant at the 0.05 level (2-tailed), ** correlation is significant at the 0.01 level (2-tailed)
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Table 10.4Demographic Data Dataset 2 
Demographic Data Mean SD % N   Mean SD % N 
Sex    107  Smoking Status     
Female   41 44  Smoker   13.1 14 
Male   59 63  Never Smoked   64.5 69 
      Ex Smoker   22.4 24 
Age 62 10.7         
      Diabetes years 13.84 6.7   
Age Groups      1-5   10.3 11 
30-45   11.2 12  6-10   24.3 26 
46-55   14 15  11-15   27.1 29 
56-65   36.4 39  16-20   18.7 20 
66-75   28 30  >20    21 
76-85   9.3 10       
86 and above   1 1  BMI Range 34.2 7.2   
      <18.5   0.9 1 
Ethnicity      18.5-24.9   6.5 7 
British   93.5 100  25.0-29.9   22.4 21 
Other   6.5 7  >30   70.1 75 
           
Marital Status      HbA1c Levels 66.3 18.3   
Single   11.2 12  <48 mmol/mol   6.5 7 
Married    60.7 65  48-59 mmol/mol   27.1 29 
Widowed   17.8 19  60-69 mmol/mol   30.8 33 
Divorced   10.3 11  70-80 mmol/mol   16.8 18 
      >81 mmol/mol   17.8 20 
Employment Status           
Employed   42.1 45  Blood Pressure     
Unemployed   8.4 9  ≥91/65   15.9 17 
Retired   49.5 53  ≥120/80   14 15 
      ≥130/85   19.6 21 
Comorbidity      ≥140/90   50.5 54 
Other Chronic Illness   80.4 86       
None   19.6 21       
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Table 10.5 Scale Scores Dataset 2 
Health Value Scales Mean SD % Yes % No N 
Health Value Part 1  17.4 3.8   107 
Health Value Part 2 17.1 3.7   107 
Health Value Part 1 Terminal Items 9.4 2.3   107 
Health Value Part 1 Instrumental Items 8 2.7   107 
Health Value Part 2 Terminal Items 8.9 2.6   107 
Health Value Part 2 Instrumental Items 8 2.5   107 
      
PDSMS 29.3 5.3   107 
      
MHLC Subscales     107 
Internal 27.8 5.7   107 
Chance 15.5 6.9   107 
Powerful Others  25.2 5.2   107 
Doctors  14.9 2.7   107 
Other People 10.4 3.9   107 
      
SDSCA Subscales     107 
General Diet 4.7 1.8   107 
Specific Diet 4 1.5   107 
Exercise 2.8 2.4   107 
Blood Sugar 5.4 2.3   107 
FootCare 3.4 2.4   107 
      
SDSCA Smoking Status      
% smoked a cigarette in last 7 days    88 14 107 
Cigarettes smoked per day 1.7 4.8    
      
      
HAD Range of Scores Anxiety %  Depression %    
 0-7 Normal 58.9 65.4   107 
8 - 10 Mild 20.6 18.7   107 
11 - 14 Moderate 15 12.1   107 
15 - 21 Severe 5.6 3.7     107 
 
 294
Table 10.6 HMR General Diet Dataset 2 
 
Predictors B SE β df R ²  ∆R2 
Block 1       
Sex -.203 .366 -.054    
Age -.011 .019 -.065    
BMI -.046 .025 -.179    
HbA1c -.022 .010 -.215*    
Years since diagnosis .029 .029 .104 101 .083  
       
Block 2       
Sex .043 .334 .012    
Age -.024 .018 -.138    
BMI -.018 .024 -.070    
HbA1c -.003 .010 -.028    
Years since diagnosis .044 .027 .160    
IHLC .006 .029 .018    
SE .181 .035 .515***    
HV .026 .044 .052 98 .284*** .201*** 
       
Block 3       
Sex .019 .347 .005    
Age -.024 .018 -.137    
BMI -018 .024 -.069    
HbA1c -.002 .010 -.024    
Years since diagnosis .043 .027 .157    
IHLC .006 .030 .019    
SE .182 .035 .516***    
HV .025 .047 .051    
IHLC x SE -.001 .005 -.009    
IHLC x HV .007 .007 .087    
HV x SE .000 .007 .002 95 .292 .008 
       
Block 4        
Sex .074 .345 .020    
Age -.026 .018 -.148    
BMI -.014 .024 -.053    
HbA1c -.001 .010 -.012    
Years since diagnosis .043 .027 .157    
IHLC -.003 .030 -.008    
SE .176 .035 .499***    
HV .038 .047 .075    
IHLC x SE .001 .005 .014    
IHLC x HV .012 .008 .142    
HV x SE .000 .007 .002    
HV x IHLC x SE  -.002  .001  -.164  94  .313  .021 
P < .05, ** P < .01, *** P < .001. 
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Table 10.7 HMR Specific Diet Dataset 2 
Predictors B SE β df R ²  ∆R2 
Block 1       
Sex .064 .315 .020    
Age .006 .017 .042    
BMI -.005 .022 -.021    
HbA1c -.012 .009 -.147    
Years since diagnosis -.010 .025 -.045 101 .028  
       
Block 2       
Sex .129 .321 .041    
Age .004 .017 .024    
BMI .006 .023 .030    
HbA1c -.007 .009 -.081    
Years since diagnosis -.005 .026 -.022    
IHLC -.011 .028 -.040    
SE .052 .033 .175    
HV .028 .042 .066 98 .056 .028 
       
Block 3       
Sex -.054 .325 -.017    
Age .004 .017 .025    
BMI .004 .023 .019    
HbA1c -.007 .009 -.086    
Years since diagnosis -.014 .025 -.061    
IHLC -.017 .028 -.064    
SE .043 .033 .145    
HV .010 .044 .023    
IHLC x SE .009 .005 .193    
IHLC x HV .009 .007 .134    
HV x SE .009 .007 .138 95 .114 .058 
       
Block 4        
Sex .022 .318 .007    
Age .001 .016 .008    
BMI .010 .022 .046    
HbA1c -.006 .009 -.066    
Years since diagnosis -.014 .025 -.061    
IHLC -.030 .027 -.109    
SE .035 .032 .118    
HV .026 .043 .062    
IHLC x SE .010 .005 .231*    
IHLC x HV .015 .007 .224*    
HV x SE .009 .007 .138    
HV x IHLC x SE  -.003  .001  -.267*  94  .169*  .055* 
P < .05, ** P < .01, *** P < .001. 
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Table 10.8 HMR Exercise Dataset 2 
Predictors B SE β df R ²  ∆R2 
Block 1       
Sex -.566 .475 -.115    
Age .030 .025 .132    
BMI -.056 .033 -.168    
HbA1c .010 .013 .078    
Years since diagnosis .001 .038 .004 101 .079  
       
Block 2       
Sex -.700 .477 -.143    
Age .024 .025 .108    
BMI -.076 .034 -.228*    
HbA1c .007 .014 .057    
Years since diagnosis .014 .038 .039    
IHLC .094 .041 .223*    
SE -.026 .050 -.057    
HV .040 .063 .061 98 .132 .053 
       
Block 3       
Sex -.709 .493 -.145    
Age .025 .025 .112    
BMI -.075 .035 -.223*    
HbA1c .008 .014 .063    
Years since diagnosis .014 .039 .040    
IHLC .096 .042 .228*    
SE -.023 .050 -.051    
HV .047 .067 .073    
IHLC x SE -.003 .007 -.042    
IHLC x HV .014 .091 .129    
HV x SE -.004 .011 -.041 95 .151 .019 
       
Block 4        
Sex -.662 .495 -.135    
Age .024 .025 .105    
BMI -.071 .035 -.212    
HbA1c .009 .014 .071    
Years since diagnosis .015 .039 .040    
IHLC .089 .043 .210    
SE -.028 .051 -.062    
HV .057 .067 .088    
IHLC x SE -.002 .007 -.027    
IHLC x HV .018  .011 .165    
HV x SE -.004 .011 -.040    
HV x IHLC x SE  -.002 .002  -.107  94  .160  .009 
P < .05, ** P < .01, *** P < .001. 
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Table 10.9 HMR Blood Sugar Dataset 2 
Predictors B SE β df R ²  ∆R2 
Block 1       
Sex .320 .454 .066    
Age .056 .024 .253*    
BMI .047 .032 .141    
HbA1c -.011 .013 -.081    
Years since diagnosis .050 .036 .142 101 .130*  
       
Block 2       
Sex .510 .456 .106    
Age .054 .024 .245*    
BMI .058 .033 .175    
HbA1c -.005 .013 -.040    
Years since diagnosis .039 .036 .110    
IHLC -.030 .040 -.072    
SE .061 .047 .135    
HV -.114 .060 -.178 98 .180 .050 
       
Block 3       
Sex .561 .470 .116    
Age .055 .024 .248*    
BMI .060 .033 .181    
HbA1c -.004 .013 -.031    
Years since diagnosis .042 .037 .119    
IHLC -.025 .040 -.061    
SE .067 .048 .148    
HV -.102 .063 -.160    
IHLC x SE -.006 .007 -.092    
IHLC x HV .012 .010 .111    
HV x SE -.066 .010 -.061 95 .202 .022 
       
Block 4        
Sex .657 .463 .136    
Age .052 .024 .234*    
BMI .067 .033 .203*    
HbA1c -.002 .013 -.014    
Years since diagnosis .042 .036 .119    
IHLC -.041 .040 -.098    
SE .057 .047 .126    
HV -.081 .063 -.127    
IHLC x SE -.004 .007 -.061    
IHLC x HV .020 .010 .186    
HV x SE -.006 .010 -.061    
HV x IHLC x SE  -.004  .002  -.222*  94  .240*  .038* 
P < .05, ** P < .01, *** P < .001. 
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Table 10.10 HMR Foot Care Dataset 2 
Predictors B SE β df R ²  ∆R2 
Block 1       
Sex -.544 .469 -.110    
Age .035 .025 .156    
BMI .042 .033 .126    
HbA1c .021 .013 .159    
Years since diagnosis .071 .037 .197 101 .119*  
       
Block 2       
Sex -.471 .478 -.095    
Age .035 .025 .153    
BMI .060 .035 .178    
HbA1c .028 .014 .208    
Years since diagnosis .076 .038 .212*    
IHLC -.037 .042 -.088    
SE .055 .050 .120    
HV .052 .063 .080 98 .142 .023 
       
Block 3       
Sex -.540 .491 -.109    
Age .031 .025 .136    
BMI .056 .035 .165    
HbA1c .027 .014 .204    
Years since diagnosis .070 .039 .195    
IHLC -.039 .042 -.092    
SE .051 .050 .112    
HV .020 .066 .031    
IHLC x SE .005 .007 .067    
IHLC x HV -.009 .010 -.086    
HV x SE .017 .010 .162 95 .170 .028 
       
Block 4        
Sex -.536 .496 -.109    
Age .031 .025 .135    
BMI .056 .035 .166    
HbA1c .027 .014 .205    
Years since diagnosis .070 .039 .195    
IHLC -.040 .043 -.094    
SE .051 .051 .111    
HV .021 .067 .032    
IHLC x SE .005 .007 .068    
IHLC x HV -.009 .011 -.083    
HV x SE .017 .011 .162    
HV x IHLC x SE  .000  .002  -.008  94  .170  .000 
P< .05, ** P < .01, *** P < .001. 
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Table 10.11 ANOVA General diet descriptive statistics 
 
ANOVA   
 
Dataset 1 N=78 
 
Dataset 2 N=107 
General 













Low HV Low IHLC Low SE 4.73 2.037 13 4.81 1.964 13 
  High SE 4.06 2.382 8 4.77 2.170 15 
  Total 4.48 2.142 21 4.79 2.039 28 
 
High 









  High SE 5.39 1.387 9 4.64 1.598 11 
  Total 5.5 1.339 18 4.92 1.397 25 
 Total Low SE 5.09 1.810 22 4.98 1.602 27 
  High SE 4.76 1.977 17 4.71 1.914 26 
  Total 4.95 1.867 39 4.85 1.750 53 
High 









  High SE 4.72 1.603 9 4.15 2.349 13 
  Total 4.75 1.574 18 4.56 2.033 25 
 
High 









  High SE 4.65 1.796 13 4.33 1.543 15 
  Total 5.07 1.615 21 4.57 1.972 29 
 Total Low SE 5.24 1.437 17 4.9 2.025 26 
  High SE 4.68 1.680 22 4.25 1.922 28 
  Total 4.92 1.583 39 4.56 1.981 54 
Total Low IHLC Low SE 4.75 1.844 22 4.90 1.768 25 
  High SE 4.41 1.970 17 4.48 2.234 28 
  Total 4.60 1.882 39 4.68 2.019 53 
 
High 













  High SE 4.95 1.647 22 4.46 1.542 26 
  Total 5.27 1.491 39 4.73 1.723 54 
 Total Low SE 5.15 1.639 39 4.94 1.805 53 
  High SE 4.72 1.791 39 4.47 1.914 54 
  Total 4.94 1.720 78 4.71 1.867 107 
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Table 10.12 ANOVA General diet tests of between subjects-effects 
General Diet Dataset 1 N=78 Dataset 2 N=107 









Corrected model 19.572 7 2.796 .940 .481 10.185 7 1.455 .401 .900 
Intercept 1857.690 1 1857.690 624.861 .000 2347.327 1 2347.327 646.788 .000 
HV levels .014 1 .014 .005 .945 1.807 1 1.807 .498 .482 
IHLC levels 11.406 1 11.406 3.837 .054 .070 1 .070 .019 .890 



































































HV levels * IHLC 





















Error 208.108 70 2.973   359.292 99 3.629   
Total 2128.000 78    2738.750 107    
Corrected total 227.679 77    369.477 106    
 R Squared = .086 (Adjusted R Squared = -.005)     * P< .05 R Squared =  (Adjusted R Squared = )     * P< .05 
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Table 10.13 ANOVA Exercise descriptive statistics 
 
ANOVA   
 
Dataset 1 N=78 
 
Dataset 2 N=107 













Low HV Low IHLC Low SE 2.65 2.436 13 3.08 2.448 13 
  High SE 3.06 2.744 8 2.27 2.219 15 
  Total 2.81 2.497 21 2.64 2.321 28 
 
High 







  High SE 2.94 2.766 9 2.77 2.621 11 
  Total 3.33 2.401 18 3.1 2.537 25 
 Total Low SE 3.09 2.302 22 3.22 2.451 27 
  High SE 3 2.669 17 2.48 2.360 26 
  Total 3.05 2.435 39 2.86 2.413 53 
High 







  High SE 3.33 2.537 9 4.12 2.670 13 
  Total 2.69 2.315 18 3.34 2.749 25 
 
High 







  High SE 2.35 2.349 13 1.97 2.202 15 
  Total 2.95 2.524 21 2.43 2.133 29 
 Total Low SE 2.94 2.449 17 2.73 2.401 26 
  High SE 2.75 2.419 22 2.96 2.546 28 
  Total 2.83 2.401 39 2.85 2.456 54 
Total Low IHLC Low SE 2.41 2.239 22 2.80 2.529 25 
  High SE 3.21 2.556 17 3.12 2.570 28 
  Total 2.76 2.384 39 2.97 2.531 53 
 
High 













  High SE 2.59 2.482 22 2.31 2.281 26 
  Total 3.13 2.443 39 2.74 2.331 54 
 Total Low SE 3.03 2.337 39 2.98 2.461 53 
  High SE 2.86 2.500 39 2.73 2.447 54 
  Total 2.94 2.405 78 2.86 2.423 107 
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Table 10.14 ANOVA Exercise tests of between subjects-effects 
Exercise Dataset 1 N=78 Dataset 2 N=107 









Corrected model 27.668 7 3.953 .662 .703 43.513 7 6.216 1.063 .393 
Intercept 682.160 1 682.160 114.286 .000 874.212 1 874.212 149.479 .000 
HV levels .595 1 .595 .100 .753 .002 1 .002 .000 .984 
IHLC levels 4.013 1 4.013 .672 .415 1.443 1 1.443 .247 .020 



































































HV levels * IHLC 





















Error 417.822 70 5.969   578.003 99 5.848   
Total 1120.750 78    1494.750 107    
Corrected total 445.490 77    622.505 106    
 R Squared = .062  (Adjusted R Squared = -.032 )    * P< .05 R Squared = .070  (Adjusted R Squared = -.004)          * P< .05 
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Table 10.15 ANOVA Foot descriptive statistics 
 
ANOVA   
 
Dataset 1 N=78 
 
Dataset 2 N=107 
Foot 













Low HV Low IHLC Low SE 4.08 2.272 13 3.65 2.419 13 
  High SE 3.13 2.735 8 1.83 2.152 15 
  Total 3.71 2.437 21 2.68 2.420 28 
 
High 







  High SE 3.5 2.449 9 4 2.049 11 
  Total 3.94 2.520 18 3.32 2.106 25 
 Total Low SE 4.2 2.379 22 3.2 2.241 27 
  High SE 3.32 2.512 17 2.75 2.338 26 
  Total 3.82 2.445 39 2.98 2.279 53 
High 







  High SE 4.17 2.077 9 4.58 2.581 13 
  Total 3.78 2.328 18 4.5 2.300 25 
 
High 







  High SE 2.08 2.308 13 4.1 2.436 15 
  Total 2.48 2.272 21 3.5 2.646 29 
 Total Low SE 3.26 2.359 17 3.58 2.564 26 
  High SE 2.93 2.407 22 4.32 2.469 28 
  Total 3.08 2.361 39 3.96 2.519 54 
Total Low IHLC Low SE 3.80 2.384 22 4.02 2.243 25 
  High SE 3.68 2.391 17 3.11 2.702 28 
  Total 3.74 2.356 39 3.54 2.515 53 
 
High 












  High SE 
2.66 2.417 22 4.06  
2.238 
26 
  Total 3.15 2.471 39 3.42 2.391 54 
 Total Low SE 3.79 2.386 39 3.39 2.389 53 
  High SE 3.10 2.428 39 3.56 2.512 54 
  Total 3.45 2.417 78 3.48 2.442 107 
 304
Table 10.16 ANOVA Foot care tests of between subjects-effects 
 Foot care Dataset 1 N=78 Dataset 2 N=107 









Corrected model 43.921 7 6.274 1.082 .384 88.155 7 12.594 2.292 .033 
Intercept 914.224 1 914.224 157.674 .000 1318.221 1 1318.221 239.881 .000 
HV levels 6.418 1 6.418 1.107 .296 22.385 1 22.385 4.073 .046* 
IHLC levels 3.275 1 3.275 .565 .455 .901 1 .901 .164 .686 



































































HV levels * IHLC 




































Total 1377.500 78    1925.500 107    
Corrected total 449.795 77    632.192 106    




Appendix G: Significant Subscale Interaction Plots from Three-way 
ANOVAs 
Figure 10.1 Blood Sugar Interaction Plots Dataset 1 
 


















Figure 10.4 Specific Diet Interaction Plots Dataset 2 
 
 
 
 
 
 
 
 
